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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Progress in Cardiovascular Surgery in Canada

Eleven of the papers appearing in this
issue of the Journal were presented at
the annual meeting of the Canadian
Cardiovascular Society in October 1977.
This editorial comments on three of
the papers in an attempt to provide
general background information for
readers whose major interest lies out
side the field of cardiovascular surgery;
the three papers are concerned with
myocardial preservation, valve replace
ment and impending gangrene of the
leg.
Some might ask why so much is cur
rently being written about myocardial
protection. The answer is that the prin
ciples of intraoperative myocardial pro
tection now have a sound scientific
basis and considerable clinical applica
tion. We have known for years that it
is sometimes necessary and often de
sirable to interrupt the coronary blood
flow, thus jeopardizing the myocar
dium. A number of options are avail
able in this situation. The heart beat
can be allowed gradually to peter out
as the heart piles up an oxygen debt
and metabolizes available nutrients, or
it can be converted to fibrillation, or
the myocardium can be cooled to re
duce its metabolic requirements.
Many surgeons could not imagine a
more physiologic solution than to cannulate the coronary arteries directly
through the root of the aorta and to
supply the needed blood from a
separate pumping system. In fact ex
tremely good results have been ob
tained with this technique, but occa
sionally hearts were damaged by underor overperfusion, and sometimes the
coronary arteries were damaged so that
late stenosis developed due to intimal
hyperplasia at the point where the
arterial endothelium was injured by the
cannula. Furthermore, keeping the heart
perfused and beating had its disad

vantages; exposure, for example, was
more difficult, and the coronary venous
effluent not only inhibited exposure
but led to unnecessary damage to blood
cells, owing to their continuous aspira
tion from the operative field. An opera
tion done with coronary perfusion
would therefore take longer than one
with induction of ischemic arrest. Thus
the surgeon had to weigh a lesser insult
for a longer time against a greater
insult for a shorter time.
Evidence accumulated that although
the operative mortality might be ac
ceptable, myocardial damage sometimes
occurred. The hearts were not always
as healthy after the operation as they
had been before. The administration of
inotropic drugs was often required
after operation, balloon pumping was
occasionally necessary and sometimes
the heart size did not decrease despite
an apparently successful operation. We
learned that the inner one third of the
myocardium was most vulnerable, par
ticularly when a hypertrophied ventri
cle fibrillated during operation.
Our new knowledge has led to in
creasing acceptance of and growing
enthusiasm for cardioplegic hypother
mia to protect the heart. A cold (10°C)
solution containing a high concentra
tion of potassium is flushed into the
aortic root, first to stop the heart
promptly, thus avoiding the agonal
beats of elective arrest and second, to
achieve uniform myocardial cooling to
the temperature of 15° to 20 °C for
preservation. Hypothermia unquestion
ably protects the heart. Witness the
satisfactory results obtained when a
heart is removed from the donor in one
city, put in a cold bath and, with no
other preservation, flown as far as 600
miles for implantation into the reci
pient.
The advent of cardioplegic hypother
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mia for myocardial protection has re
duced the need for inotropic drugs in
the recovery room and has led to the
frequent administration of nitroprusside
to reduce afterload. In other words, in
stead of hypotension, we now have
hypertension. The balloon pump is
staying in the cupboard. The periopera
tive infarction rate is decreasing sharp
ly. The heart muscle truly seems to be
in as good shape after the operation as
it was before.
Not all these benefits are obvious in
the report by Haraphongse and his as
sociates from Edmonton (page 101),
primarily because their “control” group
of patients undergoing ischemic arrest
at normothermia did so well. This un
doubtedly reflects the expeditious man
agement of aortic valve replacement by
the Edmontonians so that the duration
of myocardial ischemia was minimized.
Still, support with inotropic agents was
required in many patients of the normothermic group and rarely in the cold
cardioplegic group. Their careful docu
mentation clearly supports cold cardio
plegia.
With respect to valve replacement,
the data provided by Jamieson and his
associates (page 133) indicate that some
patients receiving porcine valves re
quire anticoagulation. All instances of
embolism occurred in patients in atrial
fibrillation and it is to be hoped that
the frequency of embolism will be
substantially reduced by the use of
anticoagulant therapy, as they advise.
The porcine bioprosthesis, one would
expect, will prove less durable than
manufactured, rigid valves, but the
manner of failure will not be catas
trophic, thus permitting semielective
valve replacement. Such a prospect will
not be pleasant for an informed patient
but will be more attractive than a valve
thrombosis or massive embolism. The
95

decision whether to use a porcine or a
rigid valve can be made on an individ
ual basis. Influenced by the present
series from Vancouver many surgeons
will opt for rigid valves in fibrillating
patients or in those with large dilated
left atria or atrial thrombi. After all,
the advantage of the porcine valve is
that anticoagulation is not required. If
anticoagulants are going to be used
regardless of the valve type one may as
well choose the more durable valve.
David and Key (page 107) re-emphasize that patients with patent deep
femoral arteries rarely lose their legs
because of chronic occlusive disease.
These authors direct their attack on the
deep femoral artery itself in patients
with rest pain or frank gangrene; they
noted symptomatic or clinical improve
ment when that artery could be canal
ized by an endarterectomy with or with
out a patch-graft arterioplasty. The
operation was beneficial even when the

outflow below the knee was occluded.
The authors caution that careful ra
diologic techniques, including oblique
and lateral views, are necessary to
evaluate the patency of the deep fe
moral artery. Experienced vascular sur
geons will agree. Compared with femoropopliteal or femorotibial bypass, re
construction of the deep femoral artery
is a simpler, better-tolerated operation
for patients with rest pain. Claudica
tion may remain but limb viability will
be restored. The authors intimate that
they have recently quantitated flow and
pressure in the legs of such patients
and we hope that the clinical benefits of
these operations will be documented by
such techniques in the future.
A nthony R.C. D o b ell ,

m d , frcs [c ]

Director,
Division of cardiovascular and
thoracic surgery,
Royal Victoria Hospital,
Montreal, PQ

Leg Amputation

Interest in the problems of amputees
was stimulated during World War II
and received further impetus in the
United States from the wars in Korea
and Vietnam. Prosthetic research labo
ratories, rehabilitation units, amputee
clinics and institutions devoted to the
training of personnel in the care of the
amputee were established and resulted
in new concepts of pre-, intra- and post
operative care. It became recognized
that each distal joint that could be
saved markedly improved the patient’s
ultimate ability to function. There was
a gradual waning of popularity for the
above-knee amputation in patients with
peripheral vascular disease despite the
high probability of satisfactory healing,
since in the case of amputation in
geriatric patients or those with peri
pheral vascular disease, the presence of
a knee could well decide whether the
patient would be able to walk with a
prosthesis. Throughout the 1960s, sur
geons began to take increasingly greater
pains to save the knee so that by the
end of that decade most clinics found
that two thirds of their healed amputa
tions performed for vascular disease
were at the below-knee level.

Later, Burgess and Zettl1 demon
strated that the use of long posterior
flaps could make possible even more
below-knee amputations, and improve
ments in techniques resulted in an in
creased salvage rate for Syme’s ankle
disarticulations.
New prosthetic components, tech
niques of immediate fitting of prostheses in selected patients and early
fitting of temporary prostheses in most
geriatric subjects have substantially re
duced the time between amputation and
successful ambulation. This has led to
a marked increase in the number of
patients using prostheses.
All this progress has been due to the
direct interaction between surgeons,
prosthetists, therapists, engineers and
other medical and nonmedical person
nel. It also required the organization of
interdisciplinary clinics and teams in
volving all of these persons in the con
tinuing care of individual patients. It is
no longer sufficient for the surgeon to
amputate a gangrenous limb and then
send the patient off in due course to a
rehabilitation unit. Other health pro
fessionals must be involved before
operation in the decision as to the level
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Hepalean®
INDICATION:
Low-dose anticoagulant. There is
now good evidence1.2,3 that low-dose
heparin is effective in preventing serious
venous thromboembolic complications in
high risk surgical patients.
CONTRAINDICATIONS:
Haemophilia and severe clotting disorders;
shock; hypersensitivity to heparin; severe
liver damage. Active bleeding from a local
lesion such as an acute ulcer or ulcerating
carcinoma. Recent neurosurgery or spinal
surgery.
WARNING:
1. Administration of large doses of HEPA
LEAN should be delayed four hours postoperatively.
2. When any of the conditions mentioned
under precautions are present the advant
ages of HEPALEAN therapy must be care
fully weighed against the possibility of
deleterious results.
PRECAUTIONS:
HEPALEAN should be used with caution in
pregnancy although it does not cross the
placental barrier and is the safest and most
useful form of therapy in thromboembolic
disorders of pregnancy.
Care must be taken where large doses of
antibiotics and/or drugs containing amino
groups are administered along with or prior to
HEPALEAN administration.
DOSAGE AND ADMINISTRATION:
Low-Dose Subcutaneous Heparin.
The usually recommended dose is 5,000 units
subcutaneously 2 hours before surgery
and then 5,000 units given either 12 hourly
or 8 hourly after surgery with the first dose
given at approximately 12 hours after surgery.
It is not necessary to monitor low-dose
prophylactic heparin.
SUPPLY:
For low-dose therapy HEPALEAN 25,000
units/ml 2 ml Vial is recommended. It pro
vides 5,000 U.S.P. units in a dose of only
0.
2.ml.
HEPALEAN is supplied in the following con
centrations and package sizes: Please note
that all Harris injectables are colour-coded.
Strength:
1,000 units/ml 1 ml ampul, 10 ml vial,
30 ml vial
10.000 units/ml 1 ml ampul, 5 ml vial
25.000 units/ml 2 ml vial
1. Reference: Kakkar V. V., Corrigan, T. P. and
Fossard D. P. 'Prevention of Fatal Post-operative
Pulmonary Embolism by Low Doses of Heparin',
An International Multicentre Trial, Lancet 45-51
July 1975.
2. Reference: Gallus, A. S., Hirsh J„ O'ESrienS. E„
McBride J. A., Tuttle R. J., Gent M. 'Prevention of
Venous Thrombosis with Small, Subcutaneous
Doses of Heparin’, (JAMA 235:1980-1982, 1976).
3. Reference: Genton £., 'Low-Dose Heparin in the
Prophylaxis of Venous Thromboembolism’, The
Canadian Journal of Hospital Pharmacy —July,
August, 1977.
Complete prescribing information is available
on request from Harris Laboratories, 1890
Brampton Street, Hamilton, Ontario L8H 7K1

Harris Laboratories

THE CANADIAN JOURNAL OF SURGERY

M. MacKay, B.Sc., Art as Applied to Medicine, (Faculty of Medicine) University of Toronto.

New “ Low-Dose” Hepalean® (25,000 u /m l) ...
provides 5,000 U.S.P. units in a dose of only
0.2 m l ... to reduce haematoma and pain at
the site of injection.
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In a multi-centre study of 4121
patients ... “ Pulmonary emboli
were considered fatal if fresh emboli were present in the pulmonary
trunk, the main pulmonary arteries,
and if no other cause of death was
found.
Using these criteria, 16 patients
(0.7%) in the control group died
due to embolism-, while only 2 fatal
emboli (0.09%) occurred in the
heparin-treated patients
(FK0.005).”
“ The frequency of D.V.T. was
reduced from 24.6% in the con
trol group to 7.7% in those receiving heparin. These findings are
similar to those reported pre
viously.” (D.V.T. — Deep Vein
Thrombosis)1

“ The effect of low-dose heparin
prophylaxis on venous thrombosis
and bleeding after major elective
surgery was studied in a prospect
ive controlled study of 820 pa
tients. The total incidence of
venous thrombosis detected with
leg-scanning using fibrinogen
labeled with radioactive Iodine
(125l)was reduced from 16.0% in
the control group to 4.2% in treat
ed patients. More important, the
incidence of popliteal or femoral
vein thrombosis was reduced from
2.9% to 1.0%. Prophylaxis
resulted in a slight increase in
bleeding — minor wound haema
toma, mean volume of blood trans
fused, and a post-operative
hematocrit fall in treated patients.
However, increased bleeding was
clinically minor, and prophylaxis
was well tolerated.” 2

Harris Laboratories

“ It would appear that low-dose
heparin fulfills most of the criteria
for an optimal prophylactic agent.
It is effective in patients exposed
to moderate provocation to throm
bosis, it is safe as regards major
complications, and is acceptably
convenient for patients and health
professionals. It can be recom
mended in patients at moderate
risk of developing venous throm
bosis, and especially in those
considered at high risk, including
the elderly, obese, those with
malignant disease or congestive
heart failure, and those who have
had prior episodes of venous
thrombosis. The drug should be
started prior to the development of
thrombosis and continued until
the risk of thrombosis has
passed.” 3

PAA B
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and type o f amputation and, likewise,
the surgeon must be concerned in the
subsequent care.
The benefits o f this multidisciplinary
activity are reflected in the paper by
Hunter and Holliday (page 176) in this
issue o f the Journal. A physician and
therapist, after reviewing the results o f
several clinics, have furthered our
awareness that saving the knee is a
tremendous aid to the patient, especially
in cases o f bilateral amputation. They
have shown that significant numbers of
patients with bilateral above-knee am
putation can be successfully fitted with
prostheses. Although almost half of
such patients used a wheelchair as a
primary aid to mobility even some of
these, we must presume, have benefited
from occasional use o f their prostheses
for transfer. In confirmation o f the re
sults o f Hunter’s study, we have man

aged 40 patients with bilateral leg am
putation in the past 7 years; 18 have
been able t o walk with the use of
prostheses.
M ore information on the manage
ment o f complicated amputee problems
is sure to becom e available. New hori
zons in amputation surgery will pro
bably be concerned with better methods
o f predicting the likelihood of success
in a given operation. At present, the
Doppler technique appears to hold con
siderable promise in this regard.
N elson S. M itchell , m d , frcs [c]
Department of surgery,
Royal Victoria Hospital,
Montreal, PQ

Reference
1. Burgess EM, Z ettl JH: Amputations
below the knee. Artif Limbs 13: 1,
1969

SESAP II Question

418 . Disorders associated with Raynaud’s phenomenon include
(1 ) thromboangiitis obliterans (Buerger’s disease)
( 2 ) progressive systemic sclerosis (scleroderma)
( 3 ) cervical rib
(4 ) atherosclerosis

F or the incomplete statement one or more o f the completions given above
is correct. Y our answer should be:
A if only 1, 2 and 3 are correct,
B
C
D
E

if
if
if
if

only 1 and 3 are correct,
only 2 and 4 are correct,
only 4 is correct,
all are correct.

F or the critique o f Item 418 see page 183 o f this issue.

(Reproduced by permission o f the American College o f Surgeons from

SESAP II Syllabus: Surgical Education and Self-assessment Program No. 2.
F or enrolment in the Surgical Education and Self-assessment Program
N o. 2 please apply to the American College o f Surgeons, 55 East Erie St.,
Chicago, IL 60611.)
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Glimpses of Surgical History:
T for Transplantation
D avid A .E . Shephard

The concept of transplantation is an
cient: Greek myths refer to transplants
o f animal tissue into man, and the
fabled chimera (part lion, part goat,
part serpent) symbolizes the potential
o f transplantation of genetically for
eign tissue. But old legends and folk
tales describe transplantation of tissue
from human donor to human recipient
too. Among such legends are the heart
transplants performed by Pien Ch’iao
and Hua T o in China two centuries
BC, and the leg transplant by medical
saints Cosmos and Damian in Italy
five centuries later. In fact the first
transplant is credited to Susruta, the
Indian, who was familiar with auto
genous pedicled grafts for wounds or
disease o f the facial area; in his coun
try, by the way, rhinoplasty had been
performed by members of the Koomas
caste of potters and tile and brick mak
ers. The first free skin graft is attri
buted to Astley Cooper who, much
later, grafted a healthy piece o f skin
from an amputated thumb to its stump.
Organ transplantation is relatively
modern. Surgeons may rightly be proud
o f their successes, but few will forget
the contributions to history of their
own patients and fellow scientists.
What lessons, for example, were learned
from the case of a 5-year-old child
whose shredded leg took hundreds of
pinch grafts from the maternal donor
under the hands of Emile Holman some
50 years ago; and what impressions
the successful temporary kidney trans
plant in a pregnant uremic woman
made on surgeons Charles Hufnagel
and David Hume two decades later!
How huge were the basic contributions
o f Victorian natural scientists Charles
Darwin and Gregor Mendel, and o f
modern immunologists like Peter Medawar and Macfarlane Burnet! Such
comment forcefully
illustrates the
theme o f this series of personal glimp
ses: the cross-fertilization from other
disciplines needed for the surgical
discipline to advance, and the human
stories behind the initial failures and
later triumphs that make surgery so
personal and yet so great a physical
transgression.
One meaning of the word chimera
is “mere wild fancy; an unfounded
conception” . The history of transplanta
tion belies this definition, to the im
mortal glory of those, often unremem
bered, who have helped surgeons shape
its progress.
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Myocardial Protection During Aortic Valve Replacement:
Normothermia Versus Hypothermia*
M ant H a ra ph o n g se , m d , F R C P [ c ] , f R o b er t S. F raser , m d , f r c p [ c ],$ R ic h a rd E. R o ssa ll , m d , f r c p [ c ],§
R . L eig h to n F isk , m d , f r c s [ c ],^| C arlos A.E. B asualdo , m d , f r c p [ c ],* * E l l io t t T. G e l f a n d , m d , f r c s [ c ]^]
and

The operative results in 32 patients
who underwent aortic valve replace
ment with aortic occlusion and normothermic myocardium (group 1) were
compared with 54 similar patients in
whom the myocardium was protected
by hypothermic coronary perfusion
through the aortic root (group 2). The
operative mortality and the incidence
of heart failure, subendocardial
ischemia and myocardial infarction
were the same in the two groups.
The maximal concentrations of
cardiac enzymes after operation in
group 2 patients were significantly
lower than those in group 1. The
postoperative cardiac performance

*From the departments of medicine and
surgery, University o f Alberta Hospital,
Edmonton, Alta.
Presented at the annual meeting o f the
Canadian Cardiovascular Society, Toronto,
Ont., Oct. 19-22, 1977

t Assistant professor o f medicine and
director, hemodynamic laboratory,
University o f Alberta Hospital
XProfessor of medicine, University of
Alberta
§Professor o f medicine and director,
division of cardiology, University of
Alberta Hospital

flAssistant professor of surgery, Univer
sity of Alberta
* * Associate professor of medicine,
University o f Alberta

md ,

FRCs[c]ff

was significantly different in that only
5.6% of group 2 patients required ino
tropic agents after operation compared
with 25% of group 1 patients. The
patients in group 2 were easier to
defibrillate after cardiopulmonary
bypass.
On a compare les resultats operatoires
de 32 patients qui ont eu un rempiacement de la valvule aortique, par
occlusion aortique, en conservant
le myocarde a temperature normale
(groupe 1), a ceux de 54 patients
semblables chez qui le myocarde a ete
protege par perfusion hypothermique
coronarienne par le tronc aortique
(groupe 2). La mortalite peroperatoire
et la frequence de I’insuffisance
cardiaque, I’ischemie sous-endocardique
et I'infarctus du myocarde ont ete
comparables pour les deux groupes.
Les concentrations maximales des
enzymes cardiaques apres I'operation
pour les patients du groupe 2 ont ete
significativement plus basses que
cedes du groupe 1. La performance
cardiaque postoperatoire a ete signifi
cativement differente, puisque seulement 5.6% des patients du groupe 2
ont necessity des medicaments inotropes
apres I’operation, en comparaison de
25% des patients du groupe 1. II etait
aussi plus facile de defebriller les
patients du groupe 2 apres derivation
cardiopulmonaire.
The myocardium must be protected
from the injurious effects of ischemia
during cardiopulmonary bypass. Meth
ods used to protect the myocardium
during aortic valve replacement (A V R )
have included direct coronary arterial
perfusion and ischemic arrest at d if

t t Professor of surgery and director,
division o f thoracic and cardiovascular
surgery, University o f Alberta Hospital
Reprint requests to: Dr. M.
Haraphongse, Director, Hemodynamic
laboratory, University o f Alberta
Hospital, Edmonton, Alta. T6G 2B7
V O L U M E 21, N O . 2, M A R C H 1978
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ferent myocardial temperatures. C oro
nary perfusion with cold lactated
Ringer’s solution through the aortic
root has recently been used at the
University o f Alberta Hospital, Ed
monton, as a method o f myocardial
protection during coronary bypass sur
gery and during valve replacement.
The morbidity, mortality and cardiac
performance improved after the intro
duction o f this technique.
This report compares the results o f
A V R under normothermic anoxic ar
rest with the results obtained under
cardiac hypothermia and cardioplegia
induced by coronary perfusion.

Patients and M ethods
A ll patients who underwent isolated
A V R between Jan. 1, 1970 and Feb.
29, 1976 were included in this study.
Group 1 consisted o f 32 patients who
had A V R between Jan. 1, 1970 and
Dec. 31, 1973 with aortic occlusion and
normothermic myocardium. Group 2
consisted o f 54 patients who had similar
operative procedures between Jan. 1,
1974 and Feb. 29, 1976 but with aortic
occlusion and hypothermic myocardium.
In group 1, the mean age o f patients
was 52 years (± 1 2 years); 20 (62.5% )
patients were men. In group 2, the
mean age was 51 years ( ± 1 4 years);
43 (79.6% ) patients were men. Pre
operative investigations (Table I) were
the same for both groups and included
complete studies by cardiac catheteriza
tion and coronary angiography.
In group 2 hypothermia was induced
by perfusion with 5% glucose and cold
lactated Ringer’s solution to which
were added potassium chloride (40
m m ol/L)
and
sodium
bicarbonate
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ischemia was diagnosed if symmetrical
T-wave inversion was noted within the
first 24 hours after surgery. Supraven
tricular and ventricular arrhythmias
were recorded. Die use of inotropic
agents to maintain circulation, and the
number of defibrillations necessary to
restore sinus rhythm following comple
tion of the procedure were also noted.
The differences in the above factors in
the two groups were compared by
X2 analysis. Serum creatine phosphokinase (CPK) and serum glutamic
oxaloacetic transaminase (SGOT) values
were measured daily for 3 days after
operation. Statistical significance of
the differences between these mean
values was calculated by using Student’s
f-test.

T a b le 1— P re o p e r a tiv e C h a ra c te r is tic s in P a t ie n ts w h o h a d A o rtic V a lv e R e p la c e m e n t w ith E ith e r
N o rm o th e rm ic (n = 3 2 ) o r H y p o th e r m ic (n = 5 4 ) M y o c a rd iu m
P a tie n ts w ith
n o rm o th e rm ic
m y o c a rd iu m ,

%

C h a r a c te r is tic
D ia g n o s is
A o r tic s te n o s is (p r e d o m in a n t)
A o r tic in c o m p e te n c e (p r e d o m in a n t)
S u b a c u te b a c te r ia l e n d o c a rd itis
A n g in a p e c to ris
S yn c o p e
H e a r t f a ilu r e
M y o c a r d ia l in fa r c tio n
E le v a te d le f t v e n tr ic u la r e n d -d ia s to lic p r e s s u r e *
N Y H A fu n c t io n a l class
i
ii
in
IV
E le c tr o c a r d io g ra m
N o rm a l
L e f t v e n tr ic u la r h y p e rtro p h y
(v o lta g e c r it e r ia )
L e f t v e n tr ic u la r h y p e rtro p h y w ith s tr a in

P a t ie n ts w ith
h y p o th e r m ic
m y o c a rd iu m ,

%

59.4
40.6
6.3
31.3
28.1
15.6
0
46.9

53.7
46.3
12.9
1 8 .5
2 5 .9
22 2
0
61.1

0
15.6
71.9
12.5

5.5
24.1
62.9
7.4

15.6

18.5

15.6
68.8

9 .3
72.2

Results

Both groups of patients were similar
with respect to age, sex, preoperative
symptoms, and previous history of bac
terial endocarditis, heart failure, or
myocardial infarction. The number of
patients who had elevated left ventri
cular end-diastolic pressure, their pre
operative functional classification and
electrocardiographic findings were com
parable in both groups (Table I). The
allocation of devices used to replace
the aortic valve is set forth in Table II.
The overall operative mortality was

♦ M e a n ± SD w a s 17 ± 9 m m H g in g ro u p 1 a n d 21 ± 12 m m Hg in g ro u p 2.

(44.6 mmol/L). After the patient was
placed on total cardiopulmonary by
pass a cross-clamp was placed on
the aorta and 500 to 700 mL of
solution was introduced into the
aorta proximal to the clamp, through
a small catheter introduced through a
purse-string suture in the aortic wall.
When the aortic valve was incompe
tent, the left ventricle was manually
compressed during the period of aortic
infusion. This maneuver aided in op
posing aortic regurgitation and prevent
ing distension of the left ventricle. Car
diac arrest occurred rapidly, after about
200 mL of the cold solution had been
injected. Additional solution was placed
in the pericardial well around the heart.
If the period of aortic cross-clamping
needed to be prolonged beyond the
time expected for completion of a pro
cedure, additional cold solution was
introduced into the aortic root and
pericardial well. Upon release of the
cross-clamp and re-establishment of
coronary arterial flow, rewarming of
the heart took place within, minutes.
Direct-current defibrillation was applied
if necessary.
T a b le

I I — D e v ic e s u sed to R e p la c e A o r tic
V a lv e
P a tie n ts w ith
n o rm o th e rm ic
m y o c a rd iu m ,

P ro s th e s is
S m e lo f f C u tte r
L ille h e i
K a s te r
B jo r k

102

%

(n = 3 2 )

P a t ie n ts w ith
h y p o th e r m ic
m y o c a rd iu m ,
%
(n = 5 4 )

72

18.5

22
6

8 1 .5
0

Both groups were analysed with re
spect to mortality, number of complica
tions and postoperative changes in the
electrocardiogram. Electrocardiograms
were obtained immediately after sur
gery, then daily for 1 week and again
just before discharge from hospital.
Myocardial infarction was diagnosed if
new Q waves appeared; subendocardial

T a b le I I I — C a rd ia c C o m p lic a tio n s
P a t ie n ts w ith
n o rm o th e rm ic
m y o c a rd iu m ,
(n = 3 2 )

P a t ie n ts w ith
h y p o th e rm ic
m y o c a rd iu m ,
(n = 5 4 )

%

C o m p lic a tio n
S u b e n d o c a rd ia l is c h e m ia
M y o c a rd ia l in fa r c tio n
A rr h y th m ia s
S u p ra v e n tr ic u la r
V e n tr ic u la r
H e a r t fa ilu r e
M o r t a lit y

T a b le

6.3
9.4

11.1
7.4

4 6 .9
12.5
6.3
3.1

4 2 .6
3 .7
1.8
1.8

IV — S u rg ic a l
P a tie n ts w ith
n o rm o th e rm ic
m y o c a rd iu m
(n = 3 2 )

A o r tic c ro s s -c la m p tim e ,
m ean ± S D , m in
C a rd io p u lm o n a ry bypass tim e ,
m ean
S D , m in
In o tr o p ic s u p p o rt p o s to p e r a tiv e ly ,
N u m b e r of d e f ib r illa tio n s n e c e s s a ry to
re s to re s in u s r h y th m ,
S p o n ta n e o u s
1
2
>2

±

%

%

4 6 .5 ±

E ve n ts
P a tie n ts w ith
h y p o th e rm ic
m y o c a rd iu m
(n = 5 4 )

P v a lu e

8.8

52.6 ± 11.8

< 0 .0 2 5

66.1 ± 16.3
25

74.3 ± 16.9
5 .6

< 0 .0 5
< 0 .0 1

16
22
28
34

30
48
11
11

%

NS
< 0 .0 0 2 5
< 0 .0 5
< 0 .0 1

N S = n o t s ig n ific a n t.
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similar in both groups (Table III). One
patient in group 1 died of subdural
hemorrhage. One patient in group 2
died of myocardial infarction. The
differences between the two groups in
the incidence of subendocardial is
chemia, myocardial infarction, post
operative cardiac arrhythmias and
heart failure were not statistically
significant.
The cardiopulmonary bypass time
(Table IV) in group 1 averaged 66.1
minutes, which was substantially short
er than the average of 74.3 minutes in
group 2. The average time of aortic
cross-clamping was also shorter in
group 1 (46.5 minutes) than in group
2 (52.6 minutes).
Inotropic drugs were given when
cardiac performance was depressed as
evidenced by an arterial systolic blood
pressure below 90 mm Hg or urine
output of less than 20 mL/h. In group
1 eight (25%) patients required an ino
tropic agent to maintain circulation, but
this was necessary in only three (5.6%)
patients in group 2.
The number of defibrillations neces
sary to restore sinus rhythm following
completion of the procedure was sig
nificantly higher in group 1 than in
group 2 (Table IV).
Postoperative concentrations of se
rum enzymes (CPK and SGOT) were
analysed (Fig. 1) in patients with a
normal postoperative course. Maximal
concentrations of enzymes in the pa-

tients with hypothermia were signifi
cantly lower than in normothermic pa
tients.
Discussion

The 30-day mortality rate and the
incidence of myocardial injury follow
ing AVR are variables that should
reflect the adequacy of intraoperative
myocardial protection. Because of the
present low operative risk for isolated
AVR, large numbers of patients would
need to be compared in order to estab
lish the superiority of one method of
myocardial protection over another.
Nevertheless, the readier restoration of
heart beat, the reduced requirement for
myocardial support after the operation
and the smaller rise in serum enzyme
values following AVR in group 2 to
gether suggest that there has been a
beneficial and protective effect on the
myocardium in these patients who had
hypothermic cardioplegia.
Ischemic cardiac arrest under nor
mothermic conditions is a safe method
for open intracardiac operation1 and is
moderately well tolerated for 30 min
utes.2 Beyond that time biochemical
changes,3 subendocardial hemorrhage4
and generalized myocardial damage are
progressive and probably irreversible.2
Furthermore, normothermic ischemic
arrest leads to a substantial reduction
in high-energy phosphates and results
in poor functional recovery.5
SGOT(IU/ L)

CPK(IU/ L)

Hypothermia affords considerable
myocardial protection by reducing the
metabolic rate6 and extends the safe
period of ischemic arrest.7 The func
tional recovery of the heart following
the termination of arrest is directly
related to the concentration of ATP
and of creatine phosphate in the myo
cardium at the end of the period of
arrest.5 Hypothermic coronary perfu
sion for intraoperative cardioplegia
provides rapid arrest and uniform cool
ing of the heart with minimal hypoxia.
Cellular levels of high-energy phos
phates are maintained and complete
recovery is possible.5’8
Cardiac performance, as estimated
by the need for support with inotropic
agents and ease of defibrillation after
operation was better in group 2 than
in group 1 even though the periods of
cardiopulmonary bypass and aortic
cross-clamping were longer in group 2
patients.
In this study, we compared two
methods of anoxic arrest during AVR.
Both groups of patients were similar
in all aspects preoperatively. Hypo
thermic coronary perfusion for intra
operative cardioplegia as a method of
myocardial protection was superior to
normothermic anoxic arrest.
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Noninvasive Assessment of Patients Following
Aortocoronary Bypass Surgery*
W J . Kostuk, md, frcp[c], facc, D. D eatrich, rt and M.J. C hamberlain, mb , ch b, frcp [c]

A simple, accurate, noninvasive method
is required for the objective evaluation
of aortocoronary bypass surgery.
Stress myocardial imaging with intra
venous injection of potassium-43 or
thallium-201 was used an average
of 4.4 months after direct myocardial
revascularization in 77 patients to
assess the accuracy of stress myo
cardial imaging in predicting complete
ness of revascularization. The results
were correlated with maximal treadmill
exercise tests, extent of revasculariza
tion and status of bypass grafts
(occlusion, stenosis and distal disease).
We found stress myocardial imaging
to be a more sensitive method than
the stress electrocardiogram for the
detection of incomplete revasculariza
tion. The method appears to be a
sensitive noninvasive means of evaluat
ing the results of aortocoronary bypass
surgery.
II existe un besoin pour une methode
simple, precise et non envahissante,
capable de realiser une evaluation
objective du pontage aortocoronarien.
La mise en evidence du myocarde a
I’effort, par injection intraveineuse de
potassium-43 ou de thallium-201 a ete
employee, en moyenne 4.4 mois apres
une revascularisation myocardique
directe, chez 77 patients, afin d'evaluer
la precision de cette technique pour
predire la reussite de la revasculari
sation. Les resultats ont ete mis en
correlation avec les tests d'effort
maximum sur tapis roulant, I’etendue
de la revascularisation et I'etat des
greffons de pontage (occlusion, stenose
ou atteinte distale). Nous avons trouve
que la mise en evidence du myocarde
a I’effort est une methode plus sensible
que I’electrocardiogramme a I'effort
pour deceler une revascularisation
*From the cardiac investigation unit,
University Hospital, London, Ont.
Presented at the annual meeting o f the
Canadian Cardiovascular Society,
Toronto, Ont., Oct. 19-22, 1977

A ortocoronary
venous
bypass
has
emerged as the procedure o f choice
for the surgical treatment o f refractory
angina pectoris.1’6 Although it is asso
ciated with considerable symptomatic
improvement in most patients, this im
provement is not always the result of
increased myocardial perfusion. Un
fortunately, the only definitive method
available for objective evaluation o f the
results o f aortocoronary venous bypass
surgery is that o f cardiac catheteriza
tion with selective graft visualization.
This method cannot be used for long
term sequential evaluation. Recently,
the noninvasive method o f myocardial
perfusion imaging after the injection o f
potassium-43, rubidium-81 or thallium201, at rest and during treadmill exer
cise, has been shown to be a sensitive
technique for detecting regional m yo
cardial ischemia.7'11 The present study
describes our experience with stress
myocardial scintigraphy in assessing the
results o f aortocoronary bypass surgery.
The results o f imaging are compared
with those obtained by electrocardio
graphy and cardiac catheterization.

Methods
Patient Selection

The study group comprised 77 pa
tients in whom aortocoronary bypass
procedures were undertaken fo r the
treatment o f angina pectoris refractory
to antianginal therapy. The patients
were selected at random mainly on the
basis o f their willingness to undergo
postoperative cardiac catheterization
and angiographic evaluation together
with exercise testing and myocardial
imaging.
Studies P erform ed

Supported by the Ontario Heart
Foundation
Reprint requests to: Dr. W.J. Kostuk,
Cardiac investigation unit, University
Hospital, PO Box 5339, Terminal A,
London, Ont. N6A 5A 5
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incomplete. Cette methode semble
etre un moyen non envahissant sensible
pour evaluer les resultats du pontage
aortocoronarien.

Stress testing by means o f maximal
treadmill exercises was carried out an
average o f 4.4 months (range, 3 to 39
months) following aortocoronary bypass
surgery. A fter undergoing standard
electrocardiography, the patients were
exercised using a graded multistage
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treadmill test. A modified Bruce pro
tocol, in which a complete 12-lead
electrocardiogram (ECG) was obtained
at 2-minute intervals both during and
after stress testing, was used.12 Exercise
was continued to an end point o f chest
pain, severe fatigue, dyspnea, depres
sion o f the ST segment or maximal
heart rate.
Stress myocardial imaging was per
formed in association with the tread
mill exercise test. A t the end point of
exercise, the radionuclide (0.5 mCi o f
43K or 1.5 mCi o f 201T1) was injected
intravenously and exercise continued
for an additional 45 to 60 seconds to
ensure adequate myocardial uptake.
Electrocardiographic monitoring was
carried out throughout the test and
continued for 10 minutes after exercise.
Scanning with a rectilinear scanner
(43K) or a mobile scintillation camera
(201T1) was started immediately after
electrocardiographic monitoring ceased.
Postoperative angiography was per
formed within 6 weeks o f the stress
testing in 70 o f the patients. Selective
bypass and coronary angiograms in
multiple projections using Judkins’ tech
nique were obtained. Myocardial scans
at rest were obtained at the time of
cardiac catheterization, by selective
injection o f labelled particles o f macroaggregated albumin (M A A ) into the
coronary arteries and the venous bypass
grafts. M A A labelled with technetium99m was introduced into the coronary
arteries
and
M AA
labelled with
iodine-131 was inserted into the bypass
grafts.13 Previously, we showed that such
scans are comparable to those obtained
at rest following intravenous injection
o f 43K .14
Criteria fo r Positive Results

All data were interpreted without
knowledge o f the patient’s clinical con
dition, or operative or angiographic
status. Chest pain was not included in
the definition o f a positive or negative
test.
Stress electrocardiograms were con
sidered positive fo r myocardial ischemia
if a flat or downsloping ST-segment
depression o f 1 mm or greater was
recorded in any o f the 12 leads for at
least 80 milliseconds with an isoelectric
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ST segment in the control tracing. A
clinical diagnosis of postoperative myo
cardial infarction was made only if
there was development of Q waves of
greater duration than 0.04 seconds in
at least two leads.
Myocardial scans demonstrating a
homogeneous distribution of radioac
tivity were interpreted as normal. A
focal defect on the stress study with
a similar defect on a rest study was
considered compatible with infarction.
Myocardial ischemia was diagnosed
only if a focal defect appeared or in
creased in size in the stress scan as
compared with the rest scan.
Severe stenosis was defined as 70%
or greater obstruction of an artery or
vein on selective angiography. Complete
revascularization was defined as the
presence of a patent graft supplying all
the major arteries that had severe
stenosis.
Clinical Improvement
In our analysis, clinical improvement
was considered excellent if there was
complete freedom from pain, ^good if
there was a lessening of pain, usually
associated with improvement by two
functional classes (New York Heart
Association classification), or unchanged
or worse when compared with the pre
operative state.
Results
The results of postoperative electro
cardiography and myocardial scanning
are correlated with the postoperative
angiographic findings in Table I. In
traoperative myocardial infarction was
diagnosed in seven patients. In all, the
rest scan detected the infarction, while
in only four did Q waves develop on
the resting ECG.
Of 35 patients without evidence of
myocardial ischemia on the stress ECG
and myocardial scan, 31 had complete
revascularization. In four patients both
noninvasive tests gave false-negative
results.
In only three patients in whom the
exercise ECG was positive for myo

cardial ischemia was the condition not
detected on the myocardial scans. In
one patient, however, there was com
plete revascularization; thus the exer
cise ECG represented a false-positive
result. In two patients “ungrafted” dis
ease or an occluded graft was evident,
making the results of myocardial scan
ning falsely negative.
In 18 patients, both the stress scan
and the exercise ECG suggested myo
cardial ischemia. In one patient there
was complete revascularization and thus
the noninvasive studies were falsely
positive. However, in the remainder,
these studies correctly identified con
tinuing myocardial ischemia.
In the remaining 21 patients the
myocardial scan was positive for myo
cardial ischemia, while the ECG was
negative. In 16 instances this was
related to “ungrafted” disease, in 3 to
occlusion of the bypass graft and in 1
to stenosis of the graft, while in 3
there was evidence of distal disease.
Thus, the exercise ECGs gave false
negative results.
In Table II the results of the non
invasive studies are related to the
symptomatic improvement that each
patient noted.
All 35 patients in whom the nonin
vasive investigations suggested no myo

cardial ischemia had an excellent to
good result in terms of symptomatic
improvement, with the majority enjoy
ing an excellent result.
Combination of the three groups in
which one or both of the noninvasive
studies were positive, showed that only
two (4.8%) patients had complete re
vascularization and restoration of nor
mal myocardial perfusion to account
for the excellent to good results. In a
further seven patients (circled numbers
in Table II), a perioperative infarction
occurred that might, by elimination of
the ischemic focus, account for the
symptomatic improvement in these pa
tients.
Overall, we found that 64% of the
patients had an excellent result, 26%
a good result, while 10% were un
changed or worse.
In Fig. 1 the heart rate-blood pres
sure product of maximal stress testing
preoperatively is related to the post
operative stress myocardial scan. In
the 39 patients with a positive scan,
the double product increased signifi
cantly from a preoperative value of 189
to a postoperative value of 260. Like
wise, for the group in whom the myo
cardial scan showed no evidence of
myocardial ischemia, a significant im
provement from 207 to 309 occurred.

Table II—Correlation of Noninvasive Tests with Symptomatic Results

Test
result

No. of
patients

Complete
revascularization
( and % )
Excellent

Negative scan
Negative electrocardiogram

35

Negative scan
Positive electrocardiogram

3

1

Positive scan
Positive electrocardiogram

18

1

Positive scan
Negative electrocardiogram

21

0

Total (and % )

77

31 (88.6)

Unchanged
or worse

33

2

0

2

1

0

6®

6

6

8®

U®

(4.8)

33 (42.9)

Good

49 (63.6)

20 (26.0)

2
8 (10.4)

Table 1—Correlation of Noninvasive Tests with Postoperative Studies in 77 Patients
Aortocoronary
bypass graft
Test
result

No. of
patients

Complete
revascularization

New
infarct

disease

Closed

Stenosis

Distal
disease

Negative scan
Negative electrocardiogram

35

31

0

2

1

2

1

Negative scan
Positive electrocardiogram

3

1

0

1

1

0

0

Positive scan
Positive electrocardiogram

18

1

4

10

4

4

2

Positive scan
Negative electrocardiogram

21

0

3

16

3

1

3
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This would imply that, in both groups,
m yocardial perfusion improved postoperatively.
Although the preoperative double
product is similar in both groups, a
difference between the postoperative
results was found. Patients in whom
m yocardial stress scintigraphy showed
no m yocardial ischemia, had a signifi
cantly higher increase in the double
product, which suggests that complete
revascularization resulted in a notably
improved myocardial blood flow com
pared w ith partial revascularization.
The sensitivity, specificity and pre
dictive value of exercise electrocardio
graphy and exercise myocardial scinti
graphy in evaluating patients after
aortocoronary bypass surgery are shown
in Fig. 2. We found a significant dif
ference in the sensitivity of these two
noninvasive tests (43% and 84% , re
spectively). The specificity and pre
dictive values are similar.
Discussion
T he striking symptomatic improve
ment noted in the majority of patients
P<0.001

FIG. 1—Heart rate (HR)—blood pres
sure (BP) product of maximal stress test
ing preoperatively and postoperatively is
related to result of stress myocardial scan
postoperatively. Postive ( + ) result in
dicates myocardial ischemia (or new in
farction), negative (—) result implies no
myocardial ischemia. Numbers indicate
patients in each group. Height of bar rep
resents mean and standard error of mean.
□

ECO

H

SCAN

sf: p <o .ooi

in this study is similar to that reported
from other series.15'18 Clinical evalua
tion of symptomatology, however, is
inadequate.19 Objective evaluation of
the results of coronary artery bypass
surgery is essential as the enthusiasm
for this procedure continues to grow.
The results of noninvasive testing with
maximal stress testing, however, may
be equivocal.4,20 To date, postoperative
cardiac catheterization by selective
coronary and graft angiography and
ventriculography has been the best ob
jective method for evaluating the re
sults of myocardial revascularization.
Unfortunately, the invasive nature of
this procedure necessitates hospitaliza
tion and is associated with a substantial
expense. This restricts its use for se
quential study.
We found that an abnormal m yocar
dial stress scan was indicative of incom
plete revascularization, attributable to
ungrafted vessels (which can be deter
mined by considering the operative
procedure and the preoperative angi
ogram) or a specific problem related
to the bypass graft itself (occlusion,
stenosis or distal artery disease). The
exact nature of the latter can only be
appreciated by postoperative angiog
raphy.
Our results show that noninvasive
testing with myocardial stress imaging
is a sensitive method for objective evalu
ation of regional myocardial perfusion
following aortocoronary bypass surgery.
Moreover, myocardial imaging is a
m ore sensitive test than stress electro
cardiography for such evaluation.
Of considerable interest was the
finding that patients with no evidence
of myocardial ischemia by noninvasive
testing postoperatively, exhibited a sig
nificant improvement in their double
product (heart rate-blood pressure)
compared with patients in whom the
noninvasive studies were abnormal.
Nevertheless, in both groups substantial
symptomatic improvement occurred.
The long-term implications of the dif
ference in patients with complete and
incomplete revascularization is un
known. Myocardial stress imaging with
201T1 is a safe, simple, noninvasive
procedure that will perm it long-term
evaluation of myocardial revasculariza
tion.
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Profundoplasty for Limb Salvage*
T irone E. David, md,

Profundoplasty was performed in 26
legs because of rest pain or gangrene;
previous arterial reconstruction had
been done in 12 of them. In 16 limbs
the popliteotibial segment was patent;
profundoplasty was successful in each
case. In 10 limbs the popliteotibial
segment was occluded, and profundo
plasty failed in one instance. One patient
died.
The authors believe that re-establish
ing blood flow and pressure to the
deep femoral artery, especially to the
descending branch of the lateral
circumflex artery and the distal part
of the deep femoral artery can
effectively improve the condition of
ischemic legs.
Une plastie de I’artere femorale
profonde a ete pratiquee sur 26 jambes,
a cause de douleurs au repos ou de
gangrene; une reconstruction arterielle
avait deja ete effectuee dans 12 cas.
Pour 16 membres, le segment popli
teotibial etait inobstruee; la plastie de
I’artere femorale profonde a reussi
dans tous ces cas. Pour 10 membres,
le segment popliteotibial etait obstrue
et cette intervention a echoue dans
un cas. Un patient est decede.
Les auteurs croient qu'en
retablissant la circulation sanguine et
la pression dans I'artere femorale
profonde, specialement dans la branche
descendante de I’artere circonflexe
externe de la cuisse et la partie distale
de I'artere femorale profonde, on peut
effectivement ameliorer I'etat d’une
jambe ischemiee.

The importance of the deep femoral
artery in the revascularization of the
lower leg has been recognized for many
years.1,2 Most patients with aortoiliac
occlusive disease and an occluded
superficial femoral artery have a re
markable improvement of the ischemic
*From the department of cardiovascular
surgery, Toronto General Hospital
and University of Toronto, Toronto, Ont.
Presented at the annual meeting of the
Canadian Cardiovascular Society,
Toronto, Oct. 19-22. 1977
Reprint requests to: Dr. Tirone E. David,
UW8 - 110, Toronto General Hospital,
Toronto, Oct. 19-22, 1977
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symptoms following revascularization
procedures that increase pressure and
flow to the deep femoral artery.3
Many patients with an occluded su
perficial femoral artery also have
stenosis or occlusion of the deep femoral
artery4 and they usually have severe
ischemia of the leg. A femoropopliteal
or femorotibial bypass is generally rec
ommended for such patients;5’6 an al
ternative to these procedures is femoral
artery profundoplasty.7'9
We believe that patients with occlu
sion of the superficial femoral artery
and stenosis or occlusion of the deep
femoral artery should have profundo
plasty instead of a bypass procedure.
Although our experience is modest, the
results of this operation for limb salvage
have been consistently good.
Material

The Operation

Under general anesthesia, the com
mon femoral, the superficial femoral
and the deep femoral arteries were ex
posed through a long vertical incision.
The lateral circumflex vein was ligated
and divided as it crossed the deep
femoral artery. The branches of the
deep femoral artery (lateral and medial
circumflex and first, second and third
perforating branches) were carefully
dissected and preserved. Care was taken
not to injure the femoral nerve or its
branches. In all our patients, the
atherosclerotic process extended to, or
beyond, the second perforating branch.
With systemic heparinization, the com
mon femoral and the deep femoral
arteries were opened longitudinally
(Fig. 1). This arteriotomy was carried
down to the level of the second or
third perforating branch, or beyond, if
necessary. Endarterectomy was then
done (Fig. 2) and each branch was
carefully explored for patency and size
with Hegar’s dilators. Patency of the
lateral circumflex artery with its
descending branch and the distal deep
femoral artery is the key to a success
ful operation. If the lateral circumflex
artery arose from the common femoral
artery, it was dissected and endarterectomized to restore adequate blood flow
through it. “Vessel-loops” were used to
control retrograde bleeding from the
branches of the deep femoral artery. A
vein patch was used to close the arte
riotomy (Fig. 3). When a vein was not
readily available, the superficial femoral
artery was opened longitudinally, endarterectomized and used as an onlay patch
to close the arteriotomy (Fig. 4). A
Hemovac suction apparatus was left in
the wound for the first day or two. No
agent was given to counteract the effect
of heparin.
Lumbar sympathectomy was per
formed on the same occasion in three
patients with an ischemic ulcer on the
foot.

Twenty-six femoral artery profundoplasties were performed on 22 patients
during the period July 1, 1975 to June
30, 1976. There were 15 men and 7
women whose ages ranged from 44 to
82 years (mean, 66 years). Four
patients were diabetic, 16 were hyper
tensive, 18 had atherosclerotic heart dis
ease and 20 were smokers.
All legs were operated upon because
of severe ischemia: 19 for rest pain, 4
for digital gangrene and 3 for an
ischemic ulcer on the foot.
Previous arterial reconstruction had
been done in 12 legs: femoropopliteal
bypass in 5 and aortofemoral bypass
in 7. Lumbar sympathectomy had been
done in nine instances; in four it had
been combined with the previous
arterial reconstruction.
Arteriography revealed that the aor
toiliac segment was mildly diseased
(17 patients) or had been replaced by
Dacron grafts (5 patients). The super
ficial femoral artery was occluded and
the deep femoral artery was either
stenotic or occluded in all limbs. Based
on the arteriographic findings in the
distal arterial tree, it was possible to
Results
divide the limbs into two groups: those
with a patent popliteotibial segment
Patients with a Patent Popliteotibial
(16 legs) and those with occluded popli
Segment
teal and proximal tibial arteries (10
Profundoplasty to the level of the
legs).
Preoperative ankle pressure was ob second or third perforating branch was
tained in only five limbs.
carried out in every case. All patients
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obtained immediate relief from rest
pain. In three patients with digital
gangrene, the digits were left to mum
mify and the stumps were healed within
3 to 6 months after the operation. One
heel ulcer healed in 3 weeks.
Follow-up ranged from 12 to 24
months. One patient died from myo
cardial infarction. One man returned
to the hospital because of sudden cold
ness and numbness of his revascularized
limb. He was treated with heparin and
his condition improved rapidly. Femoral
arteriography revealed a thrombosed
deep femoral artery, but the lateral
circumflex artery was widely patent and
supplied the distal leg through collateral
vessels with genicular branches. He can
now walk 100 to 150 yards before
claudication occurs, but it does not in
terfere with his life-style.
The remaining 10 patients (13 oper
ated limbs) continue to do well, al
though 4 of them have intermittent
108

claudication after walking more than
200 yards; in none does it affect their
life-style.
Patients with Occluded Popliteal and
Proximal Tibial Arteries

We were unable to revascularize the
deep femoral artery completely in two
patients because of advanced athero
sclerotic disease; the arteries were
totally blocked and the intima and me
dia were entirely replaced by athero
ma; the adventitia was fibrotic. In one
patient, we were able to revascularize
the lateral circumflex artery and the
first perforating branch and this was
enough to relieve rest pain (Fig. 5).
The other patient eventually required
an above-knee amputation.
One diabetic patient died from myo
cardial infarction on the 5th postoper
ative day. The operation had relieved
his rest pain.
Eight patients have been followed up
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FIG. 4—Superficial femoral artery may
be used to close arteriotomy as an onlay
patch.
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from 12 to 24 months. None have rest
pain. Three patients feel incapacitated
by their intermittent claudication, which
occurs after walking less than 100
yards. The other five are not troubled
at all, although they all experience
claudication if required to walk longer
distances than usual.
Pre- and postoperative measurements
of blood pressure at the ankle were
available in three patients. There was a
remarkable increase in the tibial arte
rial/systemic pressure ratio in two pa
tients and no change in the third patient
(who obtained relief from rest pain and
at present does not complain of inter
mittent claudication).
Discussion

One frequently overlooks the deep
femoral artery when examining an
arteriogram, unless this vessel is severe
ly diseased. Moreover, even when the
surgeon is aware of its importance he
may not be able to assess the extent of
the occlusive disease process from
anteroposterior views of the vessel.
Lateral or oblique views give more
valuable information.4
Profundoplasty can be done as an
alternative to femoropopliteal or femorotibial bypass when the superficial
femoral artery is occluded and the

deep femoral artery is stenotic or oc
cluded. Some authors believe that pro
fundoplasty is a better operation,8 while
others prefer bypass procedures.5
Both femoropopliteal bypass and pro
fundoplasty give similarly good results
when the distal arterial tree is patent.
However, when a femorotibial bypass
has to be done to relieve ischemia, the
success of the operation may be jeo
pardized by an inadequate vein or a
diseased and small tibial artery. In
our experience, profundoplasty has
been the best operation in these cases.
We reserve femorotibial bypass for pa
tients in whom profundoplasty has
failed.
If the deep femoral artery is com
promised, we prefer profundoplasty
to femoropopliteal bypass.
We believe that proximal arterial
reconstruction should always be done
first. A carefully performed extended
profundoplasty gives uniformly good
results when the popliteal artery is
patent. Physiologic studies reveal a
remarkable improvement of the blood
supply to the leg.3,8 More importantly,
ischemic symptoms are relieved and
the intermittent claudication is either
completely relieved or improved.
Some authors reported poor results
when profundoplasty was carried out on
patients with an occluded popliteotibial
segment.7,10 However, our experience
was different. Eight of 10 patients
had a notable improvement following
profundoplasty. It is possible that by
increasing pressure and flow through
the branches of the deep femoral artery,
new collateral vessels open up and may
enlarge with time. When operating on
these severely ischemic limbs, one must
remember that each tiny arterial branch
is carrying a vital amount of blood.
The importance of the descending
branch of the lateral circumflex artery
cannot be stressed enough (Fig. 5). We
have measured blood flow through
this vessel after endarterectomy and
patching of the deep femoral artery
and have found that it often carries
more blood than all perforating
branches together.
Profundoplasty can be performed un
der local anesthesia.11 However, when
an extensive dissection has to be done—
sometimes beyond the third perforating
branch—the procedure can be difficult
for both surgeon and patient.
Although the role of sympathectomy
in patients undergoing profundoplasty
has not been established, we think it
may be a useful adjunct to the arterial
reconstruction.
References

FIG.
showing
and first
complete

5— Postoperative
arteriogram
patent lateral circumflex artery
perforating branch following in
profundoplasty.

VOLUME 21, NO. 2, MARCH 1978

/

1. L eeds FH, G ilfillan RS: Importance
of the profunda femoris artery in the
revascularization of the ischemic
limb. Arch Surg 82: 25, 1961

2. M orris GC j r , E dwards W, C ooley
DA, et al: Surgical importance of the
profunda femoris artery. Ibid, p 32
3. Strandness DE j r : Functional re
sults after revascularization of the
profunda femoris artery. Am J Surg
119: 240, 1970
4. B eales JSM, A dcock FA, F rawley
JS, et al: The radiological assessment
of disease of the profunda femoris
artery. Br J Radiol 44: 854, 1971
5. L inton RR: An Atlas of Vascular
Surgery, Philadelphia, Saunders, 1973
6. N oon GP, D iethrich ED, R ichard
son WP, et al: Distal tibial artery
bypass. Analysis of 91 cases. Arch
Surg 99: 770, 1969
7. C otton LT, R oberts V C: Extended
deep profunda angioplasty: an alter
native to femoropopliteal bypass. Br
.1 Surg 62: 340, 1975

8. M artin P, J amieson C: The rationale

for and measurement after profundo
plasty. Surg Clin North Am 54: 95,
1974
9. M artin P, F rawley JE, Barabas AP,
et al: On the surgery of atheroscle
rosis of the profunda femoris artery.
Surgery 71: 182, 1972
10. M orris-Jones W, J ones CDP: Pro
fundoplasty in the treatment of the
femoropopliteal occlusion. Am J Surg
127: 680, 1974
11. Bernhard VM, M ilitello JM,
G eringer AM: Repair of the pro
funda femoris artery. Am J Surg 127:
676, 1974

BOOKS RECEIVED
This list is an acknowledgement of books
received. It does not preclude review at a
later date.
Annual Review of Birth Defects, 1976.

Part A. Numerical Taxonomy of Birth
Defects and Polygenic Disorders. Spon
sored by The National FoundationMarch of Dimes at The University of
British Columbia, Vancouver. Edited by
Daniel Bergsma and R. Brian Lowry.
163 pp. Illust. Alan R. Liss, Inc., New
York, 1977. $20. ISBN 0-8451-1011-X.
Annual Review of Birth Defects, 1976.

Part B. New Syndromes. Sponsored by
The National Foundation-March of
Dimes at The University of British
Columbia, Vancouver. Edited by Daniel
Bergsma and R. Brian Lowry. 268 pp.
Illust. Alan R. Liss, Inc., New York,
1977. $32. ISBN 0-8451-1011-X.
Annual Review of Birth Defects, 1976.

Part C. Natural History of Specific
Birth Defects. Sponsored by The Na
tional Foundation—March of Dimes at
The University of British Columbia,
Vancouver. Edited by Daniel Bergsma
and R. Brian Lowry. 257 pp. Illust. Alan
R. Liss, Inc., New York, 1977. $30.
ISBN 0-8451-1012-8.
Annual Review of Birth Defects, 1976.

Part D. Embryology and Pathogenesis
and Prenatal Diagnosis. Sponsored by
The National Foundation—March of
Dimes at The University of British Co
lumbia, Vancouver. Edited by Daniel
Bergsma and R. Brian Lowry. 298 pp.
Illust. Alan R. Liss, Inc., New York,
1977. $30. ISBN 0-8451-1013-6.

THE CANADIAN JOURNAL OF SURGERY

continued on page 113
109

Gelfoam
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Femorofemoral Bypass: A Valuable Procedure*
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Twenty-seven femorofemoral bypasses
were performed in 25 patients with
severe arteriosclerosis obliterans
affecting the iliofemoral arteries. The
series comprised 16 men and 9 women,
aged 51 to 80 years. Nineteen patients
were poor-risk cases with severe
cardiorespiratory disease. Twenty-one
patients had undergone vascular
procedures previously without success.
The operation was carried out: (a) as
the primary procedure for very poor-risk
patients in an attempt to salvage a
limb, (b) to deal with unilateral limb
occlusion of an aortoiliac-femoral
prosthesis, or (c) as management of
infected prosthetic grafts. Fourteen
Dacron grafts and 13 saphenous veins
were used for the bypasses. There
were no operative deaths. Twenty-two
patients were clinically improved, two
required amputation later and one
patient was lost to follow-up. Four
patients, including three with pre
existing graft infection, had wound
infections that cleared with drainage
and antibiotics. No other major com
plications occurred in this group of
poor-risk patients. Femorofemoral
bypass is safe and provides the surgeon
with a useful method of revascularizing
the limbs of selected patients.
Vingt-sept derivations femorofemorales
ont ete effectuees chez 25 patients
souffrant d’arteriosclerose avancee
affectant les arteres iliofemorales.
Cette serie comporte 16 hommes et 9
femmes, ages de 51 a 80 ans. Dixneuf patients souffraient de maladies
cardiorespiratoires severes et etaient
consideres comme de “mauvais risques”. Vingt-et-un patients avaient
deja subit une intervention vasculaire,
*From the division of cardiovascular
and thoracic surgery, McGill University
and the Montreal General Hospital,
Montreal, PQ
Presented at the annual meeting o f the
Canadian Cardiovascular Society,
Toronto, Ont., Oct. 19-22, 1977
tPresent address: Division of cardio
vascular and thoracic surgery, Queen’s
University, Kingston, Ont.
Reprint requests to: Dr. R.CJ. Chiu,
The Montreal General Hospital, 1650
Cedar Ave., Montreal, PQ H3G 1A4
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sans succes. L'operation a ete entreprise: (a) comme intervention primaire
chez des patients a risque eleve, pour
tenter de sauver un membre, (b) pour
corriger I’occlusion unilateral d’une
prothese de I’artere iliofemorale, ou
(c) pour traiter un greffon prosthetique
infecte. Quatorze greffons de Dacron
et 13 veines saphenes ont ete utilises
pour les pontages. II n'y a eu aucun
deces peroperatoire. Vingt-deux pa
tients ont ete ameliores cliniquement,
deux ont du subir une amputation par
la suite et un patient ne s'est pas repre
sente. Quatre patients, dont trois qui
avaient une infection pre-existante du
greffon, ont eu une infection de la plaie,
qui a gueri avec un drainage et des
antibiotiques. Aucune autre complica
tion serieuse n'est survenue chez
ce groupe de patients a risque eleve.
La derivation femorofemorale est sure
et offre au chirurgien une methode
utile de revascularisation des membres
chez des patients choisis.
The major indications for fem orofem o
ral bypass in patients with severe arteri
osclerosis
obliterans
involving
the
peripheral arteries are: cardiorespiratory
disease in a poor-risk patient, previous
abdominal surgery or irradiation, peri
toneal sepsis and occlusion o f a limb
after an aortoiliac-femoral bypass.1"1
This list may be enlarged to include
infection o f an aortoiliac-femoral pros
thesis.5 The present series was reviewed
to evaluate the usefulness o f this proce
dure in reducing operative mortality
and morbidity and in salvaging limbs
o f poor-risk patients, and to determine
the conduit o f choice for this opera
tion.

Patients and Methods

/
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From 1970 to 1977, 27 fem orofem o
ral bypasses were performed in 25
patients at the Montreal General Hos
pital. The series comprised 16 men and
9 women, aged 51 to 80 years (mean,
64.8 years). Nineteen patients were
classified as poor operative risks be
cause o f severe cardiopulmonary dis
ease. Twenty-three patients complained
o f severe intermittent claudication, 12
suffered rest pain and 1 had impend
ing gangrene, indicating an imminent
threat to limb viability. Four very poor-
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risk patients with unilateral occlusive
disease o f the iliac artery underwent
fem orofem oral bypass as the primary
procedure for limb salvage; 21 patients
had already had one or more vascular
procedures that had proved unsuccess
ful, including aortoiliac-femoral and
iliofemoral bypasses, iliac endarterec
tomy, abdominal aneurysmectomy and
others (Table I). The interval between
the first operation and the fem oro
fem oral bypass varied from 2 months
to 6 years (mean, 2.5 years). In one
patient a sympathectomy was performed
concomitantly with a fem orofemoral
bypass.
In all patients the procedure was
carried out under light general anesthe
sia. Fourteen bypasses were performed
using Dacron or D acron-velour grafts
(diameter, 5 to 8 mm). The remaining
13 grafts were reversed autogenous sa
phenous vein.
In two patients with a previous aortofemoral bypass, one limb o f the graft
was infected at the groin. In one o f
the two a false aneurysm also developed
at the site o f infection. At the time o f
operation on these patients, draping
w7as done in such a way as to isolate
and seal o ff the infected groin before
the abdomen was entered to allow in
spection o f the aortofemoral Dacron
graft. In both cases infection had not
extended to the bifurcation o f the
graft. This was later confirmed when
bacteriologic cultures produced no
growth o f organisms. The infected limb
o f the graft was then ligated and tran
sected near the level o f the bifurcation.
The peritoneum and graft tract were
closed with chromic catgut sutures to

1— In d ic a tio n s
fo r
F e m o ro fe m o ra l
B ypass in 25 P a tie n ts

In d ic a tio n
P rim a r y , u n ila te r a l ilia c d is e a s e ,
p o o r ris k
A o r to ilia c - fe m o r a l g r a ft lim b
o c c lu s io n
Ilio fe m o r a l g r a ft o c c lu s io n
Ilia c e n d a rte re c to m y o c c lu s io n
In fe c te d a o r to ilia c - fe m o r a l g r a ft
Ilia c a r te r y th ro m b o s is , p o ly 
c y th e m ia v e ra

No. o f
p a tie n ts

4

♦

%
A

12
3
2
3
-I
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prevent further contamination. The
abdominal wound was closed and
draped so as to seal it from the groin.
A segment of saphenous vein was then
removed from the noninfected thigh
and anastomosed to the noninfected
donor femoral artery. Finally, the op
posite groin was opened, the infected
limb of the prosthetic graft was removed
and the crossover femorofemoral by
pass was completed. The subcutaneous
tissue was approximated over the graft
and the skin was left open. Both pa
tients made an uneventful recovery.
In a third patient an aortoduodenal
fistula developed following the resec
tion of an abdominal aortic aneurysm
and insertion of a graft. The infected
graft was removed, and axillofemoral
and crossover femorofemoral bypass
grafts were introduced using 8-mm
Dacron prostheses. This patient also
recovered without complication.
Two patients had occlusion of one
limb of an aortobifemoral Dacron
graft. One and 3 years later, both re
ceived femorofemoral bypasses using
Dacron grafts. These grafts also throm
bosed, so that a second saphenous vein
femorofemoral bypass was required 6
months and 1 year later, respectively.
Results

No death occurred within 30 days of
the operation. In two patients limb
salvage was attempted despite poor
run-off, as indicated by severe rest pain
and imminent gangrene, using a Da
cron graft for one and a saphenous
vein femorofemoral bypass for the
other. Both bypasses failed, with the
result that above-knee amputations were
necessary after 14 and 20 days, respec
tively. Superficial infections caused by
Staphylococcus aureus developed in
four patients, including the three with
pre-existing infected grafts. All these
infections cleared after drainage and
administration of antibiotics without
removal or failure of the grafts. For up
to 14 months there was no evidence of
recurrent infection.
The femorofemoral grafts were found
pulsating in 14 patients for up to 5
years; the average duration of follow
up was 22 months. In 10 patients, 6
with Dacron and 4 with venous grafts,
pulsation could not be felt but the legs
were viable at an average follow-up
of 3 months. Pulsation in the graft was

not documented in three patients who
had viable extremities (Table II). The
patency of Dacron grafts therefore ap
pears to be not appreciably different
from that of vein grafts, although vein
grafts were used as the conduit of
choice when a Dacron prosthesis had
failed.
Twenty-two patients who had femo
rofemoral bypass showed immediate
clinical improvement after the opera
tion and had viable legs. In two of
these a second femorofemoral bypass
was performed. Two patients required
early amputation and the clinical status
of one patient is unknown.
Discussion

Whenever feasible an aortoiliac-femoral bypass is the procedure of choice
for aortoiliac occlusive disease, since
Theologically it is superior and does not
rely on the continued patency of the
donor iliofemoral artery. However, since
McCaughan and Kahn3 first performed
femorofemoral bypass in 1960, the in
dications for this procedure have
broadened. Our own experience with
27 grafts in 25 patients, many of them
for limb salvage in very poor-risk pa
tients, confirmed the advantages of this
procedure in selected cases.4 All our
patients tolerated the light anesthesia
well and there was no mortality or
serious cardiorespiratory complication.
Patients are ambulant almost imme
diately and, since the abdominal cavity
is not entered, can be fed soon after
recovery from anesthesia.
The lack of pulsation in the graft dur
ing follow-up may not indicate graft
occlusion in all cases, as it does not
necessarily lead to gangrene of the leg
or aggravation of symptoms. Moreover,
if occlusion is delayed, there may be
time for collateral vessels to develop.
Dissection of the saphenous vein for
a femorofemoral bypass is more timeconsuming than insertion of a prosthe
sis, but we tend to use the vein as the
conduit of choice in patients with a
poor run-off, because of its superiority
in the femoropopliteal area. This may
have produced a bias in our estimation
of the patency of vein grafts. No “cir
culatory steal” from the donor limb,
as reported by some authors,6 was noted
in these patients.
Femorofemoral bypass can also be
used in the treatment of certain infected

Table II— Patency of 27 Femorofemoral Bypass Grafts

Type of conduit

No. of grafts

Loss of graft
pulsation

Patency
unknown

Dacron graft
Vein graft

14
13

6/12
4/12

2
1

Total

27

10/24

3
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aortofemoral bypass grafts. An axillo
femoral bypass with the removal of the
entire infected graft is usually the
operation of choice.7 However, the
axillofemoral bypass is associated with
a high occlusion rate, a high mortality
rate and a high incidence of bilateral
amputations.5 Our experience indicates
that when the infection is localized to
the groin area with no evidence of
spread to the bifurcation of the aortic
graft, the infected graft limb can be
removed and the lower extremity re
vascularized with a femorofemoral
crossover vein graft. If upon explora
tion the intra-abdominal graft is found
to be infected, or is proved to be so by
the subsequent clinical course and re
sults of bacteriologic cultures, the en
tire graft can be removed and, in the
presence of functioning femorofemoral
bypass, a unilateral axillofemoral by
pass performed.
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Acute Cardiac Failure: The Relation Between Coronary
Flow and Oxygen Consumption*
W.J. K eo n ,

md , frcs [c ],

Y. A kyurekli,

In an initial study with dog hearts
functioning in situ on total coronary
bypass, we demonstrated that prede
termined levels of reduced cardiac pump
function could be achieved by reducing
total coronary flow through changes in
the perfusing pressure. In subsequent
experiments, oxygen values were
measured so that changes in myo
cardial aerobic consumption in response
to brief (3 minute) alterations in
coronary perfusing pressure could be
determined as well. As a result significant
linear correlations were found between
coronary flow and myocardial oxygen
availability (r = 0.98), oxygen extraction
(r = 0.49) and oxygen consumption
(r = 0.92). These changes in oxygen
values paralleled those in cardiac func
tion (stroke work, r = 0.84).
Au cours d’une etude initiale sur le
coeur de chien in situ en derivation
coronarienne complete, nous avons
demontre que des niveaux predetermines
de fonction cardiaque diminuee
pouvaient etre obtenus en reduisant le
debit coronarien total par des changements de la pression de perfusion.
Dans des experiences subsequentes,
les concentrations d’oxygene ont ete
mesurees de facon a ce que les
changements de la consomption
aerobique du myocarde en reponse a
de breves (3 minutes) alterations de la
pression coronaire de perfusion puissent
egalement etre decrits. Comme resultat,
des correlations lineaires significatives
ont ete trouvees entre le debit
coronarien et la disponibilite d’oxygene
myocardique (r = 0.98), I’extraction
d’oxygene (r = 0.49) et la consommation
d’oxygene (r = 0.92). Ces changements
dans les concentrations d'oxygene
ont ete paralleles a ceux de la fonction
cardiaque (travail systolique, r = 0.84).

*From the University of Ottawa cardiac
unit, Ottawa Civic Hospital, Ottawa, Ont.
Presented at the annual meeting of
the Canadian Cardiovascular Society,
Toronto, Ont., Oct. 19-22, 1977
Supported by the Ontario Heart
Foundation
Reprint requests to: Dr. W.J. Keon,
University of Ottawa cardiac unit,
Ottawa Civic Hospital, 1053 Carling Ave.,
Ottawa, Ont. K 1Y 4E9
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md , frcs [c ],

G .c. T aichman ,

In reviewing the literature on the
regulation of coronary blood flow
(CBF), Rubio and Berne1 stated that
several factors can influence the quan
tity of blood passing through the heart.
A primary determinant, they noted,
was myocardial oxygen consumption.
Although it is generally accepted that
coronary flow is highly responsive
to conditions of myocardial oxygen
demand under physiologic conditions,
certain pathologic states may diminish
this autoregulatory process so that CBF
may become a critical determinant of
cardiac pump function. Within the
physiologic range of flow there is a
lack of agreement on the determinant
effects of coronary flow on cardiac
pump function and myocardial oxygen
consumption. In thoracotomized ani
mals2,3 and isolated hearts4 decreases
in coronary flow produced similar
changes in cardiac work and oxygen
consumption. However, both Ross and
colleagues,5 using perfused hearts at
a constant level of work, and Sarnoff
and associates,6 using isolated supported
hearts at controlled levels of activity,
observed that alterations in flow did
not alter myocardial oxygen consump
tion. In a previous report7 we demon
strated with dog hearts working in situ
that there was a significant linear rela
tion between changes in coronary flow
and various hemodynamic indices of
cardiac pump function. The present
study was undertaken to define the
changes in aerobic consumption asso
ciated with these induced hypodynamic
states.
Methods

Short-term experiments were per
formed on male mongrel dogs (body
weight, 23 to 47 kg). As previously
described7 animals received premedica
tion of atropine (0.4 mg, intramuscu
larly) and were anesthetized with so
dium thiopental (20 mg/kg, intravenous
ly). Tracheal intubation was performed
and positive-pressure ventilation with
a Harvard pump (Harvard Apparatus,
Millis, MA) initiated. Animals were
maintained at a surgical plane of anes
thesia with a mixture of 30% nitrous
oxide and 70% oxygen plus 0.25% to
0.75% halothane. Animal core tem
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perature was maintained between 35°
and 37°C with a thermoregulating
water blanket. As a precautionary
measure against ventricular arrhyth
mias, all animals received a priming
dose of lidocaine hydrochloride (70
mg) followed by continuous infusion
(2 mg/min) throughout the experiment.
The heart was exposed through the left
fifth intercostal space and1 the peri
cardial sac opened and sutured to the
walls of the thoracic wound in order
to cradle the heart.
The major components of the coro
nary arterial circulation were isolated,
after blunt dissection, with 2-0 silk ties.
In our initial study,7 the left coronary
system was perfused through cannulas
introduced into the circumflex (CX)
and left anterior descending (LAD)
arteries at the distal end of the left
main stem (Fig. la); in the present
experiment the technique was modified
to perfuse the initial branches of the
left main coronary artery as well.8 The
CX artery was cannulated proximally
and distally at a point 3 to 5 cm from
its origin, and the left main coronary
artery was isolated at its aortic origin
with 3-0 silk. By occluding the left
main stem and perfusing the proximal
CX artery, we perfused all initial
branches of the left main stem (septal
artery) plus the LAD artery; through
the distal cannula on the CX branch
we were able to perfuse the remaining
portion of the CX artery (Fig. lb). The
right coronary (RC) artery was per
fused from a catheter introduced at
its aortic origin.
During these experiments various
hemodynamic variables were monitored.
Heart rate was computed from the
electrocardiographic (lead II) signal.
Arterial (systolic, diastolic and mean)
and left ventricular (systolic and
diastolic) pressures were measured from
fluid-filled catheters (Cordis, no. 521742, Cordis Corporation, Miami, FL)
in conjunction with Statham P23Db
transducers (Statham Instruments, Ox
nard, CA) and Electronics for Medicine
SGM-2 amplifiers (Electronics for
Medicine, White Plains, NY). Right
and left mean atrial pressures were
determined by direct cannulation and
water manometry. All pressures were
referenced to the level of the right

THE CANADIAN JOURNAL OF SURGERY

atrium. Flow through the pulmonary
artery (cardiac output) was measured
periodically by means of a thermodilu
tion technique using a Swan-Ganz
catheter (no. 93-118-7F, Edwards Labo
ratory, Santa Ana, CA) in conjunction
with an Edwards computer (model
9510). Coronary flows were measured
by three extracorporeal electromag
netic flow probes (Biotronex BLC-2032,
Biotronex Laboratories, Silver Spring,
MD)
in
series
with
perfusing
Travenol 5M0287 cannulas (Travenol
Laboratories, Deerfield, IL). At the end
of each experiment, flow probes were
calibrated by means of timed samples.
In deriving total CBF, blood flows to
all three vessels (LAD, CX and RC)
were added together and normalized
per 100 g of ventricular weight meas-

ured at the completion of the experi
ment. In analysing these hemodynamic
data, electronic signals were either
recorded directly on a Beckman S-l 1
dynograph (Beckman Instruments Inc.,
Schiller Park, IL), or stored on Bell and
Howell VR-3200 magnetic tape (Bell
and Howell, Pasadena, CA) for later
processing. Myocardial aerobic data
were obtained by measuring the up
take of oxygen across the coronary cir
culation. Accordingly, arterial (extra
corporeal) and coronary sinus blood
samples were drawn and analysed for
their oxygen content ([0]A and [Ojc«,
respectively) with a Lexington analyser
(LEX-O 2-CON-TL, Lexington Instru
ments, Waltham, MA). These data, in
combination with CBF values, were
then used to compute
1. myocardial oxygen availability
(mL/min-100 g) = (CBF)([O]A)/(100);
2. myocardial oxygen extraction (%)
=

«0 ]A

-

[0]CS)(100)/([0]A);

3. myocardial oxygen consumption
(mL/min-100 g)-(CBF)([O]A-[OW /(100).

was achieved, no further alterations
were made throughout the experiment.
Towards the end of the stabilization
period, two sets of biochemical and
hemodynamic values were obtained, 15
minutes apart. If values were con
sistent, both sets of data were averaged
and used as control values for all sub
sequent maneuvers; if not, additional
time was allocated for stabilization.
Arterial blood-gas samples were
analysed periodically for pH and oxy
gen and carbon dioxide pressures (Po2
and Pco2) by means of a Radiometer
BMS-3 analyser (Radiometer, Copen
hagen, Denmark) and appropriate ad
justments were made to the animal or
to the extracorporeal circuit by altering
the inspiratory content of carbon diox
ide or by the administration of 10%
sodium bicarbonate. Arterial blood val
ues from animal sources ranged from
7.33 to 7.47 for pH, 93 to 146 mm Hg
for P 0 2 and 28 to 36 mm Hg for Pco2,
while arterialized blood from extracor
poreal sources ranged from 7.37 to
7.43 for pH, 83 to 136 mm Hg for
Po2 and 32 to 48 mm Hg for P co2.
In these experiments nine dogs were
used to investigate myocardial oxygen
consumption at various rates of re
duced CBF. Accordingly, brief (3 min
ute) reductions in CPP were used to
reduce CBF. At the end of this period
hemodynamic and oxygen values were
ascertained, after which the CPP was
returned to 120 mm Hg. In all, eight
different hypotensive pressures were
examined from 110 mm Hg to 40 mm
Hg in a randomized fashion. Between
these hypotensive periods the animals
were allowed to recover for 10 min
utes; if at the end of this period control
hemodynamics (± 10% ) were not re
established, the data from these animals
were excluded from further analysis.

FIG. 1— (a) Initial method of cannulating and perfusing coronary vascula
ture.7 (b) Current method, left main
coronary stem ligated. LAD = left an
terior descending, CX = circumflex, RC
= right coronary.

The extracorporeal circuit was primed
with heparinized (3 mg/kg) citrated
whole blood from donor dogs and H art
mann’s solution in a 1:1 ratio. During
coronary bypass, venous blood was col
lected from both femoral veins into a
reservoir whose height regulated the
venous pressure (9 to 16 cm H 2O). This
blood was then oxygenated and heated
to body temperature (37°C) by a H ar
vey H-200 oxygenator (W. Harvey
Research Corp., Santa Ana, CA). Arterialized blood was then pumped to a
second reservoir, which subsequently
drained into the three coronary per
fusing catheters. Flows to the coronary
arteries were established on the basis
of the height of this reservoir above the
left atrium. To minimize the systemic
hypotensive states encountered during
coronary artery cannulation, the extra
corporeal system was equipped with a
partial bypass. This circuit was used
only during the initial phases of coro
nary bypass and was discontinued early
during the stabilization period. In addi
tion, excessive left ventricular pressures
were avoided by cannulating the left
atrium with a wide-bore catheter in
conjunction with the pressure reservoir.
Adjustments were made in the reservoir
height so that the left intra-atrial pres
sure would not exceed 30 cm H 2O.
Once coronary perfusion was estab
lished, animals were allowed to stabilize
for at least 60 minutes at a coronary
perfusing pressure (CPP) of 120 mm
Hg. During this period the plateau of
the Frank-Starling curve (myocardial
heterometric relation) was established
by adjusting the venous pressure until
arterial pressure and cardiac output
were maximal. Once the desired level
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Results

Since the dogs in this experiment
were cannulated in a different manner
from that previously described,7 two
were monitored for a 5-hour period
(starting 10 minutes after cannulation)
at a constant CPP of 120 mm Hg (Fig.
2). During the stabilization period flows
to all coronary vessels slowly declined
until a steady state was reached, with the
exception of RC flow which continued
to decrease throughout the observation
period. However, RC flow represented
the smallest component of the total
CBF. The reduction and developing
steady state conditions seen in the
coronary flows paralleled changes in
myocardial oxygen consumption, while
systemic hemodynamic values quickly
recovered after cannulation and re
mained relatively unchanged (range,
-17% to + 8% ). Hemodynamic values
obtained towards the end of the stabi115
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FIG . 2— Coronary flows and hemodynamic data from one dog in control study.
Records were started 10 minutes after coronary perfusion was established.

lization period (control) are presented
in Table I for the 11 animals in this
study. The results are in agreement with
those previously reported. Brief (3 min
ute) reductions in CPP evoked similar
reductions in CBF (Fig. 3), of approxi
mately equal magnitude (a 71% ± 3 %
reduction in CBF resulted from a 67%
decrease in CPP). Fig. 4 demonstrates
that the decrease in total CBF was

sustained equally by all three com
ponents of the coronary circulation
(based on our current method of cannulation and perfusing the heart). Fig. 4
also demonstrates that most coronary
flows at all levels of CPP were pre
dominantly left coronary (LAD and
CX) in origin. As a result of sharp re
ductions in CBF, myocardial oxygen
availability decreased (Fig. 5) with a

significant degree of linear correlation
(r = 0.98). The decrease in CBF caused
the heart to extract more oxygen from
its limited supply (Fig. 6). Although
the correlation coefficient for CBF
versus oxygen extraction was low
(r = 0.49), the value was significant
and can be attributed to a large varia
tion between different animals, since
individual trends for each animal (Fig.
7) demonstrated similar inverse rela
tions. In addition, the magnitude of the
change in oxygen extraction was con
siderable: at the lowest CPP (40 mm
Hg) the value had increased to 79% ±
3% from 59% ± 6% at a CPP of 120
mm Hg. In spite of this compensatory
change in the ability of the heart to
extract more oxygen, myocardial oxy
gen consumption decreased in a linear
fashion (r = 0.92) with blood flow
(Fig. 8); however, the magnitude of the
decrease (-71% ± 3%) was greater
than the reduction in oxygen consumed
(-60% ± 3 % ) . The net result of these
changes, whereby a significant linear
correlation (r = 0.84) was established
between CBF and myocardial pump
function (expressed as cardiac work),
is shown in Fig. 9.

T a b le 1— H e m o d y n a m ic D a ta in 11 D o g s *

D iscussion

V a r ia b le

M e a s u re m e n t

H e a r t r a t e , b e a ts /m in
P re s s u r e s
A r t e r i a l — m ean, m m Hg
s y s to lic , m m Hg
d ia s to lic , m m Hg
R ig h t a t r i a l , cm H 20
L e f t a t r i a l , cm H 20
L e f t v e n tr ic u la r e n d -d ia s to lic , m m Hg
M a x im u m r a t e o f le ft v e n tr ic u la r p re s s u re (m a x d P / d t ) , m m H g /s
F lo w s
C a r d ia c in d e x , m L /m in -k g
C o r o n a r y flo w , m L /m in -1 0 0 g
% le ft a n te r io r d e s c e n d in g a r t e r y
% c irc u m fle x a r t e r y
% r ig h t c o ro n a ry a r t e r y
L e f t /r ig h t ra tio
S tr o k e w o r k , k g -m /m in
H e m o g lo b in , g /d L
O x y g e n v a lu e s
A r t e r i a l c o n te n t, m L /d L
C o r o n a r y s in u s c o n te n t, m L /d L
M y o c a r d ia l a v a ila b ility , m L /m in -1 0 0 g
M y o c a r d ia l e x tr a c tio n , %
M y o c a r d ia l c o n s u m p tio n , m L /m in -1 0 0 g

127 ± 15
119
131
97
13
23
19
2204

±
±
±
±
±
±
±

8
10
9
3
6
4
184

140
94
44
38
18
4.5 1
5.1
10 .9

±
±
±
±
±
±
±
±

29
13
3
3
2
0 .4 9
0 .4
0 .3

14.4
6 .3
1 4 .8
59
8 .7

±
±
±
±
±

1 .6
0 .4
2 .0
6
0 .9

• A l l v a lu e s (m e a n ± S E M ) w e re ta k e n a t e n d o f s ta b iliz a tio n p e rio d (c o n tro l v a lu e s ).

116

VOLUME 21, NO. 2, MARCH 1978

/

In these studies, the major problem
of electrical instability, which was
evident in our initial report,7 was over
come by modifying three aspects of the
animal model: first, an alternative meth
od of cannulating the left coronary
artery was used; second, left atrial
pressure was partially regulated; and
third, lidocaine hydrochloride was in
fused continuously. Previously, the left
coronary circulation was perfused from
extracorporeal sources distal to the
main stem. In an effort to assess the
effectiveness of this type of cannulation (Fig. la), radioactive-labelled
(ytterbium-169) microspheres, 15fi ±
5/a in diameter, were introduced into
the coronary reservoir and the distribu
tion was measured.9 In three animals
cannulated as in Fig. la and perfused at
a CPP of 120 mm Hg, 78% ± 9 %
of the nutritive flow originated from
extracorporeal sources (unpublished
THE CANADIAN JOURNAL OF SURGERY
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FIG. 5—Relation between myocardial
oxygen availability and total CBF.

FIG. 8—Relation between myocardial
oxygen consumption and total CBF.
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free wall of the right ventricle.10 In
our initial study,7 the septal artery was
not perfused by the extracorporeal cir
cuit; thus, during hypotensive episodes
associated with coronary cannulation
and the induction of bypass, myocardial
areas perfused by the septal artery may
have sustained longer periods of re
duced flow. As a result, our initial
model was susceptible to ventricular
arrhythmias during either stabilization
or the subsequent experimental period.
In the present study changes in coro
nary flow were induced by 3-minute
alterations in CPP. Over the perfusing
pressure range of 70 to 130 mm Hg
Mosher and associates11 have shown
that coronary flow remains constant
(autoregulates), while below and above
this range coronary flow becomes pres
sure-dependent. Our results (Fig. 3)
indicate that such a response could not
be elicited; however, our earlier study7
demonstrated that longer periods (10
minutes) of reduced CPP were asso
ciated with a mild autoregulatory re
sponse. Part of the defect may be a
result of the hemodilution imposed by
the extracorporeal circuit, since changes
in arterial oxygen by dilution12 or desaturation13 may modify the response.
Our observations provide evidence
that cardiac pump function as well as
myocardial oxygen consumption can be
greatly influenced by reductions in
coronary flow. These observations on
dog hearts working in situ agree with
those of earlier studies2"4’13 and em
phasize the range and linearity of the
correlation. In the experiments reported
by Opie14 and Bacaner, Lioy and
Visscher13 the rate of oxygen delivery
rather than changes in CBF were con
sidered primarily responsible for the
alterations in myocardial performance
by eventually limiting myocardial aero
bic consumption.4’5 In addition, other
authors have shown that perfusing pres
sure15 and coronary flow16 can inde
pendently affect the inotropic state as
well. On the other hand, Sarnoff and
associates6 and Ross and colleagues5
have reported that CBF and myocardial
oxygen consumption were not interre
lated when external work was held
constant; however, both studies have
been criticized not only in terms of
methodology3 but also interpretation of
data.13 In the present study the primary
mechanism responsible for decreases in
cardiac pump function appears to be a
reduction in myocardial oxygen con
sumption caused by a decrease in oxy
gen availability.
Myocardial ischemia is said to exist
when coronary arterial flow proves in
sufficient to accommodate functional
demands. Since over 90% of the energy
normally produced by the consumption
of substrates and oxygen is utilized to
support mechanical activity,17 a substan-

FIG. 6—Relation between myocardial
oxygen extraction and total CBF.

FIG. 9—Relation between cardiac work
and total CBF.

FIG. 7—Relation between myocardial
oxygen extraction and total CBF. Each
line is a linear regression line for each
animal.

data), while the remaining parts of the
heart presumably either were not per
fused at all or were perfused from the
aortic root. In the dog, the left coro
nary artery carries the largest portion
of the total supply10 and usually arises
from the aortic root as a single vessel,
although double openings are occasion
ally present (12%). The main stem of
the left coronary artery is usually short
and soon divides into LAD and CX
branches. In 83% of the animals
studied, the septal artery arose from
the posterior wall of the main stem to
supply the basal portions of the inter
ventricular septum and part of the
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Patency of Aortocoronary Saphenous Vein Bypass Grafts
5 to 7 Years After Surgery*
L u c ie n C a m pea u , m d , f r c p [c ], J acques L espera n ce , m d , F red erico C orbara , m d , J acques H er m a n n , m d ,
C laude G ro n d in , m d , fr c s [c ] and M artial G. B ourassa , md

Sequential studies have been carried
out on two series of patients who
underwent aortocoronary saphenous
vein bypass grafting. The first series
was studied at the onset of our surgical
experience and the second series
2 years later after surgical techniques
had been modified. Angiographic studies
were performed at 2 to 3 weeks and
at 6 to 18 months after surgery. The

present study, which evaluates the
results 54 to 88 months after operation, is
based on 100 unselected patients who
were known to have at least one
patent graft 6 to 18 months after
operation. Only 17 of the 159 grafts
became occluded during a mean interval
of 5 years, giving an average yearly
attrition rate of 2.2% after the first
year. The mean yearly attrition rate was
2.4% in the first series (group 1) and
0.7% in the second series (group 2)
of patients. The cumulative graft
patency rate was 57.7% at a mean
postoperative time of 6.7 years in
group 1 and 83.2% at 5 years in group 2.
Late graft failure was more frequent in
grafts which, at the 6- to 18-months
evaluation, had localized stenoses at
anastomoses or on the graft trunk; such
stenoses are believed to be associated

*From the Montreal Heart Institute and
the University of Montreal, Montreal, PQ
Presented at the annual meeting of the
Canadian Cardiovascular Society, Toronto,
Ont., Oct. 19-22, 1977
Supported in part by research funds
from the J.L. Levesque Foundation
Reprint requests to: Dr. Lucien Campeau,
Montreal Heart Institute, 5000 Belanger
St. E, Montreal, PQ H IT 1C8
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with unsatisfactory surgical techniques.
Localized narrowing appearing after
the first year was observed in 14
grafts (8.8%) and was believed to be
of atherosclerotic origin. Such narrowing
may also lead to graft failure.
L’etude porte sur I'exploration angiographique 54 a 88 mois apres pontage
aortocoronarien par veine saphene. II
s’agit de I’etude la plus tardive parmi
les explorations postoperatoires
sequentielles effectuees d'une fapon
prospective chez des patients faisant
partie de deux series distinctes. La
premiere serie a ete composee de
patients parmi nos premiers operes,
et la deuxieme serie faite de patients
operes 2 ans plus tard apres modifi
cations des techniques chirurgicales.
Ces explorations ont ete pratiquees
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2 a 3 semaines et 6 a 18 mois apres
la chirurgie. Des patients ayant au moins
une greffe permeable a revaluation
de 6 a 18 mois, 100 patients ont pu
etre explores tardivement. Des 159
greffes etudiees, 17 se sont obstruees
durant un intervalle moyen de 5 ans,
pour un taux moyen annuel d'occlusion
de 2.2% apres la premiere annee. Le
taux moyen d'occlusion est de 2.4%
pour les patients de la premiere serie
et de 0.7% chez les patients de la
deuxieme serie. La permeabilite cumulee
dans la premiere serie est de 57.7%
a un temps moyen postoperatoire de
6.7 annees, et elle est de 83.2% a
5 ans dans la deuxieme serie. Les
occlusions tardives sont plus frequentes
parmi les greffes qui presentaient des
retrecissements localises 6 a 18 mois
apres la chirurgie, retrecissements
probablement reliees a des techniques
chirurgicales inadequates. Les retre
cissements localises d’apparition plus
tardive, observes sur 14 greffes
(8.8%), et probablement d'origine
atherosclerotique, peuvent egalement
produire ces occlusions tardives.

This progress report concerning the
patency of aortocoronary saphenous
vein bypass grafts forms part of a
prospective sequential evaluation of
graft changes after operation in a series
of near-consecutive patients. To date,
follow-up angiographic studies have
been carried out at 2 to 3 weeks, 6
to 18 months, 30 to 42 months,1'7 and
at 54 to 88 months after surgery. In
this the latest study, the graft failure
rate was low, and a new type of graft
alteration was observed, which appears
to be of atherosclerotic origin.

In these 100 patients 159 grafts were
restudied (Table I). It should be noted
that 27 patients (36 grafts) had also
been restudied between 30 and 42
months after operation.6 Selective coro
nary arteriography and graft opacifica
tion were performed in most cases with
preshaped catheters introduced percu-

Table I— Material

Group No. of patients
1
2
3
Total

45
37
18

59
75
25

100

159

Table II— Graft Status at 6 to 18 Months after
Operation

No narrowing > 15
Diffuse narrowing 20-80
20-45
50-80
Localized narrowing 20-80*
20-45
50-80
Total

/

31 (21)
80 (54)
72
8
37 (25)
27
10
148 (100)t

‘With or without diffuse narrowing.
f l l grafts not evaluated at 2 to 3 weeks have
been excluded.

Results

Complete graft obstruction was ob
served in 17 (10.7%) of the 159 grafts
during a mean 5-year interval, giving
an average annual attrition rate of
2.2%. The average yearly attrition rate
was 2.4% for grafts of group 1 pa
tients, 0.7% for group 2 and 6.5%
for group 3 (Table III). No late
occlusion was observed in grafts without
localized or diffuse narrowing at 6 to
18 months (Table IV). Of grafts with
diffuse narrowing 12.7% were oc
cluded and of grafts with localized
narrowing, 21.6%. These differences
are not statistically significant. A high
er late attrition rate was found, how
ever, in grafts without localized nar
rowing as compared with grafts with
localized stenosis (P < 0.02).
The cumulative patency rate was
66% for the entire series 5.8 years
after operation (Fig. 1). It was 57.7%
at 6.7 years for grafts of group 1 and
83.2% at 5.1 years for grafts of group
2 (Fig. 2). Patency rates at 2 to 3 weeks

Table I I I - Graft Attrition Between 6- to 18-Months and 54- to 88-Months Evaluations
Grafts
Attrition
Patent Occluded rate, %

Group
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No. of grafts
(a n d % )

Status, %

Patients and Methods

The 100 patients composing this
study group were operated upon between
Sept. 24, 1969 and Aug. 2, 1972 and
evaluated 6 to 18 months after surgery,
either as part of a research survey or
because of an unsatisfactory clinical
course. Most survivors among the first
138 patients to have bypass surgery
(research series, group 1) and among
patients 379 to 478 who were operated
upon after 2 years of experience (re
search series, group 2) underwent con
trol angiographic evaluation at 2 to 3
weeks and at 6 to 18 months after
surgery.4 In addition, other patients
were investigated between 6 and 18
months because of an unfavourable
course (symptom-motivated
group,
group 3).7 Out of 198 patients who had
at least one patent graft at the 6- to
18-months evaluation, 100 were re
studied 54 to 88 months after operation
(mean, 70 ± 10 months). It was not
possible to re-evaluate the other 98
patients of whom 32 had died.

No. of patent grafts
at 6 to 18 months

taneously in the femoral artery by tech
niques previously described.8
Graft changes observed at 6 to 18
months have been described elsewhere3,6
and their distribution in these 159
grafts is shown in Table II. Graft occlu
sion was studied separately in the pa
tients of groups 1, 2 and 3. The dif
ferences between the results were tested
by the Yate’s corrected x2 analysis and
by Student’s f-test.

Mean attrition
Mean interval
rate/yr,
P
between evaluations,
%
value

yr

1

51

8

13.6

5.7

2.4 -I

2

73

2

2.7

4.1

„,]

124

10

7.5

4.8

1.6 1

18

7

28.0

5.3

5.3 .

142~

lT

10.7

4.8

2.2

Research series
total
3
Total series

< 0.05

< 0.01

Table IV— Graft Attrition Related to Graft Status at 6- to 18-Months Evaluation
At 6 to 18 months

At 54 to 88 months
Occluded (and % )

Patent

Patent

No narrowing > 15

31

31

Diffuse narrowing 20-80

80

71

9(12.7) ^

Localized narrowing 20-80

37

29

8(21.6)

Status, %

P value

0
NS "I
NS

J

J

NS = not significant.
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and at 6 to 18 months after operation
were obtained from previous studies.5'7
Discussion
Patency of saphenous vein grafts is
related to the degree of distal run-off
of the grafted coronary artery as well
as to the quality of the surgery; occlu
sion within 1 month of operation in
most cases occurred when the grafted
segment of the distal coronary artery
had a small capacity.2 Graft patency
at 6 to 18 months also appeared related
to the distal run-off, graft attrition be
ing two to four times greater for grafts
to arteries with poor run-off than to
arteries with good run-off as assessed
by cinecoronary angiography, by
measurement of the artery diameter at

operation or by graft flow.7 Improved
surgical techniques also modify graft
patency favourably.4,5'7 In fact, the
patency during the first month was
improved in grafts to arteries with poor
run-off, and the 6- to 18-months patency
rate was higher in grafts to arteries with
a borderline or a good run-off. Graft
failure after the first year was seldom
observed, particularly for grafts in
group 2 patients operated upon after
surgical techniques were modified. Late
graft failure appears to be related
primarily to localized stenoses on the
graft trunk or at the sites of graft
anastomoses, which were believed to
have been caused by unsatisfactory
surgical techniques; such localized
stenoses were rare in grafts of group 2.5

The higher late attrition rate in groups
1 and 3 grafts correlates well with the
greater incidence of such localized
stenoses found at the 6- to 18-months
angiographic evaluation.
Diffuse graft narrowing owing to
medial hypertrophy and to fibrous intimal proliferation does not appear to
progress further after the first year,6
or to lead to late graft occlusion. The
influence of atherosclerosis on late
graft failure is unknown, but it does
not appear to be significant, at least
during the first 5 years after operation.
Nevertheless, 14 (8.8%) of 159 grafts
had localized stenoses after the firstyear evaluation. In two patients who
underwent a second operation the le
sions were found to be due to athero
sclerosis. This phenomenon may be
come an important factor in late graft
failure.
Graft patency of 83.2%, 5 years
after surgery, in patients operated upon
with improved surgical techniques, ap
pears satisfactory. It is rewarding to
observe the very low graft failure rate
of 0.7% per year after the first year
and the complete absence of graft oc
clusion in grafts that appeared normal
at 1 year.
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Changing Patterns of Intra-aortic
Balloon Pump Assistance*
R.D. W eisel,
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Intra-aortic balloon pump assistance
(IABPA) for cardiogenic shock is well
established. The response to balloon
pumping and patient survival are better
after low output from cardiotomy than
after myocardial infarction. Elective use
of IABPA preoperatively allows an extra
margin of safety for patients with
acute coronary insufficiency, significant
left main coronary artery stenosis, or
depressed left ventricular function.
However, advances in monitoring
techniques during the induction of
anesthesia and weaning from cardio
pulmonary bypass support, as well as
improved methods for myocardial
preservation, have reduced the
requirements for elective IABPA. Current
indications for preoperative IABPA
include: patients with acute coronary
insufficiency who are totally unre
sponsive to full medical management
and who continue to have pain and
electrocardiographic changes at rest,
and patients with serious left main
coronary artery stenosis who also have
acute coronary insufficiency or depressed
left ventricular function. The survival
of patients with valvular heart disease
and left ventricular dysfunction is not
improved with preoperative IABPA,
while most patients with depressed left
ventricular function from coronary
artery disease may now undergo
revascularization uneventfully, although
inevitably some will still require
postoperative IABPA.
Dans le choc cardiogene, (’assistance
intra-aortique par pompe a ballonnet
(AIAPB) est bien etabli. Une meilleure
reponse a Taction de la pompe a
*From the departments o f surgery,
anesthesia and medicine, Toronto General
Hospital and University of Toronto,
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ballonnet et une meilleure survie sont
associes a un faible debit suivant
cardiotomie qu'apres infarctus.
L’utilisation non urgente de I’AIAPB
avant I'operation offre une marge
de securite supplementaire pour
les patients ayant une insuffisance
coronarienne aigue, une stenose
importante de la principaie artere
coronaire gauche, ou une fonction
ventriculaire gauche deprimee. Toutefois,
['amelioration des techniques de
surveillance pendant I'induction de
I’anesthesie et le sevrage de la
derivation cardiopulmonaire, de meme
que de meilleures methodes de
protection du myocarde, ont reduit les
besoins de recourir a I’AIAPB non
urgente. Les indications presentes de
I'AIAPB dans la periode preoperatoire
comprennent: les patients souffrant
d’insuffisance coronarienne aigue et qui
sont totalement resistants a un
traitement medical complet et qui
continuent d'avoir de la douleur et a
presenter des changements electrocardiographiques au repos, et les
patients ayant une stenose grave
de la principaie artere coronaire et
une insuffisance coronarienne aigue
ou une fonction ventriculaire gauche
deprimee. La survie des patients atteints
de maladie valvulaire et de dysfonctionnement ventriculaire gauche n’est
pas beaucoup amelioree par I'AIAPB
preoperatoire, alors que la plupart des
patients ayant une fonction ventriculaire
gauche deprimee des suites d’une
maladie coronarienne peuvent maintenant
subir sans incident une intervention
de revascularisation, bien que inevitablement certains patients continueront
de necessiter une AIAPB postoperatoire.

Intra-aortic balloon pump assistance
(IABPA) is a valuable aid for the
treatment of cardiogenic shock com
plicating acute myocardial infarction
or following cardiopulmonary bypass.1"34
It has also been used successfully for
the management of medically refrac
tory ischemic pain in pre- or postinfarc
tion states.5,6,8-13,15’16'23'26,34"40 Revascu
larization is then performed urgently
rather then emergently.
Indications for elective IABPA have

R.S. B aigrie,

md , fr c p [c ]

evolved to avoid intraoperative and
postoperative ischemic complications in
patients with either left ventricular (LV)
dysfunction or stenosis of the left main
coronary artery.5"7,13,41,42 However, in
tensive pharmacologic treatment of
acute myocardial ischemia, improved
techniques for inducing anesthesia, bet
ter intraoperative myocardial protec
tion and improved postoperative hemo
dynamic monitoring, have all greatly
reduced the elective use of IABPA. This
report describes the changing patterns
of IABPA at the Toronto General
Hospital.

Patients
Between Nov. 1, 1974 and Oct. 31,
1977, 315 patients received IABPA
(AVCO-Roche, Cranbury, MA) at the
Toronto General Hospital: they repre
sented 14% of the total number of
patients undergoing open-heart surgery.
Each patient had central venous and
arterial catheters in place during
IABPA, and many had pulmonary
artery thermodilution catheters as well.
The patients were classified in three
groups.
Group 1 comprised 42 patients with
cardiogenic shock after myocardial in
farction in whom IABPA was instituted
as soon as the shock became medically
refractory. After stabilization of the
hemodynamic state, cardiac catheteriza
tion was performed without complica
tion. Surgery was performed either
when an anatomic lesion was present,
or when hemodynamic stability could
not be maintained by IABPA. All pa
tients underwent an attempt at wean
ing after 5 to 7 days of assistance. Sur
gery was delayed in those with ana
tomic lesions until 6 weeks after infarc
tion, when possible. Most of these pa
tients, however, had hemodynamic in
stability and underwent surgery earlier.
Patients without anatomic lesions who
were candidates for aortocoronary by
pass or infarctectomy were operated
upon electively if they could become
balloon-independent, or urgently dur
ing their second week of support if they
were balloon-dependent.
One hundred patients who required
IABPA in the postcardiotomy period
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constituted group 2. They were reviewed
retrospectively to identify preoperative
and intraoperative factors contributing
to their low cardiac output after cardio
pulmonary bypass.
Preoperative IABPA was used to
stabilize patients with acute coro
nary insufficiency, either before ca
theterization or before induction of
anesthesia. The balloon was also
inserted electively for patients with
left main coronary artery stenosis or
severe left ventricular dysfunction to
maintain hemodynamic stability during
induction and cannulation for cardio
pulmonary bypass. These 173 patients
constituted group 3.
Weaning from balloon support was
accomplished over a 6- to 12-hour
period by decreasing the pumping in
terval from 1:1 to 1:8. This was facili
tated by repeated evaluation of the
hemodynamic response to the reduced
pumping interval.
Results
Table I outlines the indications for
IABPA, the hospital survival and the
definitions of the clinical states en
countered for the 315 patients who had
IABPA between 1974 and 1977. Figs.
1 to 3 depict the patterns of balloon

utilization and patient survival during
this period. Use of IABPA increased
from 1974 to 1976 (Fig. 1) from 14%
to 17% of all cardiac operations, but
decreased to 11% in 1977. Fig. 2 re
veals that use of IABPA for cardiogenic
shock, following either acute myocar
dial infarction or cardiotomy, has re
mained relatively constant over the en
tire period, and that the change was
due to a decrease in elective use of
IABPA preoperatively.
Group 1

IABPA for shock after infarction
has allowed a 48% overall survival (20
of 42 patients). In 25 patients who un
derwent operation the survival rate was
68% compared with 12% in 17
shocked patients treated with IABPA
alone. Of the patients who were oper
ated upon, 21 had anatomically cor
rectable lesions, which included acute
ventricular septal defect (4 patients),
acute mitral regurgitation (5 patients),
ventricular aneurysm (8 patients), and
recurrent persistent ventricular tachy
cardia (4 patients). Seventeen (81%) of
these 21 patients survived.
Group 2

Of the 100 patients in this group,

T a b le 1— In d ic a tio n s f o r In t r a - a o r t ic B a llo o n Pum p A s s is ta n c e ( IA B P A ) ,
T o r o n to G e n e ra l H o s p ita l, 1974 to 1977

G ro u p 1— c a rd io g e n ic s h o c k fo llo w in g in fa r c tio n
T r e a te d m e d ic a lly
T r e a te d s u r g ic a lly
G ro u p 2— c a rd io g e n ic s h o c k fo llo w in g c a rd io to m y
C o ro n a ry a r t e r y b yp ass
P re o p e r a tiv e c o n d itio n s
1. a c u te c o ro n a ry in s u ffic ie n c y *
2. le ft v e n t r ic u la r d y s fu n c tio n )
3. le ft m a in c o r o n a ry s te n o s is )
V a lv e re p la c e m e n ts
P re o p e r a tiv e c o n d itio n s !
1. le ft v e n t r ic u la r d y s fu n c tio n
2. u rg e n t s u r g e ry
G ro u p 3— E le c tiv e p r e o p e ra tiv e in s e rtio n
C o ro n a ry a r t e r y d is e a s e
1. a c u te c o r o n a ry in s u ffic ie n c y
2. le ft v e n t r ic u la r d y s fu n c tio n
3. le ft m a in s te n o s is
a . c o m p lic a te d ^
b. u n c o m p lic a te d
4 . S ta b le a n g in a ( t r ip le c o ro n a ry
a r t e r y d is e a s e )
V a lv u la r h e a r t d is e a s e
T o ta l

No. of
p a tie n ts

S u r v iv a l, %

42
17
25

48
12
68

100

68

58

77

13
37
8

62
78
88

42

57

29
6

52
50

173

90

161
67
40
41
11
30
13

93
87
95
83
54
100
100

12

42

315

77
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Group 3

Elective IABPA was instituted in
1973 for the same three factors, which
had produced a high operative mor
bidity and mortality (Fig. 3). Of 161
patients who subsequently underwent
coronary artery bypass procedures, 93 %
survived. This group included 67 pa-

Patients

FIG. 1— Number of patients and hos
pital survival rate for 315 patients who
underwent intra-aortic balloon pump assist
ance (IABPA) at Toronto General Hospital
from Nov. 1, 1974 to Oct. 31, 1977.

Patients

‘ W h e n p a tie n ts w ith u n s ta b le a n g in a h ad p e rio d s o f c h e s t pain e x c e e d in g 20 m in , a s s o c ia te d w it h
r e v e r s ib le S T - T w a v e c h a n g e s , d e s p ite a p p r o p r ia te m e d ic a l th e ra p y .
(W h e n e je c t io n fra c tio n w a s le s s th a n 4 0 % o r w h e n v e n tr ic u lo g ra m w a s g ra d e d 4 on s c a le o f 1
to 4 .
)W h e n a r te rio g r a p h y r e v e a le d o b s tru c tio n o f le f t m a in c o ro n a ry a r t e r y g r e a t e r th a n 7 0 % .
§7 p a tie n ts h a d n e ith e r le f t v e n t r ic u la r d y s fu n c tio n n o r u rg e n t s u rg e ry .
IfW h e n a c u te c o ro n a ry in s u ffic ie n c y o r le f t v e n t r ic u la r d y s fu n c tio n w a s a ls o p re s e n t.
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68% survived. Of these 100 patients,
58 had undergone coronary artery by
pass operations, with an ultimate sur
vival rate of 77%. A review of the
preoperative status of these 58 patients
revealed three constant factors: 13 had
acute coronary insufficiency (survival
rate, 62%), 37 had depressed left ven
tricular function (survival rate, 78%)
and 8 had left main coronary artery
stenosis (survival rate, 88%).
Of 42 patients who required IABPA
after prosthetic valve replacement only
57% survived. Of these, 29 had de
pressed left ventricular function pre
operatively, and 52% survived. Six re
quired urgent valvular surgery for acute
decompensation and only three sur
vived. Seven patients required IABPA
postoperatively because of intraopera
tive myocardial damage and our
inability to wean them from cardio
pulmonary bypass.

/

FIG. 2— Indications for IABPA and
survival rates for the years 1974 through
1977. AMI — acute myocardial infarction.
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1974

1975

1976

1977

FIG. 3—Indications for elective preoperative IABPA are noted for patients who
subsequently underwent coronary artery bypass graft surgery. ACI = acute coronary
insufficiency, LVF = left ventricular function, LMS = left main stenosis.

tients with acute coronary insufficiency
unresponsive to medical management
(survival rate, 87%), 40 patients with
depressed left ventricular function
(survival rate, 95%) and 41 patients
with left main coronary artery stenosis
(survival rate, 83%). Of 11 patients
in whom left main coronary artery
stenosis was complicated by either
acute coronary insufficiency or de
pressed left ventricular function, only
6 (54%) survived, despite elective
IABPA. However, the 30 patients with
uncomplicated left main coronary artery
stenosis all survived. Thirteen patients
with severe triple-vessel coronary artery
stenosis (“left main equivalent”) had
preoperative IABPA during the early
years of our experience; all survived.
Table II notes the incidence of elec
tive IABPA for acute coronary insuf
ficiency, left ventricular dysfunction
and left main coronary artery stenosis,
as a percentage of total cardiac proce
dures performed in the past 4 years.
There has been a decrease in the pre
operative use of IABPA for these three
conditions in 1977.
Twelve patients with valvular heart

disease had undergone preoperative
IABPA because of poor left ventricular
function; only 42% survived despite
corrective surgery. These patients were
operated upon early in our experience
and we now believe that IABPA does
not improve surgical survival.
Discussion

IABPA remains a valuable modality
in the treatment of cardiogenic shock
following acute myocardial infarction
in those patients who continue to have
a depressed cardiac index, oliguria or
elevated pulmonary wedge pressure
despite optimal colume loading or
afterload reduction by pharmacologic
means.1-3'5-644'16-18'24-26'30 Nine of the 17
medically treated patients with shock
due to myocardial infarction were
transferred to our hospital with long
standing hypotension (more than 6
hours), despite treatment with pressor
agents elsewhere. These patients had
a poor response to IABPA and
died despite its use. Presumably
the extent of damage, lack of correct
able lesion and prolonged shock prior
to IABPA militated against a successful

Table II— Elective Preoperative IABPA. Presented as a Percentage of the Open-Heart Operations
Performed Between 1974 and 1977
Year
Indication

1974

1975

1976

1977

1974-77

Acute coronary insufficiency
Left ventricular dysfunction
Left main coronary artery stenosis
Valvular heart disease

2.9
2.0
1.8
1.1

3.7
1.6
2.3
6.9

3.3
3.2
1.8
0.3

2.3
0.5
1.3
0

3.0
1.8
1.8
0.5
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result. Of the remaining patients, 21
were found to have anatomically cor
rectable lesions. These patients have
the best prognosis from surgical therapy
after IABPA.1'3'5'6'1446'27-28'35'40 An at
tempt was made to delay surgery be
cause of apparently better survival in
patients operated upon longer than 6
weeks after acute infarction. In patients
who did not have anatomically cor
rectable lesions after infarction wean
ing was attempted between 5 and
7 days after IABPA. Patients who
could not be weaned from balloon sup
port because of hemodynamic instabi
lity, recurrent ischemia, or extending
infarction were considered candidates
for urgent surgery. They were operated
upon early and the mortality was high.
Infarctectomy alone was not usually
successful. Coronary bypass grafting to
stenotic vessels in the noninfarcted area
resulted in better survival (contralateral
revascularization).
Cardiogenic shock after cardiopul
monary bypass had a substantially better
prognosis than shock following infarc
tion, presumably because of a reversible
ischemic insult.5’6'10'lz'14'1!i'19'20'22 Early in
sertion of the balloon was favoured over
prolonged inotropic support because of
the unique advantages IABPA offers to
ischemic myocardium.
An attempt was made, by retrospec
tive analysis, to identify patients at
great risk for a low output state postoperatively and to avoid this situation
by preoperative elective IABPA.5"8'13'15
Initially, patients with valvular heart
disease and severely depressed left
ventricular function underwent elective
IABPA, but were found to respond
poorly and their survival after surgery
was not enhanced. These patients are
no longer considered candidates for
elective IABPA. Improved methods of
myocardial preservation, however, ap
pear to have reduced the number of
patients requiring postoperative IABPA
after valve replacement (12% of pa
tients receiving valve replacements re
quired IABPA in 1976, but only 6%
in 1977).
For patients with substantial left
main coronary artery stenosis or re
fractory acute coronary insufficiency,
the critical period for ischemia, ar
rhythmia or infarction is during the
induction of anesthesia, cannulation and
manipulation for cardiopulmonary by
pass, and the subsequent weaning from
bypass.5-8'34'37'39'41-55 Fig. 4 illustrates
hemodynamic events that may result in
subendocardial ischemia during induc
tion of anesthesia and sternotomy.
IABPA is an ideal means of preventing
these changes. Diastolic augmentation
will maintain endocardial perfusion de
spite systolic hypotension; hypertension
and tachycardia, however, may limit
ultimate usefulness of IABPA. Pre-
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Pre operative

EVR

Induction

1.2

In tu b atio n

0.8

V asodilatatio n

0.6

Sterno tom y

0.7

0.6

FIG. 4— Hemodynamic, electrocardiographic and endocardial viability ratio
(EVR) (diastolic pressure time index/tension time index, DPTI/TTI) changes for typical
patient undergoing coronary artery bypass.

operative IABPA was utilized in
67 patients with acute coronary in
sufficiency and in 41 patients with left
main coronary artery stenosis; not only
was the survival rate acceptable, but
the necessity for urgent postoperative
insertion was avoided. Careful evalua
tion of different techniques for induc
tion of anesthesia has allowed us to
identify many potential intraoperative
problems. Table III reports the effects
of different agents used for induction

on the endocardial viability ratio (Bell
D, Teasdale S: Personal communica
tion, 1977). It is evident that the com
bination of droperidol and fentanyl
citrate maintained a favourable endo
cardial viability ratio, suggesting the
least impairment of subendocardial
coronary flow. Monitoring of both
endocardial viability ratio and hemo
dynamic events, and the use of vaso
dilator and propranolol therapy during
induction, have reduced the incidence

Table Ill-Endocardial Viability Ratio (EVR) During Anesthesia
Relaxed, awake in
operating room
Agents used
Thiopentone, 3 mg/kg
Morphine sulfate, 1 mg/kg
Droperidol, 100 mg/kg -f fentanyl
citrate, 10 mg/kg

5 min after
induction
Mean change
in EVR

No. of
patients

EVR

EVR

8

0.97

1.21

0.52
0.69

- 0 .8 2 *
- 0 .2 6 *

8

1.49

1.11

-0 .3 3

7

*P < 0.01.

of ischemia and infarction in patients
with left main coronary artery stenosis
or acute coronary insufficiency. Elec
tive IABPA is now indicated only when
severe left main coronary artery stenosis
is complicated by either acute myocar
dial ischemia or left ventricular dys
function, and in those patients with
acute coronary insufficiency only when
the pain is not relieved by good medi
cal management.
Patients with poor left ventricular
function run increased risks from coro
nary artery bypass surgery.15,56,57 Bolooki and colleagues13have reported that
preoperative IABPA allows smoother
induction and more physiologic pulsa
tile cardiopulmonary bypass to preserve
myocardial function better. Similarly
we have used elective IABPA in 40 pa
tients with poor left ventricular func
tion and 95% survived. This is con
trasted to a 78% survival rate for 37
other patients with equally poor left
ventricular function who required
IABPA for low cardiac output after
surgery. Two factors have led to
decreased preoperative use of and post
operative need for IABPA in patients
with poor left ventricular function. The
first is intensive hemodynamic monitor
ing. Myocardial performance curves of
20 patients, constructed during weaning
from cardiopulmonary bypass, are il
lustrated in Fig. 5. These curves al
lowed early identification of patients
with poor postoperative left ventricu
lar function. The second factor is im
proved techniques for intraoperative
myocardial protection, which have
allowed better preservation of myocar
dial performance in the immediate
postcardiopulmonary bypass period.58
These two factors have permitted a de
crease in the elective use of IABPA
from 3.2% of all open-heart operations
in 1976 to 0.5% in 1977.
□

FIG. 5—Myocardial performance curves
before and after institution of IABPA are
illustrated for 20 patients who had hypo
tension following coronary artery bypass
surgery. Depressed performance is ap
parent from low stroke work, which did
not improve despite elevation of left atrial
pressure by volume loading from bypass
circuit. IABPA resulted in increase in
stroke work to acceptable levels with
similar volume loading.
128

Prior to IA B P A

TTI

F o llo w in g IA B P A

FIG. 6— Illustrative hemodynamic, electrocardiographic and EVR changes in pa
tient with postcardiotomy cardiogenic shock reveals systolic hypotension, narrow pulse
pressure, elevated end-diastolic pressure, decreased diastolic coronary filling time interval
and low EVR despite use of inotropic drugs. IABPA caused reduction in peak systolic
pressure, diastolic augmentation, reduced left ventricular end-diastolic pressure and
more prolonged diastolic filling period, resulting in more normal electrocardiogram and
more favourable subendocardial perfusion, as noted by EVR = 1.95.
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None the less, there are patients with
apparently adequate preoperative myo
cardial performance who continue to
require inotropic support for hypoten
sion, and who do not respond to an
additional period of vented cardiopul
monary bypass. They remain potential
candidates for IABPA. The monitoring
of hemodynamic variables and the endo
cardial viability ratio in the postoper
ative period may allow identification of
those patients at greatest risk. Although
they may survive the perioperative
period, subendocardial necrosis may
produce late changes in left ventricular
function. Fig. 6 illustrates that IABPA
is preferable to prolonged inotropic
support in the perioperative period for
these patients.
We acknowledge the technical skills of
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Clinical Evaluation of Porcine Heterograft Cardiac Valves
in 200 Patients*
W.R.E.

J amieson,

md , frcs[c ],

Of 200 patients who received porcine
heterograft cardiac valves, the first
100 did not receive postoperative
anticoagulant therapy. In the second
100 patients anticoagulant measures
were used when thrombogenic factors
not related to the prosthesis were
evident. Anticoagulation should be
employed following mitral valve
replacement while factors contributing
to thromboembolism prevail. The
conditions that tend to induce vascular
stasis in the left atrium followed by
embolism are chronic atrial fibrillation,
a large dilated left atrium and a calcified
left atrial wall. The results of our
study provide assurance of the continued
use of the porcine bioprosthesis.
De 200 patients qui ont recu une
heterogreffe de valvules cardiaques
porcines, les 100 premiers n'ont pas
re$u d'anticoagulotherapie apres
I’operation. Dans la deuxieme serie de
100 patients des anticoagulants ont
ete utilises quand il y avait evidence
de facteurs thrombogenes non relies
a la prothese meme. Des anticoagulants
devraient etre employes apres remplacement de la valvule mitrale alors que
des facteurs favorisant les thromboembolies sont presents. Les conditions
qui tendent a provoquer une stase
vasculaire dans I'atrium gauche suivie
d'une embolisation, sont la fibrillation
auriculaire chronique, une importante
dilatation de I'atrium gauche et une
calcification de la paroi auriculaire
gauche. Les resultats de notre etude
rassure sur le maintien de I’emploi
de la bioprothese porcine.

A.I. M unro , md, frcs, frcs [c ],
and P eter A llen , md, frcs [c]

The ideal prosthetic cardiac valve
should be functionally durable, nonthrombogenic and hemodynamically
satisfactory.1'3 The porcine hetero
graft, in our opinion, satisfies these
requirements. The prosthesis is func
tionally durable as demonstrated by 8
years of clinical experience since the
initial implantations were done.3,4 From
January 1975 the porcine bioprosthesis
has been utilized in the majority of
valve replacements at the Vancouver
General Hospital. Either the Hancock
or the Carpentier-Edwards bioprosthesis
was introduced in all valvular positions.
A clinical evaluation of the first 200
patients in whom 227 such valves were
introduced has provided evidence that
assures continued use of the porcine
heterograft.
The rate of thromboembolism was
low. The first 100 patients were man
aged without anticoagulant therapy.5
As a result of this experience it was
recommended that anticoagulation be
given after mitral valve replacement
when any of the following factors con
tributing to thromboembolism existed:
chronic atrial fibrillation, intraoperative
atrial thrombus, calcified left atrial
wall, or large dilated left atrium.
This recommendation was followed
in the management of the second 100
patients. The majority of patients in
whom factors contributing to thrombo
embolism were present received oral
anticoagulants in the postoperative
period.
Patients

The series comprised 105 females
and 95 males. Their average age was
51.8 years (range, 12 to 85 years).
*From the division of cardiothoracic
The average duration of follow-up
surgery, department of surgery, University
of British Columbia, Vancouver General was 14 months. The total number of
Hospital, Vancouver, BC
valves implanted in the various posi
tions and the duration of follow-up of
Presented at the annual meeting of the
Canadian Cardiovascular Society, Toronto, the surviving patients are shown in Ta
Ont., Oct. 19-22, 1977
ble I. More valves were placed in the
mitral than in the aortic position be
Supported by the British Columbia
Heart Foundation
cause, initially, the smaller prostheses
were not available to our institution.
Reprint requests to: Dr. Peter Allen,
Ste. 600, 750 West Broadway, Vancouver, Approximately 25% of our patients had
BC V5Z 1H5
multiple procedures such as double or
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R.T.

M iyagishima, md, frcs[c]

triple valve replacement, or valve re
placement accompanied by aortocoro
nary bypass grafting for arteriosclerotic
coronary artery disease. The series in
cludes five cases of valve replacement
in the pediatric age group, one for
pulmonary insufficiency following defi
nitive correction of tetralogy of Fallot
and four for rheumatic heart disease.6,7
The indications for surgery repre
sented a multiplicity of diseases affect
ing the cardiac valves. The aortic valve
was replaced because of pathologic
changes related to rheumatic heart
disease, calcific bicuspid aortic stenosis,
subacute bacterial endocarditis, or Mar
fan’s syndrome. Functional tricuspid in
sufficiency and rheumatic heart disease
were the indications for tricuspid re
placement. Replacement of the mitral
valve was necessary because of a
variety of conditions, namely, rheumatic
heart disease, papillary muscle dys
function, Marfan’s syndrome, ruptured
chordae tendineae, myxomatous de
generation and Barlow’s disease. The
pulmonary valve required replacement
because of post-tetralogy pulmonary in
sufficiency.
In this series 47 (25%) patients had
had previous operative intervention or
further definitive surgery during the
observation period, or both (Table II).
The majority had had mitral commis
surotomy and mitral or aortic valve
replacement. Four patients required re
operation during the observation period,
one for technical error in placement of
the mitral prosthesis and three for periprosthetic leaks.
Table I—Number of Valves Implanted in
Various Positions and Duration of Follow-up
Position
Aortic valve
Mitral valve
Pulmonary valve
Tricuspid valve
Double valve
Triple valve

THE CANADIAN JOURNAL OF SURGERY

Number

Duration,
mo

90
125
1
4
24
2

13
15
22
18
13
13
133

Results
T a b le II— S u m m a ry o f 47 P a tie n ts w h o had
U n d e rg o n e a P r e v io u s O p e ra tio n

There were 30 deaths (Table III).
Twenty-one occurred in those receiving
mitral valve replacement with or with
out aortocoronary bypass grafts.
The various causes of death, classi
fied as early or late, are set forth in
Table IV. The early or hospital mor
tality was 8% and the late mortality
was 7.6%. The two deaths related to
a pseudoaneurysm of the left ventricle
were attributed to the “sawing” action
of the strut of the mitral prosthesis
(Allen P: Personal communication,
1977). Death in these two patients was
due to severe congestive heart failure
uncontrollable by medical therapy.
The later death from hemopericar-

N o. o f
p a tie n ts

P r e v io u s o p e ra tio n
M it r a l c o m m is s u ro to m y
V a lv e re p la c e m e n t
P e r ip r o s t h e t ic leaks
P lic a t io n — m itr a l v a lv e
H o m o g ra ft
I d io p a th ic h y p e rtro p h ic s u b a o r t ic s te n o s is
T e c h n ic a l e r r o r
T r ic u s p id c o m m is s u ro to m y
T r ic u s p id p lic a t io n ( E b s t e in ’ s
a n o m a ly )

18
16
7*
1
1
1
1
1
1

*3 p a t ie n t s w ith a p o rc in e v a lv e , 4 w ith o th e r
ty p e s o f v a lv e p r e v io u s ly in s e rte d .

T a b le III— T y p e s o f O p e ra tio n P e rfo rm e d and T o ta l M o r t a lit y

S in g le v a lv e *
A o r t ic
M it r a l
P u lm o n a r y
T r ic u s p id
D o u b le v a lv e
T r ip l e v a lv e
T o ta l

Dead

A liv e

N o. o f p a tie n ts

O p e r a tio n

71
99
1
4
23
2

69
79
1
2
18
1

2
20
0
2
5
i

200

170

30

*22 p a t ie n t s h a d s in g le v a lv e re p la c e m e n t p lu s c o ro n a r y a rte ry b y p a s s ; 1 d i e d .

T a b le IV— C a u s e s o f E a r ly and L a te D e a th

L a te d e a th ,
> 30 d

E a rly d e a th ,
< 30 d

C ause
C o n g e s t iv e c a rd ia c f a ilu r e
— c a rd io g e n ic s h o c k
A r r h y t h m ia
T e c h n ic a l e r r o r
C e r e b r o v a s c u la r a c c id e n t
H e m o rrh a g e (in tra - a n d p o s to p e ra tiv e )
P s e u d o a n e u ry s m of le f t v e n t r ic le
P n e u m o n ia ( Serratia)
E n d o c a r d it is (fu n g a l)
P u lm o n a r y em bo lism
A c c id e n t a l d ea th s
S u p e r io r m e s e n te ric a n e u ry s m
H e m o p e ric a rd iu m

3
2
1
—
—
—
1
—

—

T o ta l (a n d % )

16 (8.0)

14 (7.6)

9
—

6
1
2

—

1

—

—
—
1
1
1

dium was attributed to anticoagulant
therapy and the one due to fungal
endocarditis was caused by mucormy
cosis effecting obstruction of the mitral
prosthesis.
The complications related to the
various valve sites, irrespective of un
derlying pathologic changes and treat
ment, are analysed in Table V. Such
complications were most common in
the mitral position.
There were no instances of pathologic
changes in or disruption of the valve
prosthesis. Microscopic studies of por
cine valves retrieved at autopsy were
not performed.
There were five cases of early throm
boembolism and six cases of late throm
boembolism (Table VI). Since antico
agulant therapy was instituted in the
postoperative management of patients
in whom contributing thrombogenic
factors were discovered, thromboem
bolism has occurred in only three in
stances— one early and two late.5 In all
11 cases of thromboembolism, early or
late, atrial fibrillation was present. The
rate of early thromboembolism of
the aortic prosthesis was 2.0% per pa
tient-year and the rate of late throm
boembolism was zero. The respective
figures for mitral valve replacement
were 2.0% and 3.9%.
The majority of thrombogenic fac
tors that are unrelated to the prosthesis
coexist with chronic atrial fibrillation.
They result in vascular stasis and
thrombus formation in the left atrium.
It is noteworthy that the only
death related to thromboembolism
in the entire series was attributable to
such thrombogenic factors. The pa
tient had chronic atrial fibrillation and
died of a recurrent cerebrovascular ac
cident. At autopsy there was a sub
valvular aneurysm of the left ventricle
filled with friable thrombus and a
mural thrombus on the left atrial wall;
the valve prosthesis was unaffected by
thrombosis.5
Actuarial curves analysing valve

—

1
T a b le V I— S u m m a ry o f C a s e s of
T h ro m b o e m b o lis m

V a r ia b le
T a b le V - - C o m p lic a tio n s R e la te d to P o s itio n o f V a lv e
V a lv e p o s itio n
C o m p lic a t io n
T e c h n ic a l e rro rs
P e r ip r o s t h e t ic leaks
E n d o c a r d it is
T h ro m b o e m b o lis m
G r a ft p a th o lo g y
P s e u d o a n e u ry s m o f v e n t r ic le
T o ta l

134

A o r t ic
—
1
—
2
—
—
3

M itra l
2
3

1
9
—
2
17

T r ic u s p id

P u lm o n a ry

—
—
—
—
—
—

0
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—
—
—
—
—
—

0
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Num ber
M o r b id ity
M o r t a lit y
A o r t ic v a lv e
M it r a l v a lv e
C o n t r ib u tin g fa c to r s
P r e v io u s c e r e b ro v a s c u la r
a c c id e n t
A t r ia l f ib r illa t io n
A t r ia l th ro m b u s
A n t ic o a g u la n t th e ra p y
E m b o li/ p a tie n t- y e a r , %
A o r t ic v a lv e
M it r a l v a lv e

E a rly

L a te

5
5
0
2
3

6
5
1
0
6

1
5
1
1

1
6
0
2

2.0
2.0

0
3.9
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durability in our series show that the
glutaraldehyde-preserved
heterografts
maintained good function after 30
months in 81% of cases in the mi
tral position and in 97.6% in the aortic
position (Fig. 1).
The quality of life of our patients
has been significantly improved by the
use of the porcine heterograft (Fig. 2).
Among the survivors, the number in
class I (New York Fleart Association
classification) increased from 1 preoperatively to 124 postoperatively and
the number in class IV decreased from
35 to 1.
Discussion

The porcine heterograft appears to
be highly reliable since its performance
approaches the criteria of a satisfactory
valve substitute.1'3 The purpose of our
evaluation was to consider the thrombogenicity of the prosthesis; the period
of study is too short to permit conclu
sions in regard to valve durability.

Months
FIG. 1—Actuarial curves to demon
strate valve durability in various positions.
AVR = aortic valve replacement; MVR =
mitral valve replacement.

Furtherm ore, we have no catheteriza
tion data to determine the hemodynamic
status of the prosthesis; nevertheless,
our patients were hemodynamically sta
ble on clinical assessment.
There is impressive evidence to indi
cate that tissue prostheses have a lower
degree of thrombogenicity than m echan
ical valves.1,8 The porcine heterograft
inserted without postoperative antico
agulant coverage is associated with a
reduced rate of thrombosis.2,3,8"15
Anticoagulant therapy was not used
in our first group of patients. In our
second group, we reduced the rate
of thromboembolism with the use of
anticoagulants in the presence of thrombogenic factors not related to the pros
thesis. There is reason to believe that
anticoagulation was not adequately
controlled in those patients who did
incur thromboembolic episodes while
on anticoagulant therapy.
The thrombogenic factors unrelated
to the prosthesis are primarily asso
ciated with vascular stasis in the left
atrium (resulting from chronic atrial
fibrillation, large dilated left atrium
and calcified left atrial wall) and con
tribute to cerebrovascular, visceral and
peripheral embolism. In all our patients
who experienced thromboembolic epi
sodes one or m ore of these contributing
factors was present and all patients had
chronic atrial fibrillation.
In conclusion, we recommend that
anticoagulants be administered follow
ing mitral valve replacement when con
tributing thrombogenic factors are evi
dent. Furtherm ore, anticoagulant thera
py should not be discontinued until the
patient maintains a cardiac rhythm un
complicated by atrial arrhythmias.
We thank Drs. W.G. Trapp and L.H.
Burr for permitting us to include a num
ber of their patients in our study. We
also thank Gayle Henderson, Joan Madi
son and Diane Borgon for their help in
the preparation of the manuscript.
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Permanent Transvenous Atrial Pacing*
B .S. G o l d m a n ,

m d , f r c s [c ],

Atrial pacing has electrophysiologic
and hemodynamic advantages for
patients with symptomatic bradyarrhythmias and intact atrioventricular
conduction or with certain refractory
tachyarrhythmias. Permanent atrial
pacing has been achieved in 29 patients
followed up for periods of up to 7 years
at two institutions. At Sunnybrook
Medical Centre, Toronto, 16 patients
have had coronary sinus electrodes
introduced pervenously using standard
bipolar or special unipolar catheters.
Initial pacing thresholds were acceptably
low (mean, 2.0 mA); chronic thresholds
in three patients were similar. At the
Toronto General Hospital, 13 patients had
endocardial J-electrodes, bipolar or
tined unipolar, inserted in the right
atrial appendage. Initial thresholds were
low (mean, 1.3 mA) and P-wave voltage
was adequate (3.4 mV) for pacemakers
with standard sensitivity. In both series,
conventional R-inhibited, asynchronous
or rate-programmable units have been
employed. Radiofrequency self-conversion
pacemakers were used in three patients.
Preliminary His bundle studies were
done in 10 patients; the others were
tested by rapid atrial pacing during
insertion of electrodes. Early and late
electrode stability in both series was
excellent; one electrode became dis
lodged from the coronary sinus position
and one from the right atrial appendage.
La stimulation auriculaire possede des
avantages electrophysiologiques et
hemodynamiques pour les patients
presentant une bradyarythmie avec
conduction atrioventriculaire intacte
ou certaines tachyarythmies rebelles.
Une stimulation auriculaire permanente
a ete obtenue chez 29 patients suivis

*From the departments of medicine
(cardiology) and surgery (cardiovascular),
Sunnybrook Medical Centre
and the Toronto General Hospital,
University of Toronto, Toronto, Ont.
Presented at the annual meeting of the
Canadian Cardiovascular Society, Toronto,
Oct. 19-22, 1977
Reprint requests to: Dr. B.S. Goldman,
Toronto General Hospital, 101 College
St., Toronto, Ont. M5G 1L7
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dans deux etablissements pour des
periodes allant jusqu'a 7 ans. Au
Sunnybrook Medical Centre de Toronto,
16 patients ont eu des electrodes introduites par voie veineuse dans le sinus
coronaire, a I'aide de catheters bipolaires
reguliers ou de catheters unipolaires
speciaux. Les seuils initiaux de stimu
lation ont ete faibles et acceptables
(moyenne, 2.0 mA); chez trois patients,
les seuils chroniques etaient semblables.
Au Toronto General Hospital, 13
patients ont recu des electrodes
endocardiques J, bipolaires ou unipolaires
a pointes, inserees dans I'appendice
auriculaire droit. Les seuils initials
etaient faibles (moyenne, 1.3 mA) et
le voltage de I'onde P adequat (3.4 mV)
pour les stimulateurs cardiaques de
sensibilite normale. Pour les deux series,
des unites classiques a inhibition R,
asynchrones ou a rythme programmable,
ont ete utilisees.
Des stimulateurs a auto-conversion
de frequence radio ont ete utilises
chez trois patients. Des etudes
preliminaires du faisceau de His
ont ete realisees chez 10 patients; les
autres ont eu une verification par
stimulation auriculaire rapide durant
I’insertion des electrodes. Dans le deux
series, la stability precoce et retardee
des electrodes a ete excellente;
une electrode s’est delogee de sa
position dans le sinus coronaire et une
de I'appendice auriculaire droit.

Atrial pacing has significant hemody
namic and electrophysiologic advantages
over ventricular pacing. Direct stimula
tion of the atrium ensures atrioventri
cular synchrony, normal depolarization
of the ventricle and suppression of
ectopic rhythms. The reduced need for
oxygen, regular ventricular filling and
resultant increase in cardiac output
may be important to patients with an
ischemic or poorly contractile myo
cardium.1 Direct atrial pacing is ideal
for symptomatic atrial bradyarrhythmias
and for overdrive suppression of re
current ventricular irritability.
Permanent atrial pacing has been
accomplished at thoracotomy by means
of electrodes sutured or clipped on the
epicardium, by the retrocardiac ap
plication of electrodes through medi
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astinoscopy and by the transvenous
endocardial route using trans-septal
barbed leads, coronary sinus catheters,
or atrial leads with wire hooks, nylon
barbs or preformed curves.
This report concerns 29 patients
paced for up to 7 years by atrial
catheters in either the coronary sinus
or the right atrial appendage.
Clinical Material

Sixteen patients (group 1) were
managed at the Sunnybrook Medical
Centre and 13 (group 2) at the Toronto
General Hospital. Their ages ranged
from 44 to 85 years (mean, 66.6
years) and they were paced for a total
of 589.5 pacer months (mean, 30.7
months at Sunnybrook Medical Centre
and 7.5 months at Toronto General
Hospital). The indications for cardiac
pacing are listed in Table I. Sinus-node
dysfunction was present in 21 patients
and was manifest as a variety of symp
tomatic bradyarrhythmias. Of interest
are two patients with marked sinus
bradycardia in whom atrial pacing was
used as an adjunct to high doses of
propranolol for severe angina pectoris;
both had inoperable coronary artery
disease demonstrated by angiography.
Four patients were paced for tachy
arrhythmias—recurrent ventricular ta
chycardia (two patients) and resistant
paroxysmal atrial tachycardia (two pa-

Table 1—Indications for Atrial Pacing
Indication
Sinus-node dysfunction
Bradycardia-tachycardia
Sinus bradycardia
Sinoatrial arrest
Junctional bradycardia
Slow atrial fibrillation
Sinus bradycardia —>
ventricular tachycardia
Sinus bradycardia
(propranolol)
Resistant paroxysmal atrial
tachycardia
Refractory ventricular
tachycardia
Complete heart block
Total

No. of patients
21
7
5
4
2
1
2
2
2
2
2
29
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T a b le I I — E le c tro d e s U s e d in S e rie s

C o ro n a ry s in u s

N o. of
p a tie n ts

M e d tro n ic * b ip o la r
( la t e r u n ip o la r , 4 )
“ H y b rid ” b ip o la r
C o r d is f u n ip o la r (2 m m )
C o rd is u n ip o la r “ p ig t a il”

8

A t r ia l a p p e n d a g e

No. of
p a tie n ts

M e d tro n ic u n ip o la r tin e d
A m e ric a n O p t ic a l! b ip o la r
(a s u n ip o la r , 4 )

3
2
3

7
6

’ M e d tro n ic In c ., M is s is s a u g a , O n t.
(C o r d is C o rp o ra tio n , M ia m i, FL.
^ A m e ric a n O p tic a l C o rp ., B e d fo rd , M A .

tients). Three of these were supplied
with radiofrequency, self-conversion
units for rapid atrial stimulation.3 Two
patients with complete heart block and

FIG. 1— Lateral chest roentgenogram
showing Cordis unipolar electrode in coro
nary sinus position for permanent atrial
pacing.

mitral valve prolapse had atrial-syn
chronous ventricular pacing units in
troduced using atrial-sensing catheters
(one coronary sinus, one atrial J-lead)
and a pervenous ventricular pacing
electrode.
The electrodes used in this series are
listed in Table II. The preferred coro
nary sinus catheter is now the Cordis
unipolar “pigtail” catheter (Cordis
Corporation, Miami, FL) that applies
cathodal stimulation near the coronary
sinus orifice. The Medtronic unipolar
pliant tined J-electrode (Medtronic Inc.,
Mississauga, Ont.) is the preferred
catheter for right atrial appendage fixa
tion.3 Figs. 1 and 2 show a unipolar
and a bipolar J-electrode in position
for permanent atrial pacing.
The types of pulse generators con
nected to these atrial electrodes are
listed in Table III. In group 1 pre
dominant use was made of the asyn
chronous pacing mode. In group 2 rateprogrammable pulse generators were
the type mainly employed.
Results, Follow-up and
Complications

to 5.0 mA (mean, 1.7 mA). P-wave
voltage was surprisingly consistent and
averaged 3.12 mV, with a range of 0.8
to 4.9 mV, allowing the use of con
ventional demand pacemakers with a
1.0-mV sensitivity.
The problems encountered during
long-term pervenous atrial pacing are
listed in Table IV. Three patients with
coronary sinus electrodes and demand
units experienced refractory period
bradycardia, that is, a lowering of the
expected pacemaker rate because of
inhibition by retrograde conduction and
sensing of the R-wave from atrially
paced beats, with subsequent pacer re
cycling.4 These units were converted to
the asynchronous mode. Pacemakers
currently available have a sufficiently
long refractory period to avoid this
problem. In one patient atrioventricular
block occurred after 10 months of
coronary sinus pacing and required
conversion to ventricular pacing. One
coronary sinus electrode slipped into
the ventricular cavity and continued to
provide satisfactory ventricular pacing.
In one patient a bipolar J-electrode be
came dislocated into the right ventricle
and required repositioning at 1 month,
again 3 months later and for the third
time after another month. Three pa
tients, one with coronary sinus and two
with atrial J-catheters, experienced
temporary catheter instability, with
inadequate sensing and occasional
premature atrial contractions. However,

T a b le IV — P ro b le m s E n c o u n te r e d D u r in g
L o n g -T e r m (5 8 9 .5 P a t ie n t - M o n t h s ) A t r ia l
P a c in g in 29 P a t ie n ts
C o m p lic a tio n

The initial threshold for stimulation
in the coronary sinus position ranged
from 1.0 to 4.5 mA (mean, 2.2 mA) at
the time of implantation. There was no
significant difference in the chronic
thresholds observed at the time of
battery-pack replacement. Initial thresh
olds with the J-electrodes were similar
ly satisfactory and ranged from 0.5 to
2.5 V (mean, 0.82 V), and from 0.8

C a th e te r d is lo d g e m e n t
C a th e te r in s t a b ilit y
A t r io v e n t r ic u la r b lo c k
H ig h th r e s h o ld
R e fr a c to r y p e rio d
b r a d y c a r d ia
P e r fo r a tio n
T h ro m b o s is
C o r o n a ry s in u s o b s tr u c tio n
P a c e m a k e r - r e la te d d e a th s
T o ta l

N o . o f p a tie n ts
2
3
1
1
3
0
0
0
0
10

T a b le I I I — P u ls e G e n e r a to r s U s e d *

C o r o n a ry s in u s

No. of
p a tie n ts
4
12
7
2

A s y n c h ro n o u s
P ro g ra m m a b le a s y n c h ro n o u s
Dem and
P -tr ig g e r e d
—

A t r ia l a p p e n d a g e
Dem and
H ig h s e n s it iv it y d e m a n d
P ro g r a m m a b le d e m a n d
P -tr ig g e r e d
R a d io fr e q u e n c y ra p id a t r ia l
s tim u la tio n u n its

25

FIG. 2— Lateral chest roentgenogram
showing American Optical bipolar J-elec
trode in right atrial appendage for per
manent atrial pacing.
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No. of
p a tie n ts
2
1
6
1
3
—

13
’ In c lu d e s re p la c e m e n ts .
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in each instance the catheter became
fixed in place spontaneously and did
not require repositioning. One other
patient with an atrial J-electrode had
an early increase of the initial thresh
old value within the first month after
implantation that required a higher
current output program before capture
was ultimately achieved.
There were no pacemaker-related
deaths although five patients in
whom coronary sinus catheters were
inserted died over the 7 years. The
first patient in whom a J-electrode was
inserted for sinus-node dysfunction in
1976 was a long-distance runner with
some early electrode instability. He died
suddenly after a long run, 10 months
after insertion of the electrode. A
coroner’s report stated that cardiac ar
rest was due to massive myocardial in
farction; the atrial J-electrode was
firmly in position. Autopsies performed
on two patients who had coronary sinus
electrodes showed endothelialization
but no thrombus formation in the coro
nary sinus vein. There was no evidence
of thrombosis or perforation in either
the coronary sinus or right atrial ap
pendage.
In two patients, one with a coronary
sinus and the other with an atrial ap
pendage J-electrode, atrial-synchronous
ventricular pacing was established using
an Omni-atricor pulse generator (Cor
dis Corporation, Miami, FL). In both
patients symptoms of low cardiac out
put disappeared.
In three patients with radiofrequency
self-conversion units in situ, one with
refractory ventricular tachycardia and
two with refractory paroxysmal atrial
tachycardia, no difficulties were en
countered when the patient used the
self-conversion rapid atrial stimulating
device.
Discussion
Permanent transvenous ventricular
pacing is universally accepted and
widely applied. However, astute ob
servers have noted that, although ven
tricular pacing may alleviate syncope,
it does not produce good cardiac re
habilitation, and a significant number
of patients still require digitalis and
diuretics and complain of postural
dizziness, exertional fatigue, or dys
pnea. These symptoms are usually at
tributed to old age and a poor myo
cardium. However, ventricular pacing
results in irregular filling and output,
aggravates mitral insufficiency and
produces inappropriate mitral valve
closure. Retrograde conduction may
produce re-entry tachycardias and
worsen atrial tachyarrhythmias in the
sick sinus syndrome.5'6 Furthermore,
ventricular pacing has been shown to
increase myocardial oxygen require
140

ments and aggravate angina in some
ischemic patients. The advantages of
atrial and related modes of pacing are
the preservation of atrioventricular
synchrony, normal ventricular depola
rization and the suppression of ectopic
rhythms in both atrium and ventricle.
These benefits can result in improved
cardiac output, reduction of congestive
failure and ischemic pain, increased
tolerance to propranolol, regular ven
tricular filling and prevention of re
entry arrhythmias and retrograde con
duction. Despite these advantages, less
than 1% of pacemakers with this
capability have been implanted.7 The
failure to appreciate and to utilize more
fully the potential benefits of atrial
stimulation and related modes of pac
ing is largely a result of difficulties in
the past of obtaining secure position
ing of atrial electrodes. When faced
with the choice of atrial pacing achieved
at thoracotomy and ventricular pacing
by the transvenous route, surgeons have
almost always selected the latter.
Some of the disadvantages ascribed
to permanent transvenous atrial pacing
have been difficulty in achieving elec
trode access, dependence on unreliable
or unstable endocardial electrodes, dif
ficulty in establishing adequate initial
pacing or sensing thresholds, the late
loss of atrial sensing capacity and the
occasional need to enhance the sensi
tivity of existing pulse generators. The
physiologic limitation of atrial pacing is
the loss of patient protection when
atrioventricular conduction block oc
curs, or when the atrial stimulation
threshold becomes markedly elevated.
However, our experience confirms other
recent reports that initial and chronic
sensing and pacing thresholds from
both the coronary sinus and right atrial
appendage positions are not only ade
quate but assure security of long-term
pacing.4’6
However, indications for atrial pac
ing are not universally defined and
many are not even accepted. The selec
tion of appropriate subjects often re
quires a preliminary His bundle study
(only 10 patients in our series
had intracavitary conduction studies).
At Sunnybrook Medical Centre each
patient was paced by a temporary
catheter in the coronary sinus for 24hours before implantation of a per
manent device. At Toronto General
Hospital, suitable subjects had atrial
tachypacing on the operating table to
120 beats per minute. If no evidence
of bifasicular block, prolongation of
P-R interval beyond 0.24 milliseconds,
dropped beats, or anginal pain ensued,
then it was assumed that distal con
duction was adequate and atrial pacing
appropriate.
The presence or delayed onset of
intermittent or partial atrioventricular
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block and the late development of
atrial flutter-fibrillation may be factors
limiting atrial pacing. In some clinical
instances atrial pacing is simply an
alternative to ventricular pacing. In
others, however, atrial pacing is dis
tinctly to be preferred, as in the sick
sinus syndrome, which is unresponsive
to drugs or ventricular pacing, or both,
and when there is suppression of ven
tricular irritability by overriding con
ducted atrial rhythms.6 More wide
spread application of atrial-synchronous
ventricular pacing or atrioventricular
sequential pacing is indicated in con
genital or surgical heart block in
younger patients, or in heart block
associated with congestive failure de
spite ventricular pacing.6 Bifocal pacing
and the current use of radiofrequency
self-conversion demand units make
possible the surgical management of a
wider variety of cardiac dysrhyth
mias.1’2'10
The experience gained at this univer
sity of endocardial atrial and atrialsynchronous ventricular stimulation
using coronary sinus or right atrial ap
pendage J-electrodes, or both, has been
highly valuable and we believe further
exploration of this mode of cardiac
pacing should be encouraged.
We are grateful to Barouh V. Berkovits,
D.Eng., for his stimulation and continued
assistance in the field of atrial and bifocal
pacing.
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Clinical Application of Doppler Ultrasonography
in the Thoracic Outlet Syndrome*
Z. A dam Pisko-D ubienski,

Difficulties in diagnosing the thoracic
outlet syndrome prompted a pilot
study of noninvasive Doppler ultra
sonography in 160 thoracic outlets of
healthy volunteers. Encouraged by the
results we applied the technique to
the clinical evaluation of flow
disturbances during various provocative
maneuvers. Ninety-four thoracic outlets
were examined; of these, 32 were
operated upon. Severe flow occlusion
which was detected by Doppler
ultrasonography reproduced symptoms
of which the patients had originally
complained. All patients were relieved
of their symptoms, and only five had
minor flow disturbances after resection
of the first rib and scalenotomy.
Resection of cervical ribs was carried
out in seven of nine patients with this
anomaly.
Doppler ultrasonography was found
to be a most valuable diagnostic
modality and its wider application in
this field is recommended.
Les difficultes que pose le diagnostic
du syndrome du scalene anterieur ont
incite a realiser une etude pilote de
I'ultrasonographie non envahissante de
Doppler dans 1’evaluation de 160 canaux
thoraciques chez des volontaires sains.
Encourages par les resultats obtenus,
nous avons applique cette technique a
(’evaluation clinique des dereglements
de la circulation durant diverses
manipulations. Quatre-vingt-quatorze
canaux thoraciques ont ete examines;
de ceux-ci, 32 ont ete operes. Une
occlusion severe de la circulation decelee
a I’ultrasonographie de Doppler a
reproduit les symptomes dont s’etaient
plaints les patients initialement.
Tous les patients ont ete soulages de

*From the division of surgery, University
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University of Calgary
t Chief resident, Calgary General Hospital
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leurs symptomes et seulement cinq
montraient des derangements faibles
de la circulation apres resection de
la premiere cote et scalenotomie. La
resection des cotes cervicales a ete
effectuee chez sept des neuf patients
souffrant de cette anomalie.
L'ultrasonographie de Doppler s’est
averee un outil de diagnostic des plus
utiles et son application plus
repandue dans ce domaine est
recommandee.

Much information has accumulated
about the thoracic outlet syndrome
(TOS) since the first recorded reference
to it by Hunald in 1743.' The syndrome
now encompasses costoclavicular com
pression,2 the cervical rib syndrome,3
the scalenus anticus (Adson’s) syn
drome,4 the hyperabduction syndrome5
and the Paget-Schroetter syndrome.8
Thoracic outlet disorders are also
known to be associated with Raynaud’s
phenomenon,7 with subclavian steal
syndrome,8 with whiplash injuries9 and
even with tetany of the hands.10 These
disorders can cause dilatation, aneur
ysm" and thromboembolism of the sub
clavian vessels and can mimic at least
16 other conditions, such as cervical
spondylosis, superior sulcus tumour
(Pancoast’s syndrome) and metastatic
disease of the spinal cord. No wonder
Naffziger and Grant12 were impelled to
state: “The bizarre symptoms and
insidious onset render early diagnosis
difficult as does the fact that objective
signs may appear rather late.” The
clinician’s difficulties are compounded
by the lack of satisfactory diagnostic
tests. Palpation and the use of conven
tional pressure cuffs to monitor pulse
changes during various maneuvers are
gross techniques to say the least. It is a
known fact that the pulse disappears at
a pressure of 70 mm Hg while con
tinued flow can be demonstrated by
the Doppler flow detectors to a pres
sure as low as 20 mm Hg. Measure
ment of conduction velocity of the
ulnar nerve, introduced by Caldwell,
Crane and Krusen in 1971,13 has a
great deal of merit but many limitations.
Angiography should be restricted to
cases where strong suspicion of vascu
lar complications exists.

md J

The accessibility of subclavian and
axillary vessels to Doppler ultrasound
probes prompted a pilot study in which
160 thoracic outlets of 80 randomly
selected healthy adults (41 men, 39
women) under the age of 40 years were
examined. This paper is presented in
two parts, one part dealing with the
feasibility study designed to evaluate
the usefulness of Doppler ultrasono
graphy in the detection and measure
ment of vascular flow at the thoracic
outlet, and the other detailing its
clinical application in the pre- and post
operative assessment of patients.
The Pilot Study
Instrum ents and M eth od

The instruments employed were a
Med Sonics Versatone bidirectional
Doppler model D9 with P92 and P84
probes (Med Sonics, Mountain View,
CA), a Med Sonics Doppler stethoscope
calibrated to 5.3 mHz, a chart recorder
and occasionally a Parks Electronics
directional Doppler model 806 (Parks
Electronics, Beaverton, OR). Either one
or two scanning points were selected,
one below the midpoint of the clavicle,
the other 2.5 cm above the medial epicondyle of the humerus. In each case
the point chosen was directly over the
vessel under study (Fig. 1). Arterial
and venous blood flows were examined
in six different postures: at rest, on
deep inspiration, in the exaggerated
military position, on abduction to 90°,
in hyperabduction and during Adson’s
maneuver. It was observed quite early
in the study that arterial flow dis
turbances occurred frequently by the
time the arm was abducted to 90°. For
this reason scanning was conducted
both in abduction and hyperabduction.
It should be mentioned that arterial and
venous flows sound totally dissimilar
on Doppler studies. Different flow
velocities have flow signals in different
frequency ranges, which, once heard,
are never forgotten (like the bark of
one’s own dog). The patient’s age, sex,
occupation and whether the patient had
a history of related symptoms and signs
or presented any unusual findings, were
recorded. Note was made of the point
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PROBE ON RT. SUBCL. ART. OVER 1st RIB WITH
SHOULDER SAGGING.

EQUIVALENT POSITION ON LEFT.

FIG. 1— Doppler pencil probe shown over subclavian artery below clavicle. Flat probe over brachial artery. For graphic
record-taking flat probe is more convenient. Top left: notching produced by partial compression of artery between clavicle and first
rib in resting position. Top right: normal flow in contralateral artery in resting position. Bottom: total arrest of flow in exaggerated
military position.

of onset of turbulence (bruits), the ap
pearance of Korotkoff sounds, and the
point of disappearance of pulses and of
flow signals.
Results
In the 160 outlets studied, the exag
gerated military position evoked flow
disturbances in 21, and symptoms were
provoked in 14 instances. Abduction
to 90° caused arterial compression at
15 outlets, and symptoms in 10 in
stances. Hyperabduction precipitated
turbulence 31 times and provoked
symptoms on 15 occasions. In seven
cases Adson’s maneuver caused signi
ficant turbulence; in six of these it re
produced symptoms of which the
subjects had been previously vaguely
aware. Unexpected bruits were found
at rest in four volunteers, two of whom
admitted to a definite history of symp
toms. No aneurysms or dilatations were
found. Another interesting observation
was the total cessation of venous re
turn in the subclavian vein on deep in
spiration, noted in the case of all but
six (3.7%) of the outlets (Fig. 2). Bear
ing this information in mind and con
sidering that most venograms are taken
during deep inspiration, physicians
perhaps ought to re-examine many
existing venograms.
Since the results of the pilot study
indicated that the Doppler modality
might be useful in a clinical setting, it
was applied to the clinical evaluation
of 47 patients all of whom were re
ferred with either a suspicion or a tenta
tive diagnosis of TOS.
146

Clinical Evaluation

Patients and Methods

Using the above protocol we studied
47 patients, 16 of whom were men.
Nineteen of these (six men) underwent
a total of 32 operations, which included
anterior scalenotomy, resection of the
first rib, division of fibrous bands and
excision of seven (of nine) cervical ribs
(the two left in situ were vestigial rudi
ments that were buried deep in the
muscle mass and could not possibly
have caused any symptoms).
A history of possibly related acci
dents was elicited from 17 patients;
10 had suffered falls, 7 had suffered
whiplash injuries and 4 had sustained
ipsilateral upper rib fractures. Another
interesting observation was related to
age distribution. Patients aged 20 to 30
years were generally muscular, athletic
and at times obese individuals with welldeveloped musculature of the pectoral
girdle. Those over 40 years of age
were typically frail, often debilitated, or
grossly unfit with obviously drooping
shoulders.
Predominant symptoms were pain,
numbness, paresthesia and muscle
weakness (Table I). In four of the pa
tients complaining of anterior chest
pain, angina pectoris had been diag
nosed and treated, in two instances for
over 2 years. Excessive muscularity
was noted in four young adults whereas
muscle wasting in the hands occurred
in three patients. A further three pa
tients had Raynaud’s phenomenon in
their hands. No aneurysms were en
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countered in this series, but poststeno
tic dilatation of the subclavian artery
was observed three times. Two patients
complained of hyperesthesia over the
brachial plexus. Unfortunately this was
first observed towards the end of the
series and had not been sought
earlier; consequently no valid state
ment can be made regarding its inci
dence beyond that it does occur and
should be looked for.
Arterial flow disturbances as demon
strated by Doppler flow detectors oc
curred most frequently on hyperabduc
tion and on costoclavicular compression
(Table II). Subclavian-axillary vein
thrombosis of effort, the Paget-Schroetter syndrome, was diagnosed three
times. Doppler flow detectors accurate
ly located the extent of thrombosis to
within a few millimetres. Calibrated as
they are, commercially available Dop
pler instruments pick up venous flow
signals provided the flow velocity is in
Table ^ P re s e n tin g Symptoms in the Tho
racic O utlet Syndrome (94 Outlets in 47
Patients)
Symptom
Pain
Numbness
Paresthesia
Muscle weakness
A nterior chest pain*
Sympathetic overactivity
Burning sensation
Anesthesia

No. of instances
30
25
23
14
7
5
3
2

•Angina pectoris was recorded in 4 instances.
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FIG. 2— (a) Arrest of venous return on deep inspiration found in 96 .3% o f patients in pilot study. Transient obstruction
is caused by first rib riding up to clavicle, compressing vein against it. This is artefact and should not be confused with deep vein
thrombosis, (b) Axillary—subclavian vein thrombosis o f effort, Paget—Sehroetter syndrome.
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excess o f 4 cm /s. Venous flow signals
are in a low frequency range whose
peak is between 3 and 4 kHz. They
sound somewhat like a wind storm and
are often phased with respiration. C om 
pression o f the limb below the point o f
auscultation increases the venous flow
velocity and as a result raises the fre
quency pitch. This maneuver is known
as augmentation and adds much in
formation on the nature o f the venous
flow.
Symptoms were o f sufficient severity
to cause sleep disturbance in 14 pa
tients, disruption o f working time in 11
and interference with driving in 11.
These disabilities occurred singly or in
combination and form ed the basis for
selection for surgery. This group in
cluded nurses, waitresses, housewives.

I ► A

►

Table II— Positive Provocative Tests Occur
ring Singly or in Combination in 94 Outlets
Studied

V
► h

'
r

Test
Costoclavicular compression
Abduction to 90°
Hyperabduction
Scalenus anticus (Adson's)
syndrome
Paget-Schroetter syndrome

No. of outlets
giving positive
result
47
21
51
7
3
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teachers, policemen, barbers, nursing
mothers, labourers and a choirmaster.
All were incapacitated to a significant
degree in their respective activities.
The factor com m on to all com p o
nents o f the TOS is the first rib. It acts
either by direct compression or like one
limb in a scissors, shearing the neuro
vascular bundle against the clavicle. In
A dson’s syndrome it acts as a mooring
point for the scalenus anterior muscle.
The removal o f the first rib and the
attendant scalenotomy have been cura
tive in all cases in this series. When
cervical ribs are removed as the pri
mary procedure, the first rib is excised
routinely as well. In addition a careful
search should be made fo r fibrous
bands traversing the apical space.
Although there are five approaches
to the first rib, the axillary approach as
described by R oos7 was used exclusively
in this series. After puncture o f the
axillary fascia with a scalpel the re
mainder o f the exposure was achieved
by two-finger blunt dissection. This
avoids injury to the intercostobrachial
nerve, which traverses the apex o f the
axilla and becomes vulnerable at this
stage o f the operation. The neurovascu
lar bundle was retracted as gently as
possible. The first rib was identified by
the scalene tubercle and the attachment
o f the scalenus anterior muscle. The
periosteum was elevated and the rib

was detached from Sibson’s fascia.
Puncture o f the pleura at this point (as
happened on seven occasions) was o f
no real consequence as at the time o f
closure the lung was fully inflated and
a H em ovac drain aspirated any free
air. Great care was taken to keep close
to the first rib when perform ing scale
notomy lest the phrenic nerve be in
jured. The rib was freed fore and aft
and divided with one clean bite o f the
costotome. Rongeurs were not used as
they are apt to leave ragged edges which
can result in shooting pains during the
postoperative period. Starting at the
posterior angle o f the rib approximately
two thirds was rem oved. Excessive re
section anteriorly may leave a m obile
and cosmetically disfiguring stump.
Results

Postoperative results were extremely
gratifying. All patients were relieved o f
their symptoms. D oppler flow studies
showed minor disturbances in only five
patients and in none was the flow obli
terated, even with the use o f p rov oca
tive tests in extreme positions. M inor
aches and patchy paresthesias were
transient. One patient suffered a stretch
injury to the ulnar and median nerves,
which has persisted fo r almost a year.
In another patient the first root o f the
brachial plexus was similarly injured,
but progressive recovery is taking place.
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The patient shown was once
a paraplegic due to Paget’s
Disease of the vertebral
column. Treatment with
CALCIMAR now enables
him to rise from a chair
and walk unassisted.
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C linical com m ents on reduction of
bone pain
“ Bone pain is generally improved or com
pletely relieved within several weeks of
instituting treatment, although this has not
yet been studied in a double-blind
manner.” 1
“ ...25 patients had prominent skeletal or
radicular pain, and 21 of them (84 per
cent) had significant relief of pain assoc
iated with increased exercise tolerance
and partial to complete return to normal
activity.” 2
“ Bone pain caused directly by Paget’s
disease was ameliorated in 12 of 13
patients, but pain resulting from skeletal
deformity or mechanical stress was not
alleviated.” 3 (from abstract.)
A c lin ic ia n ’s comm ent on improved
patient m o b ility
“ Among the most dramatic improve
ments is the relief of spinal cord impinge
ment, with restoration to full ambulation,

which in one series occurred in three of
four patients with pure spinal cord
involvement.” 4
A clinician’s com m ent on improvement
in neurologic function
“ Neurologic deficits other than auditory
were found in 28 patients(57 per cent)...
Twenty-one of these 28 patients (75 per
cent) showed significant subjective or
objective improvement during calcitonin
treatment.” 2
The facts about bone deform ity and
pathologic fractures
There is no long-term evidence that bone
deformity or pathologic fractures will be
forestalled with the use of CALCIMAR
(calcitonin-salmon) therapy, however,
there are numerous cases of improved
bone structure with the use of
CALCIMAR therapy.
CALCIMAR (calcitonin-salmon) therapy
generally produces an immediate fall in
urinary hydroxyproline levels, an indica
tion that the drug limits bone-destroying
osteoclastic activity. Serum alkaline
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phosphatase levels will usually decrease
after one to two weeks of CALCIMAR
therapy, an indication that bone-forming
osteoblastic activity has slowed.
C lin icia ns’ comments on laboratory
parameters
“ With chronic treatment an approx
imately 50% decrease is usually noted
in urinary hydroxyproline excretion and
serum alkaline phosphatase activity. If
these biochemical parameters are
greater than twice normal before
treatment, they usually are not suppres
sed to normal.” 1
“ During the first 4 to 8 months of
treatment with either PCT or SCT
(porcine calcitonin or synthetic salmon
calcitonin), there is a good correlation
between the clinical response and the
changes in serum alkaline phosphatase
and urinary hydroxyproline values.” 2
“ Administration of salmon calcitonin to
patients with Paget’s disease decreases
bone turnover without affecting calcium
and phosphorus balances.” 5

PAAB
CCPP

Harris Laboratories
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“Calcimar'

(calcitonin-salmon)
DESCRIPTION
The active ingredient of CALCIMAR is a
synthetic calcitonin consisting of 32 amino
acids in the same linear sequence as that
found in salmon calcitonin. It is a white or
slightly yellowish powder. It is provided in
sterile lyophilized form and its calcitonin
activity is stated in International Units.
Equivalency of M.R.C. and I.U.:
An International Unit for Calcitonin, salmon,
is defined as the activity contained in
0. 02525.mg of the International Reference
Preparation of Calcitonin, salmon, for
BioassayO).
By agreement, the International Unit is
identical to the pre-existing Medical Research
Council (MRC) unit.
ACTIONS
CALCIMAR participates in the regulation of
the homeostasis of calcium by acting primar
ily on the bone. In Paget’s disease the rate
of bone turnover appears to be decreased,
presumably by an initial blocking effect on
accelerated bone resorption.
CALCIMAR participates in the regulation of
urinary excretion of phosphate and calcium.
Administration of CALCIMAR decreases the
volume and acidity of the gastric juice and
decreases the volume as well as trypsin and
amylase content of the pancreatic juice.
(For further details see clinical pharma
cology section in the product monograph)
INDICATION
Treatment of symptomatic Paget's disease of
the bone.
CONTRAINDICATIONS
Known hypersensitivity to salmon calcitonin or
its gelatin diluent.
WARNINGS
1. Pregnancy:
Reproduction studies in two species (rats
and rabbits) have revealed decreases in
fetal birth weight, and data in humans are
not available to exclude a possible adverse
effect on the fetus. Use of this drug in
women who are or may become pregnant
requires a determination that the potential
benefit to the patient outweighs the possi
bility of risk to the fetus.
2. Nursing Mothers:
CALCIMAR has been shown to inhibit lac
tation in animals and should not be admin
istered to nursing mothers.
3. Children:
The safety of the use of CALCIMAR in
children has not been established.
PRECAUTIONS
1. Potential allergenicity o f CALCIMAR
and gelatin diluent:
Skin testing should be considered prior to
treatment of patients with suspected sensi
tivities to calcitonin or to gelatin. The follow
ing procedure is suggested: Reconstitute
CALCIMAR at a concentration of 200 I.U. per
ml with CALCIMAR Diluent. Prepare a dilu
tion of 10 I.U. per ml by withdrawing 1/20 ml
(0.05 ml) of the reconstituted CALCIMAR in
a tuberculin syringe and filling it to 1.0 ml
with Dextrose Injection 5% , U.S.P. (or Saline
Injection, U.S.P.). Mix well, discard 0.9 ml
and inject intracutaneously 0.1 ml (approx
imately 1 I.U.) on the inner aspect of the
forearm. Observe the injection site 15
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minutes after injection. The appearance of
more than mild erythema or wheal const
itutes a positive response.
Because calcitonin and gelatin (diluent)
are protein in nature, the posibility of a sys
tematic allergic reaction cannot be over
looked. The usual provisions should be made
for the emergency treatment of such a reac
tion should it occur.
2. P ossibility of hypocaicemic tetany:
The administration of calcitonin possibly could
lead to hypocaicemic tetany under special
circumstances although no cases have yet
been reported. Provisions for parenteral cal
cium administration should be available dur
ing the first several administrations of
calcitonin.
3. Laboratory Tests:
Periodic examinations of urine sediment of
patients on chronic therapy are recom
mended.
Coarse granular casts and casts contain
ing renal tubular epithelial cells were report
ed in young adult volunteers at bed rest
who were given salmon calcitonin to study
the effect on immobilization osteoporosis.
There was no other evidence of renal abnor
mality and the urine sediment became
normal after calcitonin was stopped. Urine
sediment abnormalities have not been re
ported by other investigators.
4. Instructions for the patient:
Careful instruction in sterile injection tech
nique should be given to the patient, and to
other persons who may administer
CALCIMAR.
5. Interactions with other drugs:
At the present time there are no known
interactions with other drugs.
ADVERSE REACTIONS
Nausea with or without vomiting has been
noted in about 10% of patients treated with
CALCIMAR. It is most evident when treat
ment is first initiated and tends top decrease
or disappear with continued administration.
Local inflammatory reactions at the site of
injection have been reported in about 10%
of patients.
Facial flushing occurred in about 2% of
patients.
Other systemic effects included anorexia,
a metallic taste and tingling of the hands.
These effects usually occurred early in the
treatment and tended to diminish with con
tinued therapy.
The usual laboratory parameters of liver
and kidney function and of hematologic
status remained within normal limits. Evi
dence of systemic allergic reactions was
minimal and no anaphylactic reactions were
seen. In approximately one-half the patients
tested after six months or more of treatment,
indications of circulating antibodies to calci
tonin were obtained. In most of the patients
the level of antibodies was not high enough
to interfere with the effect of exogenous cal
citonin. In a few patients resistance to calci
tonin was attributed to high levels of anti
bodies. Secondary hyperparathyroidism did
not develop in patients with Paget’s disease
as a result of the transient hypocalcemia
following a calcitonin administration.
DOSAGE AND ADMINISTRATION
Adults:
The recommended starting dose of CAL
CIMAR in Paget’s disease is 100 International
Units per day administered subcutaneously
(preferred for out-patient self-administration)
or intramuscularly. Drug effect should be
monitored by periodic measurement of serum
alkaline phosphatase and 24-hour urinary
hydroxyproline (if available) and evaluation of
symptoms. A decrease toward normal of the
biochemical abnormalities is usually seen, if
it is going to occur, within the first few months.
Bone pain may also decrease during that
time. Improvement of neurologic lesions,
when it occurs, requires a longer period of
treatment, often more than one year.

In many patients doses of 50 International
Units per day or every-other-day are suffic
ient to maintain biochemical and clinical im
provement. At the present time, however,
there are insufficient data to determine
whether this reduced dose will have the same
effect as the higher dose on forming more
normal bone structure. It appears preferable,
therefore, to maintain the higher dose in any
patient with serious deformity or neurological
involvement.
In any patient with a good response initially
who later relapses, either clinically or bio
chemically, the possibility of antibody forma
tion should be explored. Although specialized
tests for antibody titer are not widely avail
able, the following test will detect titers that
interfere with the action of calcitonin:
After overnight fasting, a sample of the
patient’s blood is taken for determination
of serum calcium and 100 International
Units of CALCIMAR are injected IM. The
patient is then permitted to eat his usual
breakfast. At 3 and 6 hours post-injection
additional blood samples are drawn and
the patient is released. The serum calcium
values are then compared. A decrease of
0.5 mg % or more from fasting level at
3 and 6 hours is usually seen in the re
sponsive patient. Decreases of 0.3 mg %
or less constitute an inadequate response
to calcitonin in the patient with active
Paget’s disease. If the hypocaicemic
action of calcitonin is lost, further therapy
with CALCIMAR will not be effective.
Patient compliance should also be assessed
in the event of relapse. In patients who re
lapse, whether because of antibodies or for
unexplained reasons, a dosage increase be
yond 100 International Units per day does
not usually appear to elicit an improved
response.
DOSAGE FORMS
CALCIMAR, Calcitonin, is available as a
sterile, lyophilized powder, 400 International
Units per vial, with 20 mg of hydrolyzed
Gelatin. Each package contains one vial of
CALCIMAR and one vial of CALCIMAR
DILUENT (sterile 16% gelatin solution with
0. 5 . phenol) 4 ml. (NOTE: 1 International Unit
is equivalent to MRC unit).
RECONSTITUTION
For intramuscular or subcutaneous use: The
contents of a vial of CALCIMAR are recon
stituted with an appropriate volume of CALC
IMAR DILUENT so that the final injection
volume is approximately 0.5 ml. Solubiliza
tion of CALCIMAR in the gelatin diluent re
quires two or three minutes of gentle agita
tion. After reconstitution, CALCIMAR in gela
tin is stable for up to two weeks in the re
frigerator.
REFERENCES:
1. Singer FR: Treatment of Paget’s Disease
of Bone. Postgrad Med 57:117-120,1975.
2. DeRose J. Singer FR, Avramides A, et al:
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56:858:866,1974.
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43:71-80,1975.
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23,1977.
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These injuries are attributed to retrac
tion at operation. One patient had
pseudotumour cerebri in the postoper
ative period.* Early in the series one
second rib was resected in error; a
second operation was performed 1 week
later. Not one instance of venous ob
struction on deep inspiration was re
corded after resection of the first rib.
Postfixation of the brachial plexus was
seen only once during the 32 opera
tions; when it is present the lowest cord
of the brachial plexus (T-2) becomes
vulnerable both in this operation and
in cervicodorsal sympathectomy and its
existence should be borne in mind.
Careful placement of the incision may
account for absence of sepsis in this se
ries. A 5- to 7-cm incision below the
axillary hair line and not encroaching
upon the axillary folds leaves an unob
trusive scar.
Discussion

Involvement of nerves of the brachial
plexus was cited in the past as the ma
jor cause of symptoms in the TOS. In
this modest series operative results
based on flow evaluation by Doppler
ultrasonography and on clinical assess
ment suggest that arterial flow occlu
sion plays an important if not a domi
nant part in the symptomatology of this
syndrome. Predominance of neurologic
symptoms was observed in the presence
of cervical ribs, in the scalenus anticus
syndrome, in the one patient with post
fixation of the brachial plexus and in
the patients with a history of whiplash
injury. Attempts at differentiating on
clinical grounds between arterial com
pression and primary nerve irritation
proved fruitless as no distinct pattern
emerged.
It is noteworthy that the patients fell
into two distinct groups based on age.
In the younger age group were healthy
individuals in their 20s, some of whom
indulged in calisthenics. These patients
displayed uniformly excessive muscular
development, which contributed to the
narrowing of the thoracic outlet and
thereby to the symptoms. Such persons
cannot be expected to benefit from
remedial exercises. In contrast, in the
older age group muscle wasting was so
advanced at times that, at operation,
the first rib could be fully mobilized by
finger dissection. In this age group
atrophy of muscles of the pectoral gir
dle must be considered as a precipitat
ing cause of the TOS and, initially,
shoulder strengthening exercises should
be advocated rather than surgery. The

*She had previously received psychiatric
treatment over a long period; the throm
bosis of the lateral sinus could have re
presented a recrudescence of a pre-exis
tent condition.
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latter can be resorted to if no improve
ment occurs after physiotherapy con
tinued for 6 months.
Poststenotic dilatation of the subcla
vian artery results from compression by
the scalene muscles, by a bulbous end
of a cervical rib or by an exostosis of
either the clavicle or a rib. When it is
present it is usually in a patient in the
younger age group.13 Subclavian aneur
ysms, on the other hand, occur in the
older patients, and one may speculate
whether poststenotic dilatations become
frank aneurysms with the passage of
time.
Wright5 claims that in the hyperab
duction syndrome obstruction of the
subclavian artery is caused by the ten
don of the pectoralis minor or by pro
trusion of the head of the humerus into
the axilla. Flow studies by Doppler ul
trasonography in this condition indicate
that no flow occurs beyond the first
rib. Cessation of flow can be pinpointed
with a high degree of accuracy, hence
the great value of such investigations
in locating an arterial embolus. It would
therefore seem reasonable to surmise
that the head of the humerus or, indeed,
the tendon of the pectoralis minor acts
as a lever causing compression of the
artery against the first rib. Another
factor in arterial obstruction during
hyperabduction is inner rotation of the
forward bulge of the medial third of
the clavicle causing compression of the
artery against the first rib.5 In any
case, compression of the artery occurs
at the level of the first rib, and not
beyond. Arteriography confirms that
compression, when it does occur, takes
place at the point where the clavicle
crosses the first rib. It is equally diffi
cult to disregard the vise-like action
between the first rib and the clavicle as
a causative factor in axillary—subclavian
vein thrombosis of effort, particularly
since this condition is frequently asso
ciated with prolonged, unaccustomed
and peculiar activity. In Alberta this
condition is still known as “haymaker’s
arm” (Pow R: Personal communication,
1976) and rightly so as the term reflects
accurately the mechanism of repeated
thoracic outlet compression, which also
occurs in the painting of a wall or of
a ceiling. Repeated scissor-like action
of the two bones upon the vein or the
artery can damage the intima and ini
tiate thrombosis. Doppler flow detec
tors can also be put to good use in this
condition as they will diagnose throm
bosis with great facility.
All the patients in this study were
assessed pre- and postoperatively by
Doppler ultrasonography. They have
shown a uniform degree of improve
ment, are free of their symptoms and
have been able to return to their full
activities and the enjoyment of an un
interrupted night’s sleep. Resection of
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the first rib and a scalenotomy abolished
all but the most minor flow disturb
ances even in extreme postures. Follow
ing surgery not a single instance of
venous flow obstruction on deep in
spiration was recorded.
On the basis of our results we con
clude that Doppler ultrasonography is a
valuable new modality in the diagnosis
and assessment of the TOS and we
recommend its wider use in this con
dition.
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Alterations in Red Cell Metabolism During and
Following Cardiac Bypass Surgery*
R obert T. Card,

md , frcp[c],

Reduced concentrations of red cell
organic phosphates and increased
hemoglobin-oxygen affinity have been
reported during and following cardiac
bypass surgery. Some have related
these changes to low concentrations
of ATP and 2,3-diphosphoglycerate
(DPG) in stored blood while others
have related them to use of the pump
oxygenator. There was a 10% decrease
in DPG concentration in seven dogs
on cardiac bypass although the animals
received no transfusions. In 16 patients
who received 0 to 7 units of blood
during cardiac bypass there was a
decrease of 10% in the red cell DPG
concentration from the preoperative
value, but it did not relate to the con
centration of DPG in the transfused
blood bags. The magnitude of the
decrease was not sufficient to impair
oxygen delivery severely. The results
suggest that a re-evaluation of indica
tions for the use of fresh red cells in
cardiac surgery is necessary.
line diminution des concentrations
des phosphates organiques dans les
hematies avec une augmentation de
I’affinite hemoglobine-oxygene ont ete
signalees durant et apres les operations
de pontage cardiaque. Certains ont
relie ces changements aux faibles
concentrations d’ATP et de 2,3-diphos
phoglycerate (DPG) dans le sang
entrepose, alors que d'autres les ont
relies a I 'utilisation de I’oxygenateur
a pompe. II y a eu une baisse de 10%
de la concentration en DPG chez sept
chiens qui ont subit une operation de
pontage, bien que ces animaux n'aient
recu aucune transfusion. Chez 16
patients qui ont recu de 0 a 7 unites
de sang pendant une intervention de
pontage cardiaque, il y a eu une baisse
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de 10% de la concentration en DPG
des hematies comparativement aux
valeurs preoperatoires, mais il n’y a
pas eu de relation avec la concentration
de DPG dans les sacs de sang pour
transfusion. La grandeur de la baisse
n’etait pas suffisante pour affecter
serieusement le transport d’oxygene.
Ces resultats indiquent la necessity de
reevaluer les indications d’utiliser
des globules rouges frais dans la
chirurgie cardiaque.

Reduced oxygen delivery during car
diac surgery may have detrimental ef
fects, especially in patients with
pre-existing ischemic heart conditions;
it is therefore necessary to establish the
cause of this reduction. The hemo
globin-oxygen dissociation, curve can
be altered by changes in the concentra
tions of red cell organic phosphates,
ATP
and
2,3-diphosphoglycerate
(DPG). Reduced values of ATP and
DPG will shift the curve to the “left”,
increasing hemoglobin-oxygen affinity
and theoretically reducing oxygen
delivery.1 Since red cells become de
pleted of ATP and DPG during blood
storage the above theoretical considera
tions have been offered as one indica
tion for the use of fresh blood during
cardiac surgery. Separate blood com
ponents will likely be used more often
during cardiac surgery and therefore it
is important to establish whether or not
red cells provided separately from co
agulation factors should be fresh. Hypo
phosphatemia and reduced ATP and
DPG concentrations with increased
hemoglobin-oxygen affinity have been
reported during and following openheart surgery.2-6 Some authors have
postulated that the decrease is related
to a direct effect of the use of the
membrane oxygenator,2,5 whereas others
have related these changes to transfu
sion of stored blood with a reduced
concentration of DPG.3,4,6 Dennis and
colleagues4 and Giannelli and col
leagues7 have provided evidence that
decreasing the hemoglobin-oxygen af
finity artificially by manipulation of
the transfused red cells can have bene
ficial effects on the patient during
cardiac surgery.
The exact cause of the reduced con

md , frcs [c]

centrations of inorganic and organic
phosphates following cardiac surgery
remains in doubt and most studies
have incorporated few controls. Be
cause relatively few reports compared
exact measurements of the interme
diates in the blood products used in
each case, we studied the effect of
cardiac bypass upon red cell meta
bolism both in dogs and in human
beings during cardiac bypass, and for
up to 8 days following bypass in the
human subjects.
M a te ria l and M ethods

Dogs

Eleven mongrel dogs (weight, 15 to
22 kg) were studied. Seven were placed
on cardiopulmonary bypass for 120
minutes at normothermia, using a
standard roller pump and the Harvey
H-1000 oxygenator (William Harvey
Research Corp., Santa Ana, CA) with
bloodless prime. In four dogs acting as
a control group, the chest was opened
for the same period of time and blood
samples were taken to correspond to
those obtained in the bypass group.
During this time the pH was maintained
at 7.27 ± 0.15. Blood samples were
obtained before induction of anesthe
sia, at the onset of bypass and at 30minute intervals until the end of bypass.
H um an Beings

Of 16 patients who underwent car
diopulmonary bypass for a variety of
indications, 9 had valve replacements,
6 underwent aortocoronary bypass and
1 had closure of an atrial septal defect.
These patients required cardiopul
monary bypass for an average of 65 ±
27 minutes. The conditions of bypass
included the use of the Harvey H-1000
oxygenator,
moderate hypothermia
(30°C) and intermittent anoxic arrest.
Arterial blood pH was maintained at
7.40 ± 0.04 throughout the procedure.
A bloodless prime was used in all cases.
Blood samples were drawn before op
eration, as soon as the patient was on
the pump, 30 minutes later, at the end
of the pump run, at the end of the
operation and again 3 hours later, then
24 hours postoperatively and approx
imately every other day for a further 7
days. The patients received 0 to 7 units
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of whole blood during bypass or later
on the operative day. One patient who
received 17 units of blood in a 24-hour
period of cardiac bypass was also
studied and is reported separately. Six
patients who underwent noncardiac op
erations constituted a control group.
Assays
Hematologic values were obtained
by standard methods used at Univer
sity Hospital in Saskatoon. Blood was
collected into tubes containing heparin
as an anticoagulant. These were imme
diately placed on ice, and perchloric
acid extracts were made within 1 hour
of blood-letting by Beutler’s method.8
Intracellular phosphate was measured
by washing the sample with normal
saline immediately following blood
letting, prior to the preparation of the
extract. Red cell ATP concentration
was measured by the method of Lowry
and associates9 and DPG concentration
by Keitt’s method.10 Red cell and plas
ma phosphate values were measured by
the method described by Chen, Toribara and Warner.11

F IG . 1— Decrease in hemoglobin con
centration during cardiac bypass in seven
dogs. Values are compared with those of
four animals in whom sham operation
was performed.

cardiac bypass, but there was a delayed
minor fall between days 2 and 5 fol
lowing the operation (Fig. 4). Despite
these decreases, which are similar to
those reported previously, there was no
significant change in the red cell ATP
concentration during the follow-up pe
riod (Fig. 5). However, in these subjects
the concentration of red cell DPG de
creased significantly during bypass and
remained low for up to 24 hours postoperatively; the concentration then
returned to normal and subsequently
increased to 134% ± 15% of the pre
operative value after 8 days (Fig. 6,
Table II). Surprisingly, the average

Results

Dogs

In the bypass group of seven dogs
the hemoglobin value decreased by
8.3 ± 2.5 g/dL during 1 to 2 hours of
cardiac bypass (Fig. 1). Red cell and
plasma inorganic phosphate values did
not change appreciably and neither
did the ATP (Fig. 2). A 10% decrease
in red cell DPG concentration did, how
ever, occur early during cardiac bypass,
but the concentration returned to con
trol values at 2 hours (Fig. 2).
The decrease in DPG concentration
tion did not correlate significantly with
plasma or red cell phosphate concen
trations, pH or ATP. A summary of the
relevant data is set forth in Table I.
Human Beings

In the 16 patients who underwent
cardiac bypass and who received 0 to
7 units of blood, the hemoglobin value
decreased to 5.3 ± 1 . 4 g/dL from the
preoperative value (Fig. 3); the extent
of the decrease did not relate to the
number of units of blood transfused.
There was no significant change in red
cell or plasma phosphate values during

FIG. 3— Changes in hemoglobin con
centration during and after cardiac bypass
surgery in 16 patients.

FIG. 2— Red cell ATP and D PG con
centrations in seven dogs undergoing car
diac bypass compared with those of control
group of four dogs.

FIG. 4— Changes in red cell and plasma
phosphate concentrations during and after
cardiac bypass surgery in 16 patients.

Table I— Changes in Hemoglobin, Plasma and Red Cell Inorganic Phosphate Concentrations and Red Cell ATP and DPG Values During Cardiac Bypass
in Seven Dogs and in Four Control Dogs. Results are Mean ± SD

Tim e

Hemoglobin,
g/dL

Inorganic phosphate,
mmol/L
---------------------------------------------------------------Plasma
Red cell

Red cell ATP,
(xmol/g Hb

Red cell DPG,
p.mol/g Hb

pH

Bypass group
Preop
Pump— 0 min
60 min
120 min

16.2
9.9
8.5
7.1

±
±
±
±

1.5
2.0*
1.5*
1.2*

1.61
1.26
1.58
2.37

±
±
±
±

0.24
0.14*
0.86
0.73f

0.58
0.80
0.83
1.56

±
±
±
±

0.25
0.23
0.24
0.94)

2.24
2.12
2.42
2.87

± 0.65
± 0.46
± 0.43
± 0.29f

20.8
18.7
20.4
22.5

±
±
±
±

2.3
1.6*
2.5
1.2

Control group
Preop
30 min
60 min
120 min

15.5
16.1
16.1
15.9

±
±
±
±

1.5
1.1
1.2
1.4

2.01
1.83
2.02
2.36

±
±
±
±

0.58
0.60
0.61
0.86

0.53
0.68
0.70
0.79

±
±
±
±

0.15
0.23
0.20
0.28

2.74
3.06
2.95
2.77

±
±
±
±

20.9
21.4
21.4
21.3

±
±
±
±

0.9
0.5
1.1
0.8

/
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0.61
0.75
0.83
0.85

7.32
7.42
7.27
7.23

±
±
±
±

0.04
0.07f
0.10
0.20

—
—
—
—

"Significantly lower than preoperative value (P < 0.05).
fSignificantly higher than preoperative value (P < 0.05).
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values of DPG in the blood bags used
for the patients could not be correlated
with the decrease in DPG concentration
during bypass (Fig. 7, Table II). There
were no differences in DPG values
between those who received 0 to 3
units and those who received 4 to 7
units of blood (Table II). In the patient
who received 17 units of blood, which
included units that were an average of
8 days old (range, 1 to 16 days), the
overall decrease in DPG concentration
was relatively small. The red cell DPG
value did not decrease in the control
group of six patients (Table II).
D iscussion

Authors who previously have re
ported hypophosphatemia and low

I

g
.■ / / ; ; / /-;--------------r
< > in )
PUMP

Ch)

(d )
POSTOPERATIVE

FIG. 5— Changes in red cell ATP con
centration during and after cardiac by
pass surgery in 16 patients.

values of ATP and DPG following
cardiac surgery have commented on the
possible detrimental effects of these
changes.2'7 Our results confirm that a
fall in DPG concentration occurs dur
ing cardiac bypass. Since the fall oc
curred in dogs who were not transfused,
and since it did not relate to the num
ber of blood bags given or the blood
bag concentration of DPG, the results
suggest that this decrease relates to the
use of the pump oxygenator and not
to the effects of the transfused blood
as suggested by others.2-5 The average
DPG concentrations in the blood bags
used for our patients were always great
er than 50% of normal adult values
since half of the blood that was given
had been stored for less than 4 days.
Thus, it is still possible that if our pa
tients received blood that was totally
depleted of DPG, then an additional
effect on DPG might have been seen,
as occurred in the studies of Dennis
and associates4 in which DPG-depleted
blood was compared to DPG-enhanced
blood. However, in our patient who re
ceived 17 units of blood for severe
postoperative bleeding, one half of the
units had been stored for longer than
8 days and had less than 50% of the
normal DPG concentration, yet the de
crease in the DPG value was relatively
minor.

BLOOD BAG DPG (»anol/g Hb)

centration during and after cardiac bypass
surgery in 16 patients.

FIG. 7— Relation o f change in D P G
value in 14 patients undergoing cardiac
bypass surgery who received transfusion
to average value of blood bag D PG .

Table II— Changes in Red Cell DPG Concentration (ixmol/g Hb) During and Following Cardiac
Bypass Surgery in 17 Patients Compared with Values for a Control Group of Six Patients
Undergoing Noncardiac Operations. Results are Mean ± SD
Bypass group
Time

0-3 units
blood

Number
Preop.
Pump— 0 min
end
Postop day— 0
1
2
4
8

4-7 units
blood

10
17.9
16.8
15.9
16.3
15.8
16.5
19.6
22.9

±
±
±
±
±
±
±
±

6
2.5
2.4
3.1
2.2
2.7‘
1.9
2.4
1.1*

18.1
17.0
17.1
16.5
15.8
16.7
20.1
23.1

±
±
±
±
±
±
±
±

‘Significantly different from preoperative value (P < 0.05).
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17 units
blood

Control
group

1
0.9
1.0‘
1.8
2.0
1.2*
1.0*
3.2
2.7*

23.9
17.1
20.7
19.6
17.6
—

20.0
21.3

6
14.0 ± 3.8
—
—

14.5
13.9
13.1
16.2
16.9

±
±
±
±
±

4.5
4.0
4.0
5.6
4.4

Despite the finding of mild hypo
phosphatemia we were unable to con
firm the presence of reduced ATP con
centrations following cardiac surgery
found by Young, Lichtman and Cohen3
and cannot explain the difference be
tween our results and theirs. Hypo
phosphatemia has been reported12 fol
lowing noncardiac surgery when dex
trose in water was used as the sole
fluid replacement for 5 days after op
eration, and it is possible that Young,
Lichtman and Cohen3 observed a con
dition in their patients that may occur
under certain circumstances following
any surgery.
The 10% decrease in red cell DPG
concentration on cardiac bypass was
not of such magnitude that hemoglobin
oxygen delivery would be severely im
paired.1 Our data suggest that the de
crease is an effect of the use of the
pump oxygenator and not of blood
storage.
Two authors4-7 have artificially de
creased hemoglobin-oxygen affinity by
various manipulations of the red cell
and have shown improved myocardial
performance during cardiac surgery by
increasing the DPG value to 150% of
normal. Further investigations in this
important area are necessary to estab
lish the overall magnitude of this bene
fit.
It is a routine procedure in our hos
pital and most centres to prepare
“fresh” whole blood (less than 3 days
old) for cardiac bypass surgery to com
pensate for reduced platelets and fibri
nogen. The discovery of the increased
oxygen affinity in stored red cells1’1*
has added another possible indication
for the use of fresh whole blood. Blood
products will be provided increasingly
as separate components (red cells and
coagulation factors). We suggest that
fresh red cells are unlikely to be neces
sary for routine maintenance of ade
quate DPG concentrations after cardiac
bypass surgery and that stored red cells
should be satisfactory where citratephosphate-dextrose (CPD) blood is
used. Further studies are required in
patients receiving stored blood totally
depleted of DPG and direct measure
ments of hemoglobin-oxygen affinity
are necessary. A recent paper14 has
questioned the provision of coagulation
factors as an indication for the use of
fresh blood or platelets during routine
cardiac bypass surgery. Our findings
suggest that a re-evaluation of the in
dications for fresh blood components
in cardiac bypass surgery is indicated.
C on clu sion s

During cardiac bypass the red cell
DPG concentration was reduced by
10% and, while this reduction was
maintained for up to 24 hours, the
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value increased to 134% of the preop
erative value by day 8 after operation.
The reduction was found to be inde
pendent of blood transfusion and not
related to D PG values in CPD blood
bags. N o such reduction was recorded
during noncardiac operations. The fall
in D P G concentration is apparently an
effect of the use of the pump oxygena
tor and does not serve as an indication
for the use of fresh blood.
We gratefully acknowledge the cooper
ation and help of the staff of the oper
ating and recovery rooms at University
Hospital, Saskatoon, and the technical
assistance of Miss Ava Stevens, Mr. Gary
Berube, Mr. Eric Gately and Mr. Ed
Webber.
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AMINOSYN INDICATIONS AND CLINICAL USES
Aminosyn 5% Injection is indicated for peripheral vein infusion as
a source of nitrogen in the intravenous treatment of acute surgical
patients with adequate stores of body fat, in whom, for short
periods of time, oral nutrition cannot be tolerated or is not desira
ble. In such instances, the patient's caloric needs are met from
their own fat stores.
Amino acids when administered with concentrated dextrose solu
tions also are indicated for central vein infusion as an adjunct in
the prevention of nitrogen loss or in the treatment of negative
nitrogen balance in patients where: (1) the alimentary tract, by the
oral, gastrostomy or jejunostomy route, cannot or should not be
used, (2) gastrointestinal absorption of protein is impaired, or
(3) metabolic requirements for protein are substantially increased,
as with extensive burns. In such usage, intravenous feeding for
prolonged periods, up to 100 days or more, has been success
fully employed7 .

CONTRAINDICATIONS

This preparation should not be used in patients with hepatic coma
or anuria or metabolic disorders involving impaired nitrogen utili
zation. Patients with azotemia from any cause should not be in
fused with amino acids without regard to total nitrogen intake.

WARNINGS
Peripheral intravenous infusion of amino acids may induce a rise
in blood urea nitrogen (BUN) especially in patients with impaired
hepatic or renal function. Appropriate laboratory tests should be
performed periodically and infusion discontinued if BUN levels
exceed normal post-prandial limits, and continue to rise. It should
be noted that a modest rise in BUN normally occurs as a result of
increased protein intake.

PRECAUTIONS

Safe use during pregnancy has not been established: therefore,
infusion of amino acids should be undertaken during pregnancy
only when this is deemed essential to the patient's welfare as
judged by the physician.
1.

Protein-sparing (peripheral use)
When amino acids (without dextrose) are infused peripherally,
care should be taken to avoid oral ingestion of carbohydrate or
infusion of carbohydrate-containing solutions if fat mobilization is
desired as the source of energy. Otherwise, full utilization of body
fat may not occur.
Serum electrolytes should be monitored and appropriate electro
lytes added to the daily infusion regimen. Acid-base balance also
should be monitored and disturbances in equilibrium corrected as
needed. The amino acid solution as formulated has no potential
fo r increasing hydrogen ion concentrations.
Do not withdraw venous blood for blood chemistries through the
peripheral infusion site, as interference with estimations of
nitrogen-containing substances may occur.
Intravenously administered amino acids should be used with cau
tion in patients with history of renal disease, pulmonary disease,
or with severe congestive heart failure so as to avoid excessive
fluid replacement. The effect of infusion of amino acids, without
dextrose, upon carbohydrate metabolism of children is not known
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peripheral vein can be continued as long as oral nutrition is im
paired However, if a patient is unable to take oral nourishment at
the end of Oto 7 days, institution of total parenteral nutrition with
exogenous calories should be considered.

at this time. Therefore, such usage of Amino Acid Injection 5%
in children is not recommended.
. Adjunctive for total parenteral nutrition
For long-term total nutrition, or if a patient has inadequate fat
stores, it is essential to provide adequate exogenous calories
concurrently, if parenterally administered amino acids are to be
retained by the body and utilized for protein synthesis. Concen
trated dextrose solutions are an effective source of such calories.
Special care must be taken when giving hypertonic glucose to
diabetic or pre-diabetic patients. In such cases crystalline insulin
should be added to the solution8. Such strongly hypertonic nu
trient solutions should be administered through an indwelling in
travenous catheter with the tip located in the superior vena cava

2.

ADVERSE REACTIONS

Adjunctive for total parenteral nutrition
For central vein infusion with concentrated dextrose solution, the
total daily dose of the amino acid solution depends on daily pro
tein requirements and on the patient's metabolic and clinical re
sponse. The determination of nitrogen balance and accurate daily
body weights, corrected for fluid balance, are probably the best
means of assessing individual protein requirements. For patients
in a stable metabolic condition the provision of amino acids as a
3.5% concentration with 20 to 25% dextrose is usually considered
adequate. Vitamins, minerals and electrolytes should be added as
indicated.

See WARNINGS and DOSAGE AND ADMINISTRATION.

DOSAGE FORMS

Peripheral Infusions

Aminosyn 5% Injection is supplied in 1000-ml ABB0-VAC*
containers.

Local reactions consisting of a warm sensation, erythema,
phlebitis and thrombosis at the infusion site have occurred with
peripheral intravenous infusion of amino acids particularly if other
substances, such as antibiotics are also administered. In such
cases the infusion site should be changed promptly to another
vein. Use of large peripheral veins and slowing the rate of infusion
may be helpful in decreasing the incidence of local venous irrita
tion. Electrolyte additives should be spread throughout the day,
and irritating additive medications may need to be injected at
another venous site. Generalized flushing, fever and nausea also
have been reported during peripheral infusions of crystalline
amino acids.

DOSAGE AND ADMINISTRATION
. Protein-sparing (peripheral vein)
This preparation (without dextrose) can be administered by the
peripheral intravenous route. It should not be infused via a central
vein, unless it is admixed with sufficient dextrose to provide full
caloric energy requirements in patients who require prolonged
total parenteral nutrition.
For peripheral intravenous infusion, 1 to 1.5 g/kg/day of total
amino acids will achieve optimal fat mobilization and spare protein
catabolism if no carbohydrate is infused or ingested.
As with all intravenous fluid therapy, the primary aim is to provide
sufficient water to compensate for insensible, urinary and other
(nasogastric suction, fistula drainage, diarrhea) fluid losses.
Those requirements as well as electrolyte and acid/base needs
should be estimated and appropriately prescribed.
Given an amino acid solution of specified total concentration, the
volume required to meet amino acid requirements per 24 hours
can be calculated. Then, after making an estimate of the total daily
fluid (water) requirement, the balance of fluid needed beyond the
volume of amino acid solution required, can be provided as a
non-carbohydrate electrolyte solution. Vitamins and additional
electrolytes (except bicarbonate) as needed to correct imbalances
may be added to the amino acid solution. If desired, one-half of an
estimated daily amino acid requirement of 1.5 g/kg can be given
on the first day The degree of fat mobilization can be gauged by
the presence and amount of acetonuria. Amino acid dosage may
be increased on the second day. Amino acid infusion into a
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A 1000-ml unit provides a total equivalent of 50 g of protein and
7.86 g of nitrogen. Each 100 ml contains crystalline amino acids
5 g and potassium metabisulfite not more than 60 mg (equivalent
to 5.4 mEq K*/litre); pH 5.25 (approx.), adjusted with acetic acid
30 mEq/litre (approx.)
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Medical Litigation in Canada*
H o n . W.Z. E stey , ba , l l b , LLMf

It is impossible to predict the future of
medical malpractice litigation in Canada.
However, the statistics indicate that
medical malpractice claims are steadily
increasing. Action should be taken now
to ensure that the problem does not
reach crisis proportions. In so far
as the medical profession itself is
concerned, it should ensure that the
competence of medical practitioners
remains on the highest possible level.
II est impossible de predire le futur
en ce qui concerne les causes pour
negligence medicale au Canada. Toutefois, les statistiques indiquent que le
nombre de poursuites pour negligence
intentees contre les medecins est en
augmentation constante. On devrait
prendre action immediatement afin de
s’assurer que le probleme ne deviendra pas hors de proportion. En ce qui
concerne la profession medicale, elle
devrait s’assurer que la competence
des praticiens demeure au plus haut
niveau possible.

The recent crisis in insurance rates for
medical practitioners and hospitals in
the United States, created by the trend
in the US towards large medical mal
practice damage awards, has led to a
great deal of speculation in Canada as
to the future of medical litigation in
Canada. It should be noted at the out
set that there are a number of legal
and sociologic differences between
Canada and the US which promulgate
the current differences in recovery in
medical litigation cases. It is necessary
*Presented at the inaugural meeting of
the Canadian Association of General
Surgeons, Toronto, Ont., May 11 and
12, 1977
t Puisne justice of the Supreme Court
of Canada; formerly chief justice of
Ontario
Reprint requests to: Hon. W.Z. Estey,
Supreme Court of Canada, Ottawa,
Ont. K1A Oil
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to add a caveat at this point in that the
big difference in the malpractice scene
should not be explained by comparing
Canada and the US but should be ex
plained and examined in the light of
the passage of time.
In most cases Canada seems to lag
behind the US by about a decade, but
eventually adopts most of its institu
tions, its principles and its way of
doing business. Canada’s survival on
many fronts— including medical mal
practice—is going to depend on our
ability to selectively adapt and adopt
the laws in the US.
If Canadian medicine adopts the
American system holus bolus it will
suffer an absolute disaster. If the Cana
dian medical profession wants to con
tinue to enjoy its independence and to
practise scientific medicine, it will have
to intervene in the political process, as
best it can, on three fronts. In the first
place, the profession must satisfy itself
whether contingency fee litigation is
a good or bad thing and react accord
ingly. Secondly, the profession must
satisfy itself that there is available to
the plaintiff in a medical malpractice
case the expertise necessary to wage a
fair lawsuit. Thirdly, the profession
must acquaint itself with the judicial
process and must determine whether or
not to participate in the defence of the
present system where it does not follow
the American system.
General Principles

Before embarking on an evaluation
of the differences between the Cana
dian and American medical malprac
tice areas, it is useful to consider the
general principles of tort liability. Med
ical malpractice litigation generally in
volves the torts of assault and battery
or negligence. Success in a negligence
suit is dependent upon the existence
of four conditions. Firstly, there must
be a legal duty owed by the doctor
towards his patient. This duty arises
as a matter of law after the doctor
accepts the patient; it is completely
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independent of contract. Secondly,
there must be negligence on the part
of the doctor; such negligence consists
of the breach of the legal duty owed
to the patient. Thirdly, the patient
must prove loss or injury resulting
from such negligence. Fourthly, the
patient’s loss or injury must be directly
related to the doctor’s negligence. It
should also be noted that a doctor can
be found negligent whether or not his
services were rendered gratuitously or
for reward.1
The standard of skill imposed on a
doctor depends on the position that
the doctor holds in the medical com
munity. In other words, a specialist
who holds himself out as possessing
special skill and knowledge has a
much greater duty to his patient. A
specialist is expected to possess a great
er degree of skill in the particular field
of his expertise than is possessed by a
general practitioner. Moreover, a phy
sician or surgeon practising in a coun
try village is not ordinarily held to the
same standard of proficiency as a phy
sician or surgeon practising in a big
city.2
Although there are a number of im
portant medical litigation cases, it is
interesting to note that the concept of
“medical negligence” was defined as
early as 1902 by Chief lustice Falconbridge, of the King’s Bench.
Malpractice (mala praxis) is bad or
unskilful practice by a physician or
surgeon, whereby the health of the patient
is injured. Negligent malpractice means
gross negligence and lack of the attention
which the situation of the patient requires;
as if a physician while in the state of
intoxication should administer improper
medicines: .. . what is charged is ignorant
malpractice, namely a course of treatment
which was calculated to do injury, which
has done harm, and which a well-educated
and scientific surgeon ought to know was
not proper in the case.3

This approach to the problem has been
followed in many cases since that time
and is still applicable.
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Statistics

Statistics on medical malpractice
litigation in Canada and the US shed
some light on the problem which now
exists in the US and indicate the direc
tion in which Canada is headed. The
Canadian Medical Protective Associa
tion (CMPA) is particularly interested
in this subject and is continually moni
toring the statistics in regard to med
ical malpractice litigation in Canada.
The figures for the cases in which the
CMPA has been involved in the period
between 1966 and 1976 are set forth
in Table I (Brown FN: Personal com
munication, 1977). They demonstrate
that the number of claims against doc
tors is steadily growing in Canada and
the total amount of settlements is also
rising. It should be noted that there was
a substantial increase in awards, partic
ularly in the years 1975 and 1976.
In considering the total amount
of the awards, of course, the number
of settlements and awards made in
those years must be taken into account.
It is also interesting to compare the
number of claims in respect of the
number of physicians in Canada during
those years. An analysis of the statis
tics for medical malpractice litigation
by Geekie4 sets forth the comparison
thus:
In 1945, while representing 3367 phy
sicians, CMPA members were involved in
nine new legal actions, or one per 374
physicians. There was no appreciable rate
change in the number of new legal actions
until 1965.. . In the 10 years 1965-74 the
annual number of new legal actions in
creased from 49 to 220. The ratio in
creased from one per 325 physicians to
one per 132. The experience of the first
half of 1975 indicates the trend is con
tinuing. During these months, 126 new
legal actions were lodged against CMPA
members compared to 100 in the cor
responding period last year.
The author also compares the increase
in the average amount of awards:

In 1950, CMPA paid an average of $2942
on behalf of members to conclude 11
malpractice claims. In 1974, the average
amount had risen to $13 386.
He then goes on to compare the settle
ment rates in the period between 1955
and 1975:
In 1955, three cases were settled out of
court for every one concluded in the
courts. In the past 3 years the ratio has
approximated 7:1, 16:1 and 6.5:1.
These statistics indicate a steady rise
in the number of medical malpractice
cases in Canada and the amount of the
awards or settlements in the various
cases. Moreover, there has been an
increase of claims against related per
sonnel such as hospital staff. Geekie
states that
it is interesting that a sizable proportion
of legal actions for medical malpractice is
not related to surgical or anesthetic
mishaps. During 1974, of 220 legal actions
against members, 91 had no relationship
to surgery or anesthesia.
In a recent case, for example, the
Supreme Court of Canada upheld a
finding of a trial judge in Ontario to
■he effect that the staff of a hospital
had been negligent in caring for a
patient who had been placed in a
Stryker frame after surgery (Joseph
Brant Memorial Hospital et al vs
Koziol et al May 17, 1977). In that
case both the staff and the hospital
were held liable, but the doctor was
not held liable.
Comparative statistics for the US
and Canada also shed an interesting
light on the subject.
In 1970, 160 suits were filed against the
21,959 members of the Canadian Medical
Protective Association, or one suit for
each 137.2 physicians. By comparison
there were approximately 6,400 suits filed
against approximately 279,000 U.S. phy
sicians in the same year, or one suit for
each 43.6 physicians.5

Table I—Malpractice Litigation in Canada—Statistical Review of Canadian Medical Protective
Association Activities

Year

No. of
awards

No. of
settlem ents

Total amount
of
settlem ents, $

No. of
members

1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976

0
5
5
0
8
10
4
2
9
9
7

22
17
20
15
21
22
29
32
58
43
64

132 137
154 812
122 819
439 247
223 951
276 292
253 371
325 087
896,858
951 609
2 664 103

17 275
18 265
19 971
21 280
21 959
23 668
24 945
26 588
29 096
30 022
30 316

No. of writs Dismissed/
served
discontinued
73
64
65
62
80
131
152
168
220
229
234

No. of physicians in Canada: 1976, approximately 40 000; 1977, approximately 42 000.
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23
25
22
25
35
45
30
44
60
115
142

It is clear from the statistics that the
number of claims per physician in the
US is far in excess of the number of
claims per physician in Canada. With
each passing year, the ratio of claims
to physicians in the US approaches 1:1.
If malpractice claims against doctors
in the US ever reach that ratio it will
be more than a crisis; it will be a disas
ter. The statistics in Canada indicate
that the number of claims per physician
is increasing to the extent that the posi
tion in Canada is now analogous to the
position in the US approximately 10
years ago. If the trend continues, Can
ada may soon experience a medical
malpractice crisis.
Before leaving the area of statistics,
it is of particular interest to note the
number of settlements in the US which
have exceeded $3 million. In 1969
there were three such awards; in 1970
there were 5; in 1971, 9; in 1972, 13;
in 1973, 24; and, finally, in 1974 there
were approximately 36 awards greater
than $3 million. These awards are
taken from California statistics only.6
The largest personal injury award in
medical malpractice litigation was
made in February 1973, when a 13year-old San Rafael boy received an
award of $4 025 000 in his suit against
a San Francisco hospital and pedia
trician.7
In Canada there have been a num
ber of personal injury awards that have
exceeded $1 million but none of them
has involved medical malpractice liti
gation. Most of the cases have been
motor vehicle accident claims against
defendant drivers. In Teno et al vs
Arnold et als the Ontario Court of
Appeal reduced a trial judgement ex
ceeding $1 million to $875 000. The
Teno case was followed in M cLeod vs
Hodgins and Hodgins (Robins J: June
1976), in which judgement was given
for $1 041 197.85. Similar judgements
have also been given in Alberta9 and
British Columbia.10 It should be noted,
however, that these judgements are not
only for general damages but also in
clude special damages (such as medical
costs). Moreover, the awards are based
on the loss of future income caused by
the plaintiff’s inability to work. The
irony, of the situation is that if the
plaintiff had died, the awards would
have been much smaller. The Teno,
Andrews, and Thornton cases are on
appeal to the Supreme Court of Can
ada and will be heard at the same time
in the hope that the proper principles
for assessing damages will be estab
lished. These principles would be ap
plied nationally and would be relevant
to medical malpractice litigation.
A fundamental sociologic question
arises which has been neglected and
ignored in the US and that is the ap
propriate level of awards. In the Niles
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and San Rafael case, for example, it
is impossible to rationalize an award
exceeding $4 million unless the spectre
of contingency fees is considered. Two
million dollars goes to the lawyer and
the jury knows it. So they make what
would have been a $2 million award a
$4 million dollar award. But even
taking the $2 million and investing it
at today’s prime rate could give the
plaintiff an annual income that is
about twice our prime minister’s salary.
Consequently, the principles utilized in
assessing damages need to be re-evalu
ated and restructured.
Causes

Conspiracy of Silence
There has been a great deal of
criticism in the US and Canada of the
reluctance of doctors to testify in cases
involving other doctors. In many cases
this reluctance has been classified as
“a conspiracy of silence”. It has been
said that this reluctance on the part
of medical practitioners to testify in
cases involving other medical practition
ers is a factor in the development of
large medical malpractice awards in
the US. For instance, the reaction to
this “conspiracy of silence” has brought
about legal doctrines which facilitate
recovery in medical malpractice litiga
tion (for example, the development of
the concept of res ipsa loquitur in Cali
fornia, discussed below).
In California in the 1960s a break
through in the “conspiracy of silence”
occurred and a number of well-qual
ified medical expert witnesses became
available for medical malpractice litiga
tion cases.11 The problem is, however,
that these expert witnesses are, in truth,
plaintiffs’ witnesses. Hence the avail
ability of such expert testimony assisted
in the development of the large awards
in California litigation cases. It can be
said that if the expert witnesses were
objective, the awards might not be
quite so high.
The problem of the availability of
expert witnesses has caused some con
cern in Canada, Sharpe and Weisstub12
consider the problem and cite an ar
ticle written by Mr. Justice Haines of
the Ontario Supreme Court:
In contrast, Mr. Justice Haines o f the
Ontario Supreme Court wrote some
twenty years ago in the Canadian Bar
Review that the time has come for the
profession to assume corporate responsi
bility for providing an injured claimant
with the necessary medical evidence to
enable him to place before the court the
appropriate standards of care, so that
justice can be done between the parties.

The authors then go on to discuss the
current situation in Canada:
158

In support of this judgment of the Cana
dian context, a recent statement has em
phasized the “infernal silence” that afflicts
the medical profession. Empirical evidence
obtained in a questionnaire completed by
Ontario physicians reveal that few, if any,
would volunteer information to a patient
victimized by an act o f gross negligence.
Based on this study, it appears a discon
certing number would face contempt
charges rather than make a disclosure in
court.

The authors also point out that one of
the reasons for the development of the
“conspiracy of silence” is the belief
among medical practitioners that test
ifying against other practitioners will
result in a bad reputation in the profes
sion. They go on to say that
one should not underestimate the factor
of loss of business. Once a physician loses
cordial relations with his fellow-practi
tioners and is branded a plaintiff’s witness,
he may suffer loss o f referrals and pre
judicial treatment in appointments to
hospitals’ staffs, which can easily result
in a serious downgrading of status and in
come.

Unfortunately, the absence of objective
witnesses can lead to the development
of the “plaintiff’s expert witness”,
which can ultimately lead to an in
crease in injury awards.
In 1965, Mr. Justice McRuer was
appointed to a commission to study
the problem of expert witnesses in med
ical malpractice litigation. That com
mission evaluated the various altern
atives proposed in the US. In their re
port the commission rejected the use
of court-appointed witnesses and sug
gested that a body of expert witnesses
should be appointed by the medical
profession and made available at the
request of an injured party. The re
commendation of the commission was
that medical reports should be ex
changed by the parties. As a result of
that report, the Ontario Evidence Act
was amended to provide for such ex
change of medical reports prior to
trial.
The current experience in Ontario
is that there is always a well-qualified
medical practitioner available for mal
practice cases. In every case such wit
nesses have remained objective and
have been of great assistance to the
courts. In this respect, the judge is
better able to evaluate the issues and
the evidence and can make a more
objective assessment of the plaintiff’s
injuries. Consequently it appears that
the “conspiracy of silence” is no longer
of great concern in the medical—legal
context of malpractice litigation in
Canada. Fortunately, we were able to
avoid the type of development which
occurred in the US as an offshoot of
such factors as the “conspiracy of
silence”.
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Contingency Fees
The concept of contingency fees in
litigation in the US has a history which
reaches back to the American Revolu
tion. Even before the revolution,
Thomas Jefferson advocated the use
of contingency fees in litigation. Jef
ferson conceived that if the lawyer
were given part of the damage award
he would take a case on for nothing
and thus open the courts to impecu
nious litigants. In addition, he felt that
the poorest member of the community
would be able to get the best lawyer
or have equal access to the best lawyers
because he could offer the same reward
as the richest member of the com
munity.
On the other hand, the American
Constitution prohibits the awarding of
costs to a successful claimant. Costs is
a deterrent conceived by the British
500 years ago to make the courts
available to those who have genuine
causes and to penalize those whose
causes have no merit. But in the US
there is no penalty, no retardant, for
the man who abuses his right to go to
court, either for the plaintiff who drags
the doctor into court unnecessarily or
for the doctor who defends unneces
sarily.
Indeed, the impact of the contin
gency fee system in the US is almost
beyond imagination. Essentially, the con
tingency fee system is a partnership deal
between the lawyer and the person
having the claim. The lawyer foots the
bill in staging the lawsuit, and where
there is no state intervention he gets
about half the award.
The contingency fee was tried in
England about two centuries before
Jefferson and was eventually pro
hibited. Now in England a contingency
fee arrangement is a disbarment of
fence for the legal profession and is
also an offence in the nature of con
tempt of court. The English see it as a
perversion of the role of the lawyer
who is an officer of the court. If he is
in the pay of one of the litigants on the
basis that he shares in the outcome, he
cannot give independent advice.
Besides doctors, there are at least
three segments of society that have
an interest in watching how the con
tingency fee operates. The first group
is the general public which bears the
cost of these “bizarre fights” in the law
courts. Through taxes, the public pays
for the hospital insurance premiums,
and where medicare schemes are not
in effect, the public pays the contin
gency fee through increased rates
charged by doctors and hospitals. Sec
ondly, the government itself has an in
terest if it is financing hospitals and
medical care. Thirdly, the courts have
an interest in watching the contingency
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fee system. If the courts are going to
be deluged by litigation on a specul
ative basis— which is what happens—
then the courts become clogged and
other people with legitimate claims
cannot get access to them, or, altern
atively, the taxpayer m ust foot the bill
to expand the num ber of courts.
It is often said that the use of con
tingency fees has contributed to the de
velopment of the large injury award in
the US. In a speech delivered to the
American Orthopaedic Association in
Hot Springs, Virginia, in June 1975,
Mr. Justice Haines of the Ontario Su
preme Court stated:
In my opinion the contingent legal fee
whereby the lawyer receives 25-50% of
the recovery is at the very top of the list
[of differences between Canada and
U.S.] . .. this is the reason why American
verdicts in tort litigation have always
been higher than the Canadian. Your
jurors know of the contingent fee system.
How much do they add for the lawyer?
Similar statements have been made by
a number of lawyers and medical prac
titioners in both Canada and the US.
On the other hand, Professor Wil
liam J. Curran of H arvard believes
that contingency fees may be a neces
sary part of the litigation system in the
US. He states:
There is a good deal of hostility on the
part of the medical community against.. .
[contingency fees] .. . No physicians
function on this basis and most cannot
understand it. They object not only to the
contingency itself, which they consider
gambling over human misfortunes, but to
the amount of money the plaintiffs’
lawyers recover in the spectacular cases
which receive publicity in the medical
publications or are talked about in medi
cal group gatherings. Some physicians
insist that the “contingent fee” system is
the largest single factor in the allegedly
sharp increase in malpractice claims and
suits in recent years. No amount of ar
gument about the social value of the
practice as “the poor man’s opportunity
to obtain effective legal representation”
can convince these doctors that the evils
don’t outweigh any advantages.13
The same type of reasoning is applied
in the report of the Commission on
Medical Malpractice in the US. The
commission reported in 1973 and one
of its conclusions was to the effect
that
the commission believes that most phy
sicians generally place undue emphasis on
the influence of the contingent fee system
upon malpractice litigation, and that only
harm will result from perpetuation of the
common beliefs about its role in the
overall problem. Our study data show that
the contingent fee systems tend to discour
age acceptance of legally meritorious mal
practice cases involving minor injury and
VOLUME 21, NO. 2, MARCH 1978
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relatively small potential recovery, and
we view this as a wholly undesirable and
unfair result of the system. However, most
individuals are also unable to afford legal
services in malpractice cases on a fixed
fee basis. The net result is the same in
both instances: recovery for injury de
nied.14
It should be noted that the problem set
out above does not really exist in C an
ada. The successful litigant can obtain
the costs of the litigation. Moreover,
legal aid exists for those parties who
cannot afford to bear the cost of litiga
tion themselves. The very fact that the
successful party is awarded costs acts
as a deterrent.
The CM PA does believe that contin
gent-fee billing is a factor in large
awards and settlements.
Contingency billing and ambulance-chas
ing lawyers who make a practice of pro
moting medical malpractice litigation on
a contingency billing system in the United
States are generally considered to have
been a major factor contributing to the
US medical malpractice insurance fiasco.
The Canadian Medical Protective Asso
ciation, however, believes that to date con
tingency billing has not been a major
factor in the increase in legal actions or
the size of awards in Canada. Never
theless, it admits that if contingency bil
ling were to become a widespread practice
and if lawyers were to alter their normal
system of practice and to begin active pro
motion of medical malpractice lawsuits on
the basis of contingency billing, both
could contribute to a major problem in
the not-too-distant future.4
It should be noted that a number of
jurisdictions in Canada are moving
towards the contingency-fee billing sys
tem. Indeed, there are current discus
sions in Ontario relating to the prob
lem, and it is not entirely clear what
the result of these discussions will be.
The general impression gained from
such discussions is that the profession,
as it is now constituted, is against the
use of contingency billing in Ontario.
Trial by Jury
The right to trial by jury is constitu
tionally guaranteed in the US. As a
result, a litigant can come before the
court in a medical malpractice case and
insist that a jury try the case on the
facts and assess the amount of the
award. It is generally felt in Canada
that the presence of a jury leads to
higher awards in malpractice litigation
cases.
In his speech to the American O r
thopaedic Association in June 1976,
Mr. Justice Haines stated:
In medical malpractice cases there is no
constitutional right to trial by jury in

Canada. . . as a result a prospective liti
gant cannot rely on the jury sym
pathetically bending the law against the
doctor whose ability to bear the loss is
probably underwritten by insurance. Loss
bearing capacity is always a potent factor
in doubtful cases.
These sentiments were reflected in the
case law as early as 1902. C hief Jus
tice Falconbridge, chief justice of the
King’s Bench, stated:
Actions of this kind were, as a matter of
course, formally tried, both here and in
England, by a jury; and it was the almost
inevitable result that juries, perhaps in
nocently and unconsciously, looked more
favourably upon the case presented by the
patient than on that presented by the phy
sician or surgeon. To remedy this condi
tion of affairs, and not to leave doctors
entirely at the mercy of juries, the courts
in this country early became astute to lay
down limitations and restrictions on the
actions of the twelve; or, rather as to what
matters ought to be left to them to deal
with. For example, in 1869 the Court of
Queen’s Bench held in Jackson v. Hyde,
28 U.C.R. 294, that in an action against a
surgeon for negligent malpractice, where
the evidence is as consistent with the ab
sence [as] with the existence of negligence,
the case should not be left to the jury. . .
The next step in the practice was the sug
gestion by the courts that this class of
cases ought more properly to be tried by
a judge without a jury. This was the corol
lary that this case is tried by me without a
jury, the parties having practically con
sented to my so doing.3
The reasoning of Chief Justice Falconbridge has been consistently followed
in Canadian and English cases. It is
often repeated by academics when dis
cussing the problem of trial by jury in
medical m alpractice litigation.
There is no constitutional guarantee
in C anada that permits a party to in
sist on the use of a jury in a civil case.
There is legislation that requires the
use of a jury in certain cases, such as
libel and slander and malicious prose
cution, but apart from this legislation
there is no “constitutional guarantee”.
In this respect the Canadian experience
is different from that of the US and
that difference is reflected in the m ed
ical m alpractice area.
Sociologic Factors
The sociologic differences between
Canada and the US are very difficult to
pinpoint; it is almost impossible to assess
the impact of such factors on the differ
ence between Canadian and A m erican
medical m alpractice litigation. H ow 
ever, it is a com m on belief that various
sociologic differences are factors in
the development of the larger medical
malpractice awards in the US. In a re
port issued by the California State As-
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sembly,6 there is a reference to a num 
ber of sociologic factors which have
contributed to the large medical mal
practice awards in that state. The re
port concludes that more patients are
electing to sue. According to the Cali
fornia State Assembly there are at least
five m ajor reasons for this trend: a) a
changing doctor-patient relationship;
b) the legal rights explosion; c) the im
pact of the media; d) increased profi
ciency of trial lawyers; e) change in
legal doctrines. This trend towards in
creased litigation can be said to be a
product of the “affluent society”.
There can be no doubt that there
has been a substantial change in the
physician-patient relationship. The Ca
lifornia State Assembly points out
(page 22) that “the neighbourly kind
and benevolent family doctor epitom
ized by the television physician ‘M ar
cus Welby’ is fast disappearing”.6
There are a number of reasons for this.
In the first place, there is a definite
trend away from personal care. The
tremendous demand for services and
on the physician’s time have meant
that the physician is not able to
give an individual the personal at
tention that is necessary to establish
a patient-physician rapport. M ore
over, the trend towards specialization
in medical practice has also con
tributed to the problem. A patient
may be seen by a number of different
physicians in the course of any one
given illness. N o doubt the patient
benefits from the technical expertise
of the specialists, but it is also clear
that there is little time for each special
ist to establish a relationship with the
patient. This lack of physician-patient
rapport is reflected in the fact that
specialists such as anesthesiologists and
orthopedists are subjected to a higher
frequency of medical malpractice liti
gation claims.6
A part from the physician-patient re
lationship itself, the trend towards u r
banization has also played an im port
ant role in decreasing the physicianpatient rapport. The trend towards
social stratification tends to make the
physician more alien to his patients
than he was in the past. The physician
is no longer the recognizable member
of the community that the doctor in
bygone years was.8
Added to this development is the
legal rights explosion which began in
the 1960s. Americans are a more li
tigious society today than ever before.
There is a growing feeling among the
citizenry that newly perceived rights
should be enforced by litigation, if ne
cessary. The California State Assembly
suggests (page 25) that this develop
ment may be a product of the highly
technologic western society.6 On the
160

other hand, the California State Assem
bly believes (page 26) that some blame
must lie with the government:
. .. other branches and levels of govern
ment, including the legislature, must
assume some responsibility for our citizens’
propensity to seek judicial relief. After
all, the recent civil rights explosion began
in the courts-and was only later carried to
the legislatures, because the legislatures
had initially defaulted in their representa
tion of discrete and insular minorities, of
those without political clout.6
The development of associations dedi
cated to the enforcement of legal rights
has also assisted in the legal rights ex
plosion. F or example, the existence of
such groups as “N ader’s Raiders” has
meant that a party who feels aggrieved
can now seek redress through an as
sociation with sufficient strength to
match the power of the offender. The
development of the class action has
also assisted the small claimant to pur
sue his action. The existence of legal
aid in many jurisdictions has also con
tributed to the legal rights explosion.
It is generally felt that Canadians
are not as “claims-conscious” as Amer
icans. In his speech Mr. Justice Haines
stated:
Canadian people are not claims-conscious.
I think they look in astonishment at their
neighbours and their astronomical verdicts.
With respect it seems to me the American
people are fascinated with litigation of all
kinds. Their television programs bear
eloquent testimony. Every high school
student is imbued with the history of your
courts in the protection of great rights. As
a people you are more familiar with the
law and its institutions than most and you
are prepared to engage in the use of them.
Not only are malpractice actions more
numerous in the United States, but so are
personal actions of all kinds, defamation,
injury, products liability, workmen’s com
pensation and a host of others. Your
courts may be utilized without expense.
Jury trials are guaranteed in most cases.
So it is only natural that a disgruntled
citizen should exercise his felt rights so
long as he can find a lawyer to assist him.
As a result the American people are
probably the most litigation-conscious in
the western world.
On the other hand, Canadians are not
as conscious of their constitutional
rights. It is not that we do not respect
the rights and freedoms of other peo
ple, it is just that we are less oriented
towards individual rights and are more
concerned with the rights and freedom
of the community as a whole. More
over, Canadians tend to look towards
government to provide the protection
necessary in specific instances. For this
reason there is a plethora of legislation
dealing with consumers’ rights and
other areas of interest to the individual.
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Media
The media have a tremendous impact
on medical malpractice litigation. In
the first place the media contribute to
the belief that medicine is an exact
science and that medical practitioners
should not err in the performance of
their duty. In its report on medical
malpractice, the California State As
sembly states:
Another factor influencing more patients
to file malpractice claims is the attention
given by the media to the practice of
medicine and malpractice litigation. Both
printed and electronic media continually
discuss and praise the technological ad
vances made by modern medicine. The
impression these reports make with the
public is that modern medicine is an exact
science capable of correcting or alleviating
a vast variety of human maladies.6
Moreover, the media have paid partic
ular attention to the size of awards in
medical malpractice litigation. The re
port goes on to say that
medical malpractice litigation has also
been given considerable attention by the
media, particularly those cases involving
substantial dollar verdicts or settle
ments. . . Virtually every major medical
malpractice verdict and settlement in
California in the past year has been
publicized in the local press. This public
ity makes more persons aware of their
legal rights and remedies, and understand
ably prompts some to fully investigate the
desirability of litigation when they have
suffered an untoward medical injury.
This is m uch like the controversy over
violence on television. It is said that
the glorification of violent behaviour
is a factor in the increase in violence
in the real world. Finally, it is not clear
what impact the information dissemin
ated by the media in medical malprac
tice cases has on the citizen who will
sit on a jury in a future case. Perhaps
there is a natural tendency to go one
better as each case comes before a
jury.
Specialization
The growth of a bar specialized in
the practice of medical malpractice
litigation in the US has also contributed
to the problem in that country. Mr.
Justice Haines stated:
We have not in Canada claimant’s lawyers
specializing in malpractice litigation. We
have some excellent general counsel of the
highest quality, but the presentation of a
contested malpractice claim in the Cana
dian climate requires expenditure of
enormous legal fees which the average
client will not invest.
It should be noted, however, that there
is a specialized defence bar in Canada.
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Most of these legal specialists are re
tained by the insurance companies who
cover the medical field or other areas.
In representing their client on an on
going basis these counsel attain a great
deal of specialized knowledge in the
defence of such claims. Indeed, the
existence of a specialized defence bar,
in juxtaposition to the nonexistence of
a specialized plaintiff’s bar, may be
a factor in keeping the amount of
damage awards in Canada at a reason
able level in relation to the amount
of damage awards in the US.
Legal Doctrines
Res Ipsa Loquitur
The concept of res ipsa loquitur has
very little application in negligence
law. The basic premise of the concept
is that the situation speaks of neg
ligence. The concept is designed to
facilitate the plaintiff’s burden of
proving his case. In “Charlesworth On
Negligence,”15 the author states:
The maxim is not a rule of law. It is ‘no
more than a rule of evidence affecting
onus. It is based on common sense, and
its purpose is to enable justice to be done
when the facts bearing on causation and
on the care exercised by the defendant
are at the outset unknown to the plaintiff
and are or ought to be within the know
ledge of the defendant’.

oping the present malpractice situation in
California. Indeed, throughout the coun
try, the medical profession has called for
legislation eliminating res ipsa entirely in
actions against physicians.6
Moreover, it is not clear what effect
the concept has on the jury; it is dif
ficult to determine whether the jury
can fully understand the application of
the concept.
We say the doctrine can only be
applied where the circumstances are
all within the control of the people
acting in the event and where negli
gence is probably present. In the US,
by what I think is judicial careless
ness, the doctrine has been allowed to
drift to the position where now “the
thing speaks for itself’ if the jury
thinks it does. If the events are not en
tirely controlled by the defendant why
should he be deemed liable in negli
gence because the jury thinks the se
quence of events leads inexorably to
damages.
Development of Concept of
Informed Consent

have had operations recently and are
not satisfied with the results. Then they
get the persons into their offices and
go over the effect of the operation and
decide whether or not the doctor ac
quainted them with all statistics of the
risks attending the treatment they re
ceived.
In a discussion of the problem Robert
C. Strodel16 states:
There is nothing more fundamental than
the right of an individual to make in
telligent, free, personal choices of what is
or is not to be done to his person by
someone else. A person has a right to
enough information to be able to choose
alternative treatments or to accept or
reject recommended treatment. .. the doc
trine of informed consent applies to elec
tive procedures and is intended to give the
patient a choice in keeping with his intel
ligence and mental capacity to understand.
The Courts recognize these distinctions
and apply a rule of reason, often going
so far as to require expert testimony as to
what the standards are in the particular
area for the explanation to a given patient
regarding a given procedure.
The legal concept of informed con
sent in Canada does not differ much
from that in the US. The difference
arises in the application of the concept.
As stated above, the issue is left to the
jury in the US, whereas it is decided
by the judge in Canadian cases.
The concept of informed consent is
discussed at great length by Mr. Jus
tice Haines in Reibl vs Hughes.11 In
that case the plaintiff, Reibl, developed
constant headaches and sought med
ical advice from the defendant,
Hughes. The defendant conducted a
number of tests on the plaintiff. The
defendant discovered a murmur over
the left carotid artery in the plaintiff’s
neck, slightly behind and below the
ear. Subsequent arteriographic examin
ations revealed a build-up of plaque
which significantly narrowed the left
internal carotid artery about 2.5 cm
above the bifurcation. The narrowing
or stenosis had reduced the cross-sec
tion of the artery at that point by ap
proximately 80% to 90% , permitting
only about 15% of normal blood flow
through the vessel. The defendant con
cluded that the major occlusion in the
left internal carotid artery was asymp
tomatic, in that it was not causing any
detectable neurologic dysfunction or
abnormality at that time. Despite this
opinion the defendant concluded that
the occlusion should be surgically re
moved to reduce the risk, over the next
several years, of a stroke caused by
diminution of blood supply to the brain.
The operation was subsequently per
formed on the plaintiff. Immediately
after the operation the plaintiff suf
fered a massive stroke which paralysed
the right side of his body and left him

res ipsa was extremely important in devel-

The doctrine of informed consent is
the most controversial of the legal doc
trines. It exposes doctors to daily liabil
ity and it is a doctrine which cannot
be precisely defined by the legal pro
fession today.
The doctrine is not new, nor is it
confined to medical matters. It covers
all contracts and simply means that a
consent is not valid and binding un
less the person giving it has been ade
quately informed of his position. The
concept of informed consent places a
substantial burden on the physician.
The physician must take all reasonable
precautions to communicate all neces
sary information to the patient in
order to enable the patient to make an
informed decision on surgery. Without
such informed consent the doctor may
be liable in battery and negligence.
In the US the issue of informed con
sent is generally left to the jury. The
jury is allowed to determine for them
selves whether the doctor has given the
patient sufficient information to obtain
informed consent. There is no presump
tion of informed consent which the
patient must rebut by showing such
things as emotional duress or inca
pacity.
In Ontario, the requirement of in
formed consent has not reached a very
high level. The law requires informed
consent, but the patient does not have
to have independent legal advice be
fore consenting.
The doctrine itself goes back to the
1880s. Unfortunately, it has been
turned into a kind of racket in the US.
Lawyers advertise for patients who
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It should be clear that where the
maxim of res ipsa loquitur applies, the
onus on the plaintiff to prove his case
is effectively reduced. If the concept
were applied in medical malpractice
litigation cases it would facilitate rec
overy for the patient.
The problem is that the concept has
been applied improperly in medical
malpractice litigation in the US, par
ticularly in California. The report of
the California State Assembly states
(page 29) that
res ipsa loquitur (the thing speaks for it
self) is an evidentiary rule of law which
allows the jury to draw an inference of
negligence based upon circumstantial evi
dence. Generally speaking, the jury is only
allowed to draw this inference when the
circumstantial evidence is such that it in
dicates the probability of negligence. Yet
in a couple of notable California Supreme
Court decisions, the doctrine has been
applied in cases involving rare medical in
juries without consideration as to whether
or not such injuries indicate a probability
of negligence. This has substantially eased
the plaintiffs burden of proof in rare
medical injury cases, thereby widening
the scope of liability.6
The Assembly comes to the conclusion
that

/
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impotent. Mr. Justice Haines found
that the plaintiff was unfit for work
and would remain so for the rest of his
life. On the basis of the evidence, Mr.
Justice Haines concluded that there
were a num ber of risks inherent in such
a surgical procedure. In his judgement,
he lists these as being:
First, manipulation of the artery during
the initial stages of surgery and before the
artery is clamped can dislodge platelets
from the stenosis which would per force
be carried up into the brain with the flow
of blood and possibly block a smaller
vessel; second, once the artery is clamped,
there is the danger to which I have alluded,
of collateral supply from the three other
sources being insufficient to supply the
brain during the period of the surgery;
third, there is the danger that the upper
severed edge of the inner lining of the
vessel may be left loose from the wall of
the artery, allowing the resumed upward
flow of blood to force it back, blocking
the artery as a flap or valve; fourth, there
is a danger of a blood clot forming in
the vessel at the operative site after the
operation, either blocking blood flow to
the brain at that point, or breaking off to
occlude smaller vessels in the brain; fifth,
there is the danger of the artery being
narrowed by sutures too tightly drawn;
and finally there is the danger of blood
leaking from the sutured vessel after the
outer incision is closed, clotting in the sur
rounding tissue and by compression of the
artery restricting the flow of blood
through it. Each realized eventuality re
sults in a restricted supply of blood to the
cells of the brain, which when starved of
oxygen, become dysfunctional or die.17
Mr. Justice Haines also dealt with the
qualifications of the defendant and his
knowledge of the risks. He states (page
6) that
between 1953 and 1970, prior to perform
ing this operation on the plaintiff, the
defendant had carried out between 60 and
70 like operations. Between 8 and 10 of
those operations had resulted in fatalities,
although most of those occurred in the
earlier years when the technique was re
latively new. The defendant’s understand
ing was that given the state of the devel
opment of technique by 1970, the risk of
his patient dying as a result of the opera
tion was less than 4% and that the risk of
neurological damage or non-fatal stroke
was about 10%. Those risks he knew to
be cumulative: in 1970 a patient on whom
he performed this operation was subject
to roughly a 14% risk of mortality or
morbidity as a result of the operation
itself.17
In discussing the defendant’s liability,
Mr. Justice Haines notes that there
was no allegation of malpractice in the
perform ance of the operation. The
plaintiff’s case was based on two allega
tions: first, that the plaintiff had not
given his informed consent to the per
form ance of the endarterectomy and
second, th a t the defendant was negli166

gent in the postsurgical treatment of
the plaintiff once it was discovered that
the plaintiff was in danger of a stroke.
The issue of liability essentially re
volves around the issue of informed
consent. Before discussing the law in
relation to this specific case, Mr. Jus
tice Haines refers to a judgement of
Mr. Justice M orden in Kelly vs Hazlett
(unpublished, July 29, 1976). Mr. Jus
tice Haines quotes from that judge
ment:
Broadly speaking a battery is the inten
tional, unconsented to, touching of the
person of the plaintiff by the defendant,
while negligence (in the context of the
case such as this) consists of the sub
standard execution of a duty of care by
the doctor resulting in damage. The doc
tor’s general duty of care includes not
only the duty to exercise due skill and
competence in diagnosis and treatment,
but also to give reasonable information
and advice to the patient. This latter duty
is one of variable content depending on
the circumstances of the case and the
determination of its proper scope is very
often a matter of considerable difficul
ty. . .The issue of informed consent can
arise in both battery and negligence cases:
with respect to the former a lack of
proper information communicated by the
doctor to the patient can vitiate an ap
parent consent while, with respect to the
latter, failure to see to it that the pa
tient is properly advised can amount, in
certain circumstances, to an act of negli
gence.17
Mr. Justice Haines points out that the
issue of informed consent revolves
around ‘the right of an adult person
of sound mind to determine what shall
be done with his own body”.17 F u r
ther, where the issue of informed con
sent is raised, the onus to prove con
sent as a defence falls upon the de
fendant doctor.17 (In Canada, where
there is a written consent, there is a
presumption of consent and the onus
is then on the plaintiff to establish that
there was not “informed consent”.)
In deciding what information should
be brought to the attention of the pa
tient, the doctor must also consider
“collateral risks”. Mr. Justice Morden
in Kelly vs Hazlett, stated that: “F ur
ther, even if a risk is truly collateral,
but still material, it could be said that
its disclosure is so essential to an in
form ed decision to undergo the oper
ation that lack of such disclosure
should vitiate the consent.”17 Mr. Jus
tice Morden refers to a case in which
the defendants performed experimental
surgery on the plaintiff. The plaintiff
had volunteered for the surgery. It
was decided that the defendants had
not given the plaintiff sufficient infor
mation on which to base his decision
to proceed with the experimental sur
gery.18
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In deciding what information and
what risks should be brought to the at
tention of the patient, it is not incum
bent on the doctor to point out dangers
that are incident to or possible in any
surgical procedure, such as the dangers
of anesthesia or the risk of infection.17
Such matters are presumed to be within
the ordinary knowledge of all men and
it is further presumed that the patient
appreciates such risks.
In determining whether informed
consent has been given, the courts will
rely heavily on expert medical testi
mony. Mr. Justices Haines points out
that
the difficulty evident for the independent
evaluation of these factors by a lay tri
bunal has caused the law of this jurisdic
tion to leave the definition of the scope
of this duty in any particular case a
matter essentially of medical judgment,
one to be determined by the court on the
basis of expert medical evidence.17
Moreover, the duty of the surgeon in
the particular circumstances is defined
by accepted general practice in the
community of surgeons.17
In the circumstances of the partic
ular case, Mr. Justice Haines finds
that there was not informed consent.
He states:
I am satisfied had Dr. Hughes said to the
plaintiff — calling him in and making a
sketch if necessary to clarify his meaning
— “I propose to remove a partial plug of
an artery a few inches from your brain.
There is a risk that as a result a fragment
of tissue may slip into your brain and if it
does, you have a 4% chance of dying and
a further 10% chance of having a stroke”,
there is no question the plaintiff would
flatly have refused.17
Mr. Justice Haines finds that the
plaintiff was entitled to know the
nature of the risk involved in the sur
gery. The specific finding of Mr. Jus
tice Haines can be found in the follow
ing:
First, I find that although the defendant
did impart to the plaintiff an understand
ing of the mechanics of the operation, to
the extent that the plaintiff was made
aware the pluggage was to be surgically
removed from an artery leading to his
brain, the defendant did not take sufficient
care to communicate to the plaintiff the
purpose of the operation. I find that as a
result the plaintiff was probably left with
the misunderstanding that the operation
was being undertaken to alleviate his
headaches and hypertension and to permit
him to function effectively at his job.
Further, and most importantly, I find that
the defendant did not take sufficient care
to convey to the plaintiff and assure that
the plaintiff understood the gravity, nature
and extent of risks specifically attendant
on the endarterectomy, in particular the
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risk that as a result of the operation he
could die or suffer a stroke of varying
degrees of severity. . . I find that he did
not address with the attention required of
him the specific risks of an adverse result
of the operation itself.17
As a result, Mr. Justice Haines finds
the defendant liable both in negligence
and by the tort of battery.
In so far as damages are concerned,
Mr. Justice Haines takes into consi
deration the fact that the defendant is
unable to work and has been ren
dered impotent by
reason of the
stroke suffered after the operation.
Given the facts of the case, Mr. Justice
Haines assesses the total damages
at $225 000.17
The decision in Reibl vs Hughes is
now under appeal to the Ontario Court
of Appeal and we do not have the final
word on the subject. However, one
should note that the damages awarded
in the case are in no way similar to
the awards granted in the US.
In both Canada and the US the de
fendant must show that valid consent
to the operation was obtained. In Can
ada, if a signed consent form is avail
able, there is a presumption of consent.
(This is one of the changes proposed
in the US.) It is then incumbent on
the plaintiff to demonstrate that in
formed consent was not given. This can
be shown by proof of mental incapacity
or emotional duress. In the US, how
ever, the issue of informed consent is
left to the jury; the jury also makes
the final assessment of damages in the
case. Consequently, the issue of in
formed consent is integrally related to
the impact of the role of the jury in the
US on medical malpractice litigation,
as discussed above.
Effects
Insurance Rates
As a result of the enormous damage
awards in the US in medical malprac
tice litigation, insurance rates in the
US have risen dramatically in the past
few years. In the article already
alluded to, Geekie4 states: “In recent
months Canadian physicians have read
. . . reports on the USA medical mal
practice insurance fiasco. That annual
malpractice insurance premiums could
be an average $4000 and even as high
as $35 000, for a few specialties in
some states, was difficult to believe.”
As a result of the insurance fiasco, it
appeared that a number of hospitals
would have to close down and that a
number of doctors would have to go
out of business. Consequently, a num 
ber of states passed legislation requi
ring insurance companies to cover
hospitals and doctors and limiting the
amount of liability of doctors and hosVOLUME 21, NO. 2, MARCH 1978
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pitals in particular situations. M ore
over, some states passed statutes set
ting up compensation funds in place of
medical malpractice litigation. It re
mains to be seen whether such legisla
tion can effectively deal with the prob
lem. O ther legislation dealing with
limitation of rights in the m alpractice
field has been challenged as uncon
stitutional and the courts have struck
down such legislation in many states.
Defensive Medicine
In the summary of recommendations
of the Secretary’s Commission on M ed
ical M alpractice,19 reporting in 1973,
the commission dealt with the effect
of the medical malpractice “fiasco” on
the medical profession. One of the ef
fects found to exist by the commis
sion was that of “defensive medicine”.
The commission states:
The Commission finds that defensive
medicine is the alteration of modes of
medical practice, induced by the threat of
liability, for the principle purposes of
forestalling the possibility of law suits by
patients as well as providing a good legal
defense in the event such law suits are
instituted.19
The commission then goes on to de
fine three types of defensive medicine.
Positive defensive medicine is the conduct
ing of a test or the performance of a
diagnostic or therapeutic procedure which
is not medically justified but is carried out
primarily (if not solely) to prevent or
defend against the threat of medical-legal
liability. . .Negative defensive medicine
occurs when a physician does not perform
a procedure or conduct a test because of
the physician’s fear of a later malpractice
suit, even though the patient is likely to
benefit from the test or procedure in
question.19
A third form of defensive medicine
was also brought to the commission’s
attention.
There appears to be a reluctance on the
part of some physicians to publish in
medical journals case reports describing in
detail noted adverse effects of diagnostic
and therapeutic procedures. The fear is
that the material will be picked up and
used as evidence in a law suit.19
The quality of medical care can only
suffer by such techniques.
It also appears that the concept of
“defensive medicine” is not unknown
in Canada. In her valedictory address
as president of the Canadian M edical
Association, Dr. Bette Stephenson
stated:
Perhaps the most hazardous result of mal
practice litigation phobia is defensive
medicine. In order to protect themselves

in the possible event of suit, physicians
may submit each and every patient to the
full range of laboratory testing procedures
and radiographic examinations. Already
some evidence of this phenomenon has
been exhibited in physicians’ practice pro
files. Widespread advocation of such
superdefensive practice is fraught with
real danger for both individual patients
and society as a whole. The individual pa
tient may be subjected to bad medical care
and the hazards of excessive investigation
and at the same time be denied access to
the benefits of relatively new treatments.
Society as a whole suffers the impedence
of advances in medical science and the in
tolerable burden of explosively expanding
costs of medical care. The picture of a
malpractice inhibited medical profession is
neither encouraging nor pretty.4
In a climate of medical malpractice
phobia, the quality of m edical care
can only suffer. As a result, it may be
incum bent on the legislature to deal
with the problem.
Cures
Lim itation Periods
In Ontario, the limitation period for
medical malpractice is set out in the
H ealth Disciplines Act (Statutes of O n
tario, 1974, chapter 47). By virtue of
section 17 of that act
no duly registered member of a college
is liable to any action rising out of
negligence or malpractice in respect of
professional services requested or rendered
unless such action is commenced within
one year from the date when the person
commencing the action knew or ought to
have known the fact or facts upon which
he alleges negligence or malpractice.
This change in the lim itation period
increases the time in which a patient
may sue a doctor in that the period
runs from the date when the person
commencing the action knew o r ought
to have known of the facts of the
negligence. In the past, the lim itation
period was related simply to the act
of surgery. A lthough the new legisla
tion basically extends the lim itation
period it is generally felt that it is
m uch fairer than previous legislation.
In the US, many states have taken
up the challenge and have passed legis
lation dealing with the problem of m ed
ical m alpractice litigation. In this re
spect. many of the states dealt with the
question of limitation periods for m ed
ical m alpractice cases.
Professor C urran13 sets out the types
of changes which have occurred:
The most common substantive legal
change was a reduction in the statute of
limitations
for
malpractice
claims.
Changes of some type were enacted in 17
states. (California, Florida, Illinois, In-
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diana, Iowa, Louisiana, Maryland, Mas
sachusetts, Michigan, Nevada, New York,
North Dakota, Ohio, Oregon, South
Dakota, Tennessee and Texas.) Most of
the statutes covered all practitioners of the
healing arts and health-care institutions,
but some were limited to physicians, as in
Maryland. There was no pattern at all to
the periods. They ranged from one to ten
years for all actions including later dis
coveries of foreign bodies left behind in
operations. All laws covered both tort and
contract actions of malpractice. The most
common feature of the amendments was a
stated limitation on the time within which
later-discovered matters could be brought.
Most of the statutes allowed an added two
years for these situations, though Illinois
allowed ten years. Most also controlled
the time for filing by minors. The strictest
law was that of Indiana where all actions
without exception must be brought within
two years except for minors under six who
have until their eighth birthday to bring
the action. Next strictest was Louisiana
where the time was cut to one year for all
actions except later discovered matters
where the action must be brought within
one year of its discovery, but in no event
more than three years after the original
operation or treatment.
It can be seen from this that the legis
lation in Ontario is much simpler in
its approach and basically much fairer
in its application. The existence of a
10-year limitation period places a sub
stantial burden on the medical profes
sion and undoubtedly leads to an in
crease in insurance rates.
T he problem is, again, that such
legislation has been challenged in the
courts. In the December 1976, issue
of the Association of Trial Lawyers of
A m erica Newsletter, there is a com
m ent on an Idaho case which dealt
with the constitutionality of such le
gislative remedies. In many cases such
legislation has been struck down. The
cases are not right on point in so far
as lim itation periods are concerned
but they do indicate that legislative
remedies are not always the best solu
tion to a problem. Given the trend in
the courts in the US, it remains to be
seen w hether legislation dealing with
the m edical malpractice dilemma will
be as effective as hoped for.
Lim itation o f Am ount
M any states in the US have imposed
limits on the amount of recovery in
m edical malpractice litigation. C urran13
states:
Six states have imposed flat limits on total
recovery from source (California, Idaho,
Illinois, Indiana and Louisiana [sic]). Wis
consin imposed an automatic limit of
$500,000 if the pooled fund should fall be
low $2,500,000; otherwise there is no limit
on recovery from the pool. The most com
mon limit for practitioners is $100,000
imposed in Florida, Indiana, Louisiana,
168

and for one class of physicians in Oregon.
The Oregon law covers only physicians
(all others cover different types of
practitioners plus hospitals or other facil
ities) in six classes with the highest two
groups covered for $500,000. No total
limits are imposed in Florida or Oregon
but “caps” are put on recoveries from cer
tain groups of providers. In these states
the remainder of the recovery must come
from the pool arrangement.
As of Apr. 1, 1977, Virginia has im
posed a limitation of $750 000 in re
spect of medical malpractice litiga
tion.20
Again, such legislation has been
challenged as being unconstitutional
in many courts. In Illinois21 and Ohio22
the legislation has been held to be un
constitutional. These cases are not bind
ing on the other states but the trend
may persist and the legislation may
be held to be unconstitutional in many
more states.
Notwithstanding the issue of con
stitutionality it is not clear whether the
legislation will be effective. Curran13
also points out that
even if these laws were to survive consti
tutional attack they would have little ef
fect on insurance rates. Recoveries in six
figures and over constituted only 3% of
all payouts in 1970. They may constitute
more now, but not much more. Also,
these large verdicts have been covered by
two methods which take them out of the
regular rate computation: (1) reinsurance;
and (2) separately purchased “umbrella
policies” for very large dollar awards. . . if
the limitation were to survive constitu
tional attack, they would affect the in
come of the highly paid trial lawyers like
those in the selective survey of the legal
systems study, since these attorneys handle
nearly all the large recovery cases. It
should be recalled that this group
averaged a recovery of $81,000 in the
cases they handled during the survey
period.
This approach to the problem, there
fore, is not entirely effective.
Compulsory Arbitration
There is also a trend in the US to
remove medical malpractice litigation
from the courts and place it with civil
tribunals. This is similar to what was
done for workmen’s compensation
cases in Ontario. Again, however, the
states of the US face particular prob
lems in this respect. In an article en
titled “Medical malpractice arbitra
tion: a comparative analysis”23 it is
stated:
The element of compulsion creates new
problems, however. Forty-eight states
guarantee the right to jury trial in civil
suits; a state requirement that parties in
voluntarily submit to arbitration must pro
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vide an opportunity at some time to
present the dispute to a jury. The right of
appeal to a jury and conditions governing
such appeal will have a substantial effect
on the arbitration process itself.
Despite these pitfalls, the authors con
clude that arbitration is a desirable
alternative to the present system.
Arbitration is one alternative that an
increasing number of states are choosing.
Since January 1975, nine states have en
acted arbitration statutes applicable ex
clusively to medical malpractice claims
(Alabama, California, Louisiana, Mary
land, Michigan, Pennsylvania, South Da
kota, Virginia, Ohio). These statutes
variously permit, encourage, or require
parties to malpractice disputes to avail
themselves of arbitration. Despite the
similarity of each state’s problems and
goals, clear difference between arbitration
models are emerging that reveal funda
mental value choices.
It should be noted that there is a
distinct difference between compul
sory arbitration and voluntary arbitra
tion by agreement. In respect of com
pulsory arbitration there is the prob
lem of constitutionality; in respect of
voluntary arbitration, there is the prob
lem of judicial review of the arbitration
decision.
Despite the handicaps inherent in a
system of arbitration, it is felt that
there are many advantages to such le
gislation. In the same article,23 it is
stated:
Louisell and Williams state three primary
advantages of arbitration for medical
malpractice claims. First, substituting
arbitration panels including medical ex
perts for lay juries may result in more
accurate determinations in less time with
less evidentiary input. Second, the presence
of legally-expert panel members may per
mit relaxation of technical rules intended
to protect juries from unreliable evidence,
resulting in less-formal, speedier hearings.
Third, panel expertise and informality
plus the finality of arbitral awards prom
ise more rapid resolution once disputes
get to actual hearings, reducing costs and
saving the time of parties, lawyers,
witnesses and triers of fact.
It is still too early to tell whether such
legislation will be so effective.
In Canada, arbitration is not blocked
by constitutional provisions. Moreover,
there are distinct advantages to this
method of solving malpractice dis
putes. We may be well advised to util
ize arbitration because it relieves the
courts of a substantial burden, it allows
the community to appoint experts to
the arbitration panels from the medical
profession and related disciplines, and
in most cases arbitration boards can
act more quickly and at less cost than
the courts.
It may well be that Canada is head-
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statements can then be used in court as
evidence). There is no limit to the awards
that can be set by the review boards
though in Florida all malpractice judg
ments over $100,000 would be paid out
of a compensation fund that costs phy
sicians $1,000 a year and hospitals $300
a bed (in Florida last month, a paralyzed
dentist and his wife were awarded —
under the old system — $1.6 million in
damages from a Lake Worth neuro
surgeon who operated on the dentist after
an automobile accident).

*The Supreme Court of Ontario is
currently conducting pretrial conferences
in both civil and criminal cases with
the intention of resolving various issues
and expediting the trial. It is expected
that current draft rules will eventually be
embodied in the rules of procedure in
respect of civil cases. These conferences
are not a screening mechanism but they
are designed to encourage settlements
which are satisfactory to both sides.

claimed for the client. In negligence
cases this means that the amount
claimed is included in the pleadings.
In the US this amount may go before
the jury. In Canada there is no ques
tion that the amount pleaded in the
statement of claim is not put before
a jury. In a trial by judge alone, of
course, the judge may be aware of the
amount pleaded in the statement of
claim, but this is not known to have
any effect on the judge’s decision. In
most cases the amount claimed in the
The mechanism for the screening tri pleadings is far in excess of the amount
bunal can be quite elaborate. In Flo which the lawyers hope to obtain at
rida, Illinois, Massachusetts and Ten trial. It is felt, however, that an excess
nessee, for example, the system is close amount should be claimed in case the
to a court hearing and is headed by a amount awarded is higher than ex
trial court judge. In some states the pected. If a low amount is claimed and
panel consists of members of the pub the amount awarded is higher, the
lic and a lawyer as well as physicians. excess over the amount claimed may
In all current legislation, except that in not be collected. In other words, the
Nevada, the decision of the panel is ad client loses the excess over the amount
missible in evidence at trial.13
claimed unless the pleadings are amen
ded by the trial judge.
In California, the report of the Ca
Compensation Fund
lifornia State Assembly recommended
As pointed out above, Florida has that the ad damnum clause, which in
established a compensation fund for cludes the amount claimed, should be
medical malpractice litigation. For eliminated. The report states: “This
judgements over $100 000 the judge clause gives the public a distorted
ment is paid out of a compensation view of the value of the typical mal
fund that costs physicians $1000 a year practice case. A study by the Califor
and hospitals $300 a bed. It is thought nia Hospital Association showed that
that such compensation funds spread the these demands were, on the average,
cost of liability among the profession. some fifty-three times higher than the
In this way insurance rates are de actual awards.”6 There is no comment
creased and the cost of practising med in the report on the effect which such
icine is supposedly reduced. In the claims may have in a jury trial. In
speech by Otto Lang quoted above, it other states, ad damnum clauses have
appears that a compensation fund been amended because of the fear that
could be established in Canada. It is up such claims will have an adverse effect
to the medical profession to decide on the jury. In Florida, Indiana, Iowa,
whether such a fund would be a de Louisiana, Massachusetts and Ohio
the ad damnum clause was eliminated
sirable alternative.
altogether. In Wisconsin the pleadings
only contain a statement of whether
Changes in Legal Doctrines
the claim is above or below $10 000. In
Tennessee the ad damnum clause is re
Res Ipsa Loquitur
tained but there can be no disclosure
As pointed out above, the concept of of the amount claimed to the jury. In
res ipsa loquitur assists the plaintiff this respect the Tennessee legislation
in obtaining a judgement in a medical faces the problem squarely and deals
malpractice litigation case. Again, many with the precise issue.13
of the states of the US are moving
Contingency Fees
towards legislation dealing with the
problem of the doctrine of res ipsa
As pointed out above, the contingency
loquitur. In the legislation that now fee is said to be one of the major fac
exists, however, there is no indication tors in the current medical malprac
that the doctrine has been substantially tice litigation crisis. Professor Curran13
altered. In most legislation the applica sets out the changes in this area:
tion of the doctrine has been defined,
but the extent of the doctrine has not The physician’s favourite bugaboo, the
been limited.13 Therefore, one would contingent fee arrangement, was reformed
question the efficacy of such legislation. in seven states. The fee percentage cannot
exceed one-third in Oregon and Tennessee,
though in the latter the judge can set it
below this figure depending on the time
Ad Damnum Clauses
and effort expended. Idaho imposed a flat
In preparing pleadings in any case, limit of 40%, thus possibly increasing the
the lawyer will include the amount fees of most lawyers who usually charge
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ing for a similar alternative. In a
speech to the annual meeting of the
Canadian Hospital Association, Justice
Minister Otto Lang stated: “If we want
to pay compensation to persons who
have injuries during the course of med
ical treatment, I believe it ought to be
done through a scheme that directs it
self to the purpose of compensation
and is not based on fault.”4 Lang’s con
cept is a revolutionary one, perhaps
unique in the world. It involves a statesupervised fund for the payment of
injuries, and payments are made with
out reference to fault. We are moving
into no-fault insurance with respect
to automobile accident cases, and per
haps in time we will move in that di
rection in the medical litigation field.
In any event, there has been an up
surge in arbitration in labour law and
in general contractual disputes. I think
it should be tried in the medical field.
Some day we may find provincial le
gislation analogous to workmen’s com
pensation laws which will allow the
state to intervene and settle malpractice
claims.
Screening
An alternative to the compulsory
arbitration or voluntary arbitration tri
bunal is a “screening mechanism”. A
screening mechanism is basically a tri
bunal which would be designed to
eliminate nuisance suits. The parties
would be required to come before the
tribunal before going to court and it
would be necessary to demonstrate a
prima facie case before they could pro
ceed to trial. This procedure would also
be designed to cut down on trial time
and to define the basic issues.*
The California State Assembly re
commended that such a screening me
chanism should be made mandatory.'
At this point, however, the California
State Assembly has not passed such
legislation (but other legislation has
been passed in t!:r* state, as mentioned
above). In an article entitled “Malprac
tice weather: stormy on coasts but
calmer inland”, it is stated that
Florida and Tennesses legislatures both
have Indiana-type laws that establish
review boards before which plaintiffs must
present their cases before suing in court.
The boards can recommend settlements
but they are not binding (though panel
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one-third. Indiana imposed a 15% maxi
mum on the amount recovered from the
pooled arrangement which allows pay
ments in cases from $200,000 to $500,000.
No limit is imposed on the fee recovered
in the first $100,000 from providers. Since
this limit is tied closely to the pool it
might be declared invalid along with the
general limitation on recoveries, if that
plan is attacked in the courts. California
imposed a graduated reduction in the per
centage of the fee as the recovery goes
up: 40% of the first $50,000; one-third of
the next $50,000; 25% of the next
$100,000; and 10% of recoveries over
$200,000. Iowa merely authorizes the
courts to set reasonable contingent fees. In
Wisconsin the attorney must allow a client
to pay on a pro diem basis if he desires.
The contingent fee is not controlled in
Wisconsin except to the extent that it
cannot be assessed against medical ex
penses, past or future. Indiana’s law also
gives the client the right to pay on a
mutually acceptable per-diem basis.
The changes in this area will not
dramatically affect medical malpractice
litigation. For example, in California,
if a judgement of $1 million is granted,
the lawyer stands to gain about
$140 000 in fees. If a judgement of $4
million is granted, the lawyer stands
to gain approximately $440 000 in fees.
As the cases in California indicate, rec
overies between $ 1 million and $4
million are not that unusual. Therefore,
lawyers in California still stand to
gain a great deal of money in medical
malpractice litigation cases. As a re
sult, the damage awards will remain
high in order to compensate the
plaintiff for the cost of the contin
gency fee.
Collateral Sources
This is one area of concern which
has not been discussed above. In Cali
fornia, for example, a plaintiff can
obtain recovery from the defendant for
monies which he has obtained from
other sources. In other words, if the
plaintiff receives disability benefits
from another source, this does not pre
clude him from obtaining full recovery
in the subsequent medical malpractice
case. In essence, therefore, the injured
patient obtains double recovery in re
spect of the injury in so far as he is
obtaining payments from more than
one source. The same problem exists
in m any other states. At present many
of the states in the US are moving to
change this situation.
Six states installed some reform in the
collateral source rule which is applicable
in the majority of the states at present.
Under the rule, plaintiffs are allowed to
recover economic losses from the de
fendant in personal injury suits even if
they have already recovered them, or can
recover them, from other sources such as
insurance. Many commentators in a num
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ber of states consider this allowance un
fair in providing double recoveries. In
many situations, however, it is not double
since the providers of the other benefits
have subrogation rights to recover the
money. . . The reform statutes are rather
complicated and require close analysis. As
I read them, only two states (Indiana and
Iowa) totally bar the recovery of such
elements. New York and probably Cali
fornia merely allow submission into evi
dence at trial of the fact of payment from
other sources and leave it to the trier of
fact to consider. Tennessee eliminates bene
fits paid by any third party, including an
employer, but allows them if paid for by
the plaintiff or his immediate family out
of assets or by insurance. Ohio bars re
covery only of benefits paid by third
parties, not if received as a result of pay
ment of premiums or otherwise by the
plaintiff, his employer, or anyone on his
behalf.13

be told to the plaintiff about major risks.
The law requiring the least informing,
that of Nevada, creates the strongest
presumption (conclusive) of validity if
followed. The Tennessee law requires the
court to make a determination about in
formed consent before submitting the case
to the jury.

In Ontario the problem is solved sim
ply by the understanding that when the
plaintiff sues he is deemed to be suing
on behalf of all other parties who have
rights in the issue. F or example, the
plaintiff sues on behalf of Ontario Hos
pital Insurance Plan for recovery of
medical costs. Moreover, where insu
rance is involved the plaintiff also sues
on behalf of the insurance company
for recovery of insurance amounts paid
out. In this respect, there is no need
for such complicated legislation in Can
ada as exists in the US. The proposed
solution in California does not deal
adequately with the problem; the jury
is still free to give double recovery.

Basically, it is impossible to predict
the future of medical malpractice
litigation in Canada. However, the sta
tistics indicate that medical malprac
tice claims are steadily increasing. We
should act now to ensure that the prob
lem does not reach crisis proportions.
In so far as the medical profession it
self is concerned, it should ensure that
the competence of medical practitioners
remains on the highest possible level.
To quote the time-worn proverb, “An
ounce of prevention is worth a pound
of cure.” Moreover, competence is
one of the best legal defences avail
able.

Conclusion

References

Informed Consent
As discussed above, the concept of
informed consent is also one of the
major issues in medical malpractice
litigation. In the legislation dealing
with the problem of medical malprac
tice litigation, many states have dealt
with the issue of informed consent.
Professor Curran13 states in his report:
Eight states passed legislation in 1975
regarding the requirement of informed
consent (Florida, Idaho, Iowa, Louisiana,
Nevada, New York, Ohio and Tennessee).
The objectives of the legislation were much
clearer than what one would gather from
the Malpractioe Commission Report. The
first aim was to provide some prior pro
tection for the physician so as to remove
somewhat the uncertainty of the applica
tion of the doctrine years later in a court.
This took the form of imposing a pre
sumption of valid consent when the con
sent was obtained in writing and meeting
certain standards. The most elaborate ef
fort in this regard was in Ohio where the
statute contains an actual suggested con
sent form with check-offs and added
blanks for filling in specific risks of the
procedure or treatment. The Iowa, Loui
siana and Ohio laws are quite detailed and
very similar in the content of what must
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Again, it remains to be seen whether
such legislation will be sustained, given
constitutional challenges. As pointed
out above, in Canada there is a pre
sumption of consent when the patient
has signed a consent form. However,
the issue of informed consent can still
arise. It is hoped that recent cases will
give doctors some idea of what must
be communicated to a patient in order
to obtain informed consent.
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Angiography in Determining the Cause and Treatment
of Gastrointestinal Bleeding*
D.M. G race ,

R.E. G old ,

m d , f r c p [c ]

successful for gastric or duodenal
bleeding since the collateral blood
supply prevents infarction. Some of the
methods and complications of
embolization are discussed and
examples are given. Standard surgical
principles should still apply in most
cases.

Angiography is useful in the diagnosis
of active gastrointestinal bleeding if
the rate is greater than 0.5 mL/min.
For upper gastrointestinal bleeding,
endoscopy is the preferred initial
investigation and angiography is used
for diagnosis only if the site of bleeding
is still obscure. Angiography is the
preferred method for investigation
of massive lower gastrointestinal
bleeding if results of sigmoidoscopy
are negative. Vasopressin infusion is
most useful for control of bleeding
from esophageal varices, erosive
gastritis and diverticular disease of
the colon. Embolization with Gelfoam
or clot is possible for massive
hemorrhage from a single source in
poor-risk patients. This is most
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L’angiographie est utile dans le diagnos
tic du saignement gastrointestinal
lorsque le taux est superieur a 0.5
mL/min. Pour les saignements gastrointestinaux superieurs, I’endoscopie
est la methode de choix initialement,
et I'angiographie n'est utilisee pour fin
de diagnostic que lorsque le foyer
hemorragique demeure obscur.
L’angiographie est la methode de
premier choix pour la recherche des
saignements gastrointestinaux inferieurs
massifs si les resultats de la
sigmoi'doscopie sont negatifs. La
vasopressine en perfusion est des plus
utiles pour controler le saignement des
varices oesophagiennes, d'une gastrite
erosive et d’une diverticulose du colon.
L’obliteration du vaisseau par le
Gelfoam ou un ca iIlot est possible
pour les hemorragies massives
provenant d'un seul foyer chez les

patients a risque eleve. Ceci reussit
particulierement dans les hemorragies
gastriques et duodenales car la
circulation collateral previent
I'infarcissement. On discute quelques
unes des methodes d’obliteration des
vaisseaux et leurs complications, et
on en donne des exempted. Les principes
chirurgicaux standards devraient
s'appliquer dans la plupart des cas.

Gastrointestinal bleeding continues to
be a problem for the general surgeon.
To locate the site of bleeding in the
operating room can be difficult, and
emergency operation during a massive
bleed carries a high mortality. Angio
graphy is valuable in determ ining the
site of bleeding and offers an oppor
tunity to control acute bleeding by
means of vasopressin infusion or oc
clusive techniques. W e propose to re
view briefly its usefulness from both
standpoints.
G astrointestinal bleeding m ay be
acute or chronic and its source
high or low. High, or upper, gastro
intestinal bleeding, defined as bleeding
from a source above the ligam ent of
Treitz, is usually from peptic ulcers,
superficial gastritis including stress ul-
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cers, or esophageal varices.1 Other
causes include Mallory-Weiss tears,
gastric tumours and carcinomas, and
hiatus hernias. The most frequent
causes of lower gastrointestinal bleeding
are diverticular disease, ulcerative col
itis, Meckel’s diverticulum (in children)
and hemorrhoids. Arteriovenous mal
formations are being recognized with
increasing frequency as a source of
such bleeding.2
Initial Assessment

In the investigation of gastrointestin
al bleeding a careful history-taking and
physical examination are essential. A
history of bowel disease, peptic ulcera
tion or epigastric pain, excessive alco
hol intake or ingestion of drugs con
taining acetylsalicylic acid is important.
The vomiting of blood or passage of
black stool may help to define the
level of bleeding; dark red stools do
not indicate the level of bleeding.
In physical examination the blood
pressure and pulse must be recorded
early and repeatedly in the case
of an acute hemorrhage. Signs of
liver disease should be sought. Rectal
examination must never be omitted. If
the patient is vomiting blood or the
site of bleeding is uncertain, a naso
gastric tube should be inserted. Essen
tial laboratory studies include baseline
hemoglobin and clotting measurements
as well as those necessary for assess
ment of renal and hepatic function.
Upper Gastrointestinal Bleeding

For acute upper gastrointestinal
bleeding aggressive investigation and
treatment have decreased mortality.3
Barium studies may be useful in the
case of chronic bleeding or after acute
bleeding is controlled, but barium must
not be given early, since it will inter
fere with endoscopy and angiography.
Endoscopy should be carried out early
in every case of upper gastrointestinal
bleeding. It may not only demonstrate
several lesions, but will indicate which
one is bleeding. Acute gastric erosions
are common4 and may be recognized
only by this means. Endoscopic elec
trocoagulation of bleeding lesions is
now possible5 although still an experi
mental procedure.
Angiography is of value if the diag
nosis is still uncertain, since operation
without a diagnosis carries an increased
mortality.1 If endoscopy is impossible or
difficult owing to poor patient coopera
tion, continued active bleeding, massive
clots, an obstructing neoplasm or a pre
vious gastrectomy, then angiography
may be helpful in diagnosis. Its role in
the investigation and treatment of up
per gastrointestinal bleeding is summar
ized in Table I. Since patients often
172

bleed at inconvenient times, the angio
graphic team must be available on short
notice. To be seen at the time of angio
graphy, bleeding must be active and at
a minimum rate of 0.5 mL/min from
a single site.6 The bleeding site is most
likely to be located in patients who
have been in shock or who have re
ceived multiple transfusions.7 Since
bleeding is often intermittent, the cath
eter may be left in place to allow
further studies if a bleeding site is not
discovered. Because of the dual blood
supply to the stomach and duodenum,
both celiac and superior mesenteric anteriography should be carried out, util
izing selective studies for suspicious
areas. Extravasation of blood from eso
phageal varices cannot be detected by
angiography although the venous phase
of the arteriogram may allow detection
of portal hypertension or esophageal
varices.
We have often confirmed by angio
graphy the source of bleeding when
this has been a duodenal ulcer, gastric
stress ulcer or Mallory-Weiss tear. Un
usual sites of bleeding also have been
identified, such as a pseudoaneurysm in
the head of the pancreas. The following
example illustrates the value of angio
graphy in locating the site of bleeding.
A patient was transferred to our hospital
after laparotomy had failed to discover
the source of active upper gastrointesti
nal bleeding. The patient had previously
had a Billroth II gastrectomy and no
bleeding site could be found by en
doscopy although there was blood in
the stomach. Angiography revealed a
bleeding tumour in the third part of
the duodenum. This proved to be a
leiomyoma, which was successfully re
sected. Lesions of this area are parti
cularly difficult for the operating sur
geon to identify.
Vasopressin Infusion

Infusion of vasoconstrictive agents
Table I—Angiography for Upper Gastro
intestinal Bleeding
1. Diagnosis
Active bleeding
Site not clear after endoscopy
2. Therapy
Vasopressin infusion
Esophageal varices
Erosive gastritis
Other: Mallory-Weiss tear, ar
teriovenous malformation, etc.
Embolization
In poor-risk patients only
For bleeding stress ulcers, some
gastric and duodenal ulcers
As palliation in case of extensive
bleeding tumours
Rarely in Mallory-Weiss tears
For transhepatic obliteration of
esophageal varices (on experi
mental basis)
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has controlled the bleeding from some
lesions. Bleeding from erosive gastritis
or esophageal varices is most likely to
be affected8,9 although there are some
dissenting voices.10 Epinephrine was
formerly used but vasopressin is now
the standard agent, infused at a rate
of 0.1 to 0.2 pressor units/min. Infu
sion into the left gastric artery is used
for bleeding gastric lesions and into the
superior mesenteric artery for bleeding
varices. In our experience the success
rate has been high and catheters have
been left in place as long as 1 week
without complications. Systemic effects
of vasopressin, which include vaso
constriction and angina, seem to be
reduced by local infusion. However,
we do not yet have evidence showing
that local infusion of vasopressin is
more successful and less dangerous
than peripheral administration. Because
of the high mortality associated with
gastric resection for bleeding gastritis
and with portal-systemic shunting for
bleeding esophageal varices, vasopressin
infusion should be tried before resort
ing to emergency operation.
Vasopressin infusion is not successful
for rapid arterial bleeding11 or for
bleeding from erosion of a major
branch of the gastroduodenal artery by
a duodenal ulcer.9 In such cases early
operation is indicated, especially for
older patients, since the mortality is re
lated to age and the amount of blood
transfused.1 Embolization techniques
may rarely be indicated for the very
poor-risk patient.
Embolization

Control of gastric bleeding by ar
terial embolization was first reported
as recently as 1972.12 A number of
cases have been described and the sub
ject has recently been reviewed.13 Bleed
ing from a wide variety of lesions has
now been controlled by embolization.
Because of the potential complications
(Table II), embolization is usually re
served for high-risk patients; many com-

Table II— Complications of Vascular
Occlusion
Technical
Arterial obstruction at entry site
Perforation of artery by guide wire
Due to dye overload
Pulmonary edema
Renal failure
Infarction
Especially of small or large bowel
Associated with shock, vasopressin
infusion and increasing age
Misplacement of emboli to liver, kidneys or
extremities
Continued bleeding
Failure to occlude vessel
From collaterals of stomach and duodenum
Delayed operation
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plications have probably not been re
ported. Stomach and duodenum are
suitable for the use of this technique
because their rich collateral blood sup
ply decreases the chance of infarction.
However, this is still a highly experi
mental procedure and should be carried
out only by experienced angiographers
willing to perfect their technique by
animal experimentation. The methods
of vascular occlusion are listed in
Table III. We have most often used
Gelfoam, but this agent usually causes
permanent vascular occlusion, hence
infarction is a danger. Clot is con
venient but may lyse early. Balloon
catheters offer temporary control, and
silicone solutions may be applicable
Table I I I — Methods of Vascular Occlusion by
Angiography
1. A rterial
Embolization
Blood clot
Clot + aminocaproic acid or
thrombin
Gelfoam
Ivalon sponge
Oxycel (oxidized cellulose)
Autogenous muscle or fa t
Other: Silastic or silicone micro
spheres, glass beads, lead shot,
stainless-steel pellets
Perfusion
lsobutyl-2-cyanoacrylate
Silicone
Balloon tamponade
Electrocoagulation

for arteriovenous malformations or vas
cular tumours in the future.
We have applied embolization tech
niques infrequently and only in very
poor-risk patients; our experience is
summarized in Table IV. We have had
considerable reported and unreported
experience with this procedure in
dogs.11,14 We used electrocoagulation
successfully in one patient, but in an
imals this carries a high risk of vessel
perforation. A recent area of interest
has been the transhepatic catheteriza
tion and obliteration of bleeding eso
phageal varices.15 While this may be
effective in controlling massive bleeding
and may reduce the need for emer
gency surgery, recanalization of varices
occurs16 and a definitive surgical opera
tion may still be necessary.
Embolization techniques are still in
their infancy. Undoubtedly they will
be developed further, but at present
they should be applied rarely. We still
use the standard methods, along with
vasopressin infusion or operation for
most cases of upper gastrointestinal
bleeding.

are often on the right side of the
colon.17’18 In many cases the bleeding
has been controlled by infusion of
vasopressin.18"20 If bleeding persists or
recurs, one may perform a less exten
sive procedure than the subtotal colec
tomy often advised for these patients.
We have found angiography very
useful in locating the source of bleed
ing in cases of diverticular disease
and arteriovenous malformations. Such
sources as Crohn’s disease of the ileum
and a fistula between a common iliac
artery graft and the ileum have been
precisely localized by angiography. We
have been able to determine the origin
of massive hemorrhage from the lower
rectum by angiography in patients with
leukemia and hepatic failure.21 Bleeding
was so profuse that the site could not
be discovered during sigmoidoscopy,
but with angiographic evidence the
bleeding site was readily identified so
that ligatures could be placed. Arterial

Lower Gastrointestinal Bleeding

Acute rectal bleeding is less fre
quently encountered but is perhaps more
of a diagnostic problem than upper
gastrointestinal bleeding. Early angio
graphy is the principal diagnostic tech
nique in the investigation and treatment
of this situation as summarized in
Table V. Diverticular disease is the
most frequent source but the diverticula

2. Venous
Embolization — clot, Gelfoam
Sclerosis — hypertonic glucose

Table V— Angiography for Low er G astroin
testinal Bleeding
Diagnosis
All active bleeding (sigmoidoscopy is not
diagnostic)
D ive rticu lar disease, especially of rig h t
colon
Arteriovenous m alform ations
O ther: tum ours, ulcerative co litis, etc.
Therapy
Vasopressin infusion
Especially for d iv ertic u lar disease
Embolization
Only for extensive tum ours
High risk of bowel infarction

Table IV - Experience at U niversity Hospital, London, Ontario w ith Vascular Occlusion for Upper Gastrointestinal Bleeding, 1973 to 1977

Sex

Age
yr

i

M

34

2

M

58 Psuedoaneurysm, head of
pancreas

3

M

25

4

M

5

Patient
no.

Source of bleeding

Reason for vascular occlusion

Lesser curve gastric stress
ulcer

Duodenal stress ulcer

Method

Result

Shock, abdominal sepsis, mul L e ft gastric arte ry occluded
w ith Gelfoam
tiple operations, total
sm all-bowel resection

Bleeding controlled. Survived
4 years on home parenteral
nutritio n

Chronic pancreatitis, recur
Electrocoagulation of feeding
rent bleeding not controlled
vessel
afte r 3 laparotomies

Bleeding controlled

Quadriplegic

O bstruction of gastroduodenal Bleeding controlled
a rte ry w ith wedged cath
e te r fo r 48 h

40 Lesser curve gastric erosion

136 kg, alcoholic

B ranch of le ft gastric arte ry
em bolized w ith Gelfoam

Bleeding controlled

M

67 Leiomyoma, 3rd part of
duodenum

Previous gastrectomy, lapa
rotomy w hile bleeding un
successful

Feeding vessels embolized
w ith Gelfoam

Angiographic dem onstration of
controlled bleeding. Tum our
resected a few hours la te r

6

M

63 Carcinoma, proximal stomach Shock, extensive malignant
lesion obstructing eso
phagus

L e ft gastric arte ry occluded
w ith Gelfoam

Bleeding stopped tem porarily,
emboli passed through ex
tensive feeding vessels. Pa
tie n t died afte r resection of
tum our

7

M

59 Esophageal varices

T ra n s ju g u la r catheterization
of varices, Gelfoam em
bolization

Reduced rate of bleeding. Pa
tie n t died 24 h la te r of
hepatic failu re
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hepatoma of right lobe
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embolization for control of bleeding
from the small or large bowel is
not recommended because of the
danger of bowel infarction. However,
this does not exclude its use to control
rectal bleeding22 and bleeding from ab
dominal tum ours (including one of the
large bowel).23 Recently, embolization of
the right colic artery was used to check
massive bleeding caused by diverticular
disease of th e ascending colon when
vasopressin infusion was unsuccess
ful;24 surprisingly, bowel infarction did
not occur. In spite of such instances,
embolization of small- or large-bowel
lesions should be reserved for very
high-risk patients. A barium enema
should still be given after control of
lower gastrointestinal bleeding, but it
must be remembered that the demon
stration of diverticula does not neces
sarily m ean they are the source of
bleeding. Occasionally administration
of a barium enema during acute hem
orrhage m ay be therapeutic.25

14.

15.

16.

17.

angiographic techniques as an aid or
alternative to operation. Surg Gynecol
Obstet 143: 469, 1976
G race DM, G old RE: Creation of a
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catheterization and obliteration of the
coronary vein in patients with portal
hypertension and esophageal varices.
N Engl J Med 291: 646, 1974
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portal hypertension and esophageal
varices treated with percutaneous
obliteration of gastric coronary vein.
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L ewis EE, Schnug GE: Importance
of angiography in the management of
massive hemorrhage from colonic di
verticula. Am J Surg 124: 573, 1972
Baum S, R osch J, D otter CT, et al:
Selective mesenteric arterial infusions
in the management of massive diver
ticular hemorrhage. N Engl J Med
288: 1269, 1973
Baum S, A thanasoulis CA, W alt
man AC: Angiographic diagnosis and
control of large-bowel bleeding. Dis
Colon Rectum 17: 447, 1974
T homson JG, G old RE, G race DM,
et al: Rectal wall bleeding—an over
looked source of massive lower gastro
intestinal hemorrhage. J Can Assoc
Radiol 28: 142, 1977

Trasytol
• increases the chances
of survival in acute
pancreatitis
• prevents the enzymatic
release of toxic
polypeptides and kinins
• stops hyperfibrinolytic
hemorrhage

Indications and Dosage
Hyperfibrinolytic Hemorrhage
These conditions occur in sur
18.
gery, including open heart sur
g e ry , p ro s ta tic s u rg e ry and
pathological obstetrical bleeding
19.
conditions, such as in abruptio
placentae.
Initial dosage: 200,000 — 500,000
K.I.U. of which 200,000 K.I.U.
20.
should be given by intravenous
injection (at a rate not to exceed
References
5 ml per minute), the rest if neces
21.
sary by slow infusion. Administra
1. H imal HS, Watson WW, J ones CW,
et al: The management of upper gas
tion should be continued up to
trointestinal hemorrhage: a multi1,000,000 K.I.U. per day until the
parametric computer analysis. Ann
hemorrhage has been arrested.
Surg 179: 489, 1973
2. C avett CM, Selby JH, H amilton JL, 22. H umeau F, F ourre D, R oquais P,
Pancreatitis
et al: L’embolisation arterielle dans
et al: Arteriovenous malformation in
Initial dosage: 100,000 — 200,000
le
traitement
des
tumeurs
neoplasiques.
chronic gastrointestinal bleeding. Ann
K.I.U. to be followed by 100,000
Nouv Presse Med 4: 1709, 1975
Surg 185: 116, 1977
3. H ellers G, Ihre T: Impact of change 23. G oldstein HM, M edellin H, Ben - K.I.U. every six hours for a period
M enachem Y, et al: Transcatheter of 4-5 days. The drug is adminis
to early diagnosis and surgery in major
arterial embolization in management tered either by intravenous injec
upper gastrointestinal bleeding. Lancet
of bleeding in the cancer patient. Ra
2: 1250, 1975
tion (at a rate not to exceed 5 ml
diology 115: 603, 1975
4. Sugawa C, Werner MH, H ayes DF,
per minute) or by slow infusion.
et al: Early endoscopy. A guide to 24. G oldberger LE, Bookstein JJ:
Transcatheter embolization for treat Warnings and Precautions
therapy for acute hemorrhage in the
ment of diverticular hemorrhage. Ra
upper gastrointestinal tract. Arch Surg
Trasylol is a polypeptide and thus
diology 122: 613, 1977
107: 133, 1973
may act as an antigen. Although
25.
A
dams
JT
:
Therapeutic
barium
enema
5. P a p p JP: Endoscopic electrocoagula
for massive diverticular bleeding. Arch adverse reactions due to hyper
tion of upper gastrointestinal hemor
Surg 101: 457, 1970
sensitivity have been described
rhage. JAMA 236: 2076, 1976
6. N usbaum M, Baum S: Radiographic
in fre q u e n tly , this p o s s ib ility
demonstration of unknown sites of BO O KS REC EIVED
should
always be kept in mind.
gastrointestinal bleeding. Surg Forum
In patients with a history of hyper
continued from page 135
14: 374, 163
7. Stanley RJ, Wise L: Arteriography Shaw’s Textbook of Operative Gynaeco sensitivity, the usual precautions
in diagnosis of acute gastrointestinal
logy. 4th ed. Revised by John Howkins for the prevention and arrest of
bleeding. Arch Surg 107: 138, 1973
and Christopher N. Hudson. 547 pp. a lle rg ic reactions should be
8. A thanasoulis CA, W altman AC,
Illust. Churchill Livingstone, Edinburgh; observed prior to the administra
I mbembo AL, et al: Control of hem
Longman Canada Limited, Don Mills,
tion of Trasylol.
orrhagic gastritis by intraarterial in
1977. $98. ISBN 0-443-01394-2.
fusion of vasopressin (abstr). Gastro
Availability
Spinal Disorders. Diagnosis and Treatment. Trasylol (aprotinin) is available in
enterology 64: 693, 1973
9. Baum S, A thanasoulis CA, Walt
Edited by Daniel Ruge and Leon L.
man AC, et al: Gastrointestinal hem
Wiltse. 444 pp. Illust. Lea & Febiger, 10 ml ampuls containing 100,000
orrhage. II. Angiographic diagnosis
Philadelphia; The Macmillan Company K.I.U. in boxes of 5 ampuls.
and control. Adv Surg 7: 149, 1973
of Canada Limited, Toronto, 1977. Trasylol® Product Monograph is
10. M ackenzie RL, Bury KD, P rovan
$49.95. ISBN 0-8121-0452-8.
available on request.
JL, et al: The failure of intra-arterial

pitressin infusion to control upper gas
trointestinal bleeding in cirrhotic pa
tients. J Surg Res 20: 505, 1976
11. G old RE, G race DM: Gelfoam em
bolization of the left gastric artery for
bleeding ulcer: experimental consider
ations. Radiology 116: 575, 1975
12. R osch J, D otter CT, Brown MJ:
Selective arterial embolization. A new
method for control of acute gastro
intestinal bleeding. Radiology 102:
303, 1972
13. G race DM, Pitt DF, G old RE: Vas
cular embolization and occlusion by
174

Surgery of the Stomach and Duodenum.

3rd ed. Edited by Lloyd M. Nyhus and
Christopher Wastell. 788 pp. Illust. Lit
tle, Brown and Company (Inc.), Boston,
1977. Price not stated. ISBN 0-31660536-0.

Transactions of the American Association
of Genito-Urinary Surgeons. Volume

LXVIII, 1976. 137 pp. Illust. American
Association of Genito-Urinary Surgeons,
Baltimore; Burns & MacEachern Lim
ited, Don Mills, 1977. $17.25.
continued on page 184

VOLUME 21, NO. 2, MARCH 1978

/

The object of

Trasylol:
Control of proteolytic enzymes.
FBA Pharmaceuticals Ltd.

Distributed by:
Boehringer Ingelheim (Canada) Ltd.
2121 Trans Canada Highway, Dorval, P.Q. H9P 1J3

PAAB
CCPP

FBA-94-77

THE CANADIAN JOURNAL OF SURGERY

ORIGINAL CONTRIBUTIONS

Review of Function in Bilateral Lower Limb Amputees*
G ordon A. H unter ,

A review of the results of bilateral
lower limb amputation in 53 individuals
indicates that the physician can now
be more optimistic when considering
the use of prostheses and the value
of rehabilitation in patients with bi
lateral amputation. Many patients
continue to use a prosthesis after the
second amputation, irrespective of
the site of the first. Associated disease
and lack of motivation delay successful
rehabilitation. About half of the
amputees used a wheelchair as a prin
cipal aid to mobility. A number of
patients found that amputation of the
second limb necessitated a change of
accommodation, reduced their degree
of independence and decreased their
social activities. Individuals with
bilateral lower limb amputation prefer
to retain the knee joint, even if they
already have unilateral above-knee
amputation.
line revue des resultats de I’amputation
bilaterale des membres inferieurs
chez 53 sujets, indique que le medecin
peut maintenant etre plus optimiste
lorsqu’il considere ('utilisation de
protheses et la valeur de la readaptation
chez les patients qui doivent subir
une amputation bilaterale. Plusieurs
patients poursuivent I'emploi d’une
prothese apres la seconde amputation,
independamment du niveau de la pre
miere. Les maladies associees et le
manque de motivation retardent la
reussite de la readaptation. Environ la
moitie des amputes utilise une chaise
roulante comme principal moyen de
locomotion. Un nombre de patients ont
trouve que I'amputation du second

*From the Amputee Research Centre,
Toronto, Ont.
Funded by the Ontario March of Dimes
t Amputee unit, University of Toronto,
West Park Hospital, Toronto, Ont.
Reprint requests to: Dr. G.A. Hunter,
Am putee Research Centre, West Park
Hospital, 82 Buttonwood Ave., Toronto,
Ont. M 6M 2J5
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membre avait necessity un changement
d'installation, avait reduit le degre
de I’independance et diminue leurs
activites sociales. Les amputes des
deux membres inferieurs preferent
conserver I'articulation du genou,
meme si I’amputation du premier
membre a ete faite au dessus du genou.

Peripheral vascular disease is the most
common reason for amputation of a
lower limb,1'3 and the loss of both limbs
is not uncommon.4'6 The best site for
amputation of the second limb is con
troversial.
In the geriatric patient who has to
undergo amputation of the second limb,
preservation of the knee joint is im
portant.3,7,8 Many authors9'14 support
the view that length should be preserved
in amputation of the second limb, re
gardless of the level of the first amputa
tion and the success of prosthetic re
habilitation. However, Murdoch15 and
others16’17 believe that if rehabilitation
with a prosthesis is unsuccessful in a
person with amputation of one limb,
then amputation of the second limb at
a lower level is a disservice to the pa
tient. Clarke-Williams17 believes that it
is easier for the patients to maintain
balance on prostheses and to walk if
both amputations are at the same level.
The patient with above-knee amputa
tions can be fitted with short nonarticulated pylons, which can be gradually
elongated. In the opinion of Vitali and
Harris16 the asymmetrical rhythm pro
duced by training at two different
levels often results in failure of rehabili
tation.
In view of this conflict of opinion,
we decided to assess the functional re
sults of bilateral amputations performed
in the Toronto area.
Questionnaire

A comprehensive questionnaire was
compiled to acquire information regard
ing function in the area of accommoda
tion, mobility, self-care, independence
(ability to use stairs, public transporta
tion and to go outside alone), occupa
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tion, hobbies and self-evaluation of
disability (none, mild, moderate, severe)
during each stage of the amputation
process. Persons with one above-knee
amputation and one below-knee am
putation were asked to state the ad
vantages or disadvantages in having
two different leg lengths. The results
were compared to determine function
in the various combinations of amputa
tion levels. The questionnaire was ad
ministered by one interviewer. When
the patient was out of town, contact
was made by mail with a detailed cov
ering letter.
Individuals with major amputation
of both legs for any cause were con
sidered for the study. If any person
was unable to comprehend or answer
the questionnaire, or if sufficient in
formation was not available from files,
family, or closely associated persons,
the candidate was not included in the
survey. Sufficient information was re
ceived on, one deceased amputee to
permit his inclusion in the study.
Clinical Material

Patients were drawn from amputa
tion clinics in three Toronto hospitals.
Sufficient information for their inclu
sion in the study was obtained on 53 of
them. The cause and level of the ampu
tations are outlined in Table I. Of the
53 patients, 46 (87%) were male.
Twenty-three were diabetic. In patients
with peripheral vascular disease the
average age was 62 years at the time of
the first amputation and 63 years at
second amputation. The time between
amputations varied from 0 to 85
months. In patients undergoing simul
taneous bilateral amputation for trauma,
the average age at amputation was 42
years. In three patients whose legs
were amputated because of frostbite,
the average age was 37 years.
Results

Follow-up ranged from 6 months to
32 years. Prescription of prostheses and
their use at follow-up in each bilateral
group is outlined in Table II. Of the
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Table I— Level of Amputation and Etiology in 53 Patients
Level of amputation
Total

A K /A K

A K /B K

B K /B K

Mixed*

Arteriosclerosis (w ith or w ithout diabetes),
including Buerger’s disease
Trauma
Frostbite

9
1
—

13
1
—

17
3
1

3
3
2

42
8
3

Total

10

14

21

3

53

Cause

*2 bilateral Syme’s am putation, 3 Syme’s/B K , 1 Syme’s/A K , 1 bilateral through knee,
1 AK/through hip.
AK = above knee; BK = below knee.

Table I I — Prosthetic Use at Follow-up in 53 Patients w ith B ilateral Amputation
Level of amputation
A K /B K
B K /B K
A K /A K
(n = 10) (n = 14) (n = 21)
Patients w ith unilateral amputation who
used a prosthesis
Patients w ith bilateral amputation fitted
w ith prostheses
Continued use of prostheses at follow-up

Mixed
Total
(n = 8) (N = 53)

2

11

13

1

27

5
4

12
9

19
16

6
6

42
35

Table I l l - U s e of Prostheses. Hamilton and Nichols' C lassification* Applied to 53 Patients w ith
Bilateral Amputation
Level of amputation
A K /A K

Use

A K /B K

B K /B K

Nil
Wheelchair independence
Minim al usage
Reasonable usage
Good general use

—

6
1
1
2

5
6
1
2

1
4
2
1
13

Total

10

14

21

—

Mixed

Total

2
—
—
6

1
17
9
3
23

8

53

—

‘ Grading system: N il = the patient is practically or to tally dependent; w heelchair independence
= the patient uses w heelchair to perform self-care activities independently; minimal usage =
patient wears appliance only part of day or only occasionally for assistance in walking o u td o o rs prosthesis is not a substitute limb to increase total functional activities of patient; reasonable
usage = patient wears appliance in and around house either all day or part of most days; good
general use = p atient is able to w alk more than 91 m (100 yd) and wears prosthesis all or most of
day and regularly outdoors.

Table IV — Principal M obility Aid for 53 Patients w ith B ilateral Amputation
Level of amputation
Principal aid

A K /A K

A K /B K

No aids
1 or 2 canes
C rutches/w alkerette
W heelchair

—

2
1
7

1
2
11

Total

10

14

—

B K /B K

Mixed

Total

1
13

4
2

7

2

5
18
3
27

21

8

53

—

—

Table V— Independence by Level of Amputation in 53 B ilateral Cases a t Follow-up

entire group 42 patients were fitted
with either one or two prostheses, and
a high percentage in each group con
tinued to use the prosthesis at the time
of follow-up.
We applied the classification system
of Hamilton and Nichols to the am
putees in this series (Table III). Our
results show that 35 of 53 patients con
tinued to make some use of their
prostheses.
A change in the type of living accom
modation was necessary for 12 of 53
patients.
With respect to mobility (Table IV),
27 patients used a wheelchair as the
primary means.
The greatest decrease in self-care
activities, which included dressing,
feeding, washing, shaving, transfers,
toilet use and bathing, occurred in sub
jects with bilateral above-knee amputa
tion.
With regard to the independence
category, Table V shows the functional
achievement at each level of amputa
tion.
Occupational status was unchanged
in 50% of patients with bilateral above
knee amputation, in 20% of those with
one above-knee and one below-knee
amputation, in 52% with bilateral below-knee amputation and in 38% of
the patients with “mixed” amputations.
All groups reported a decrease in
participation in hobbies and pream
putation social activities.
Five patients assessed themselves as
having no disability; of these four had
bilateral below-knee amputation. Six
patients reported a mild degree of dis
ability. Thirteen patients assessed them
selves as having a moderate disability
and 22 believed that they were severely
disabled. Seven patients did not respond
to this question.
Only four patients made negative
comments about different lengths of
amputation. One thought the belowknee amputation was a nuisance when
the prosthesis was not worn and an
other found it difficult to balance with
uneven leg lengths. The other two
negative comments were related to the
fact that healing was delayed in the
below-knee amputation and, as a result,
the rehabilitation program was delayed.
The remaining 10 patients did not
find the extra length a hindrance; all
would have preferred bilateral belowknee amputations because of the ease
in walking with a below-knee pros
thesis.

Level of amputation
Degree
of independence

6
7
3

Unable to use public transportation
Unable to use stairs
Unable to go outside alone or w ith help
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B K /B K
Mixed
A K /A K
A K /B K
(n = 10) (n = 14) (n = 21) (n = 8)

/

8
7
1

11
6
2

3
2
1

Total
(N = 53)
28
22
7

The ability to use one prosthesis be
fore the second leg is amputated is
considered by some5,9,18 to be crucial to
successful prosthetic rehabilitation. In
our series, two of the five patients with
bilateral above-knee amputation were
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fitted with a prosthesis prior to the
second amputation; at follow-up four of
this group of five who were fitted with
two prostheses were still using the ap
pliances. In the other groups (Table II)
the majority of patients with bilateral
lower-limb amputation were fitted with
prostheses, and a high percentage of
these patients continued to use pros
theses at follow-up.
Some authors6'9,12 are pessimistic
about rehabilitation with prostheses in
those with bilateral above-knee am puta
tion. O ur results showed that 4 of 10
patients in this group were using their
prostheses at follow-up.
Prior to this survey we, like McCollough,9 believed that successful rehabili
tation with prostheses was more likely if
the first amputation was above the knee
and the patient learned to walk before
losing the second leg. In our series, 8
of 14 patients who had one above-knee
and one below-knee amputation had
the above-knee amputation before the
below-knee procedure. Of these, seven
used a prosthesis after the first opera
tion and five were still using prostheses
at follow-up. In five persons the belowknee preceded the above-knee proce
dure. F o u r of these used a prosthesis
after the first procedure and three of
them were still using prostheses
at the tim e of follow-up. These results
indicate that there is little difference
in prosthetic rehabilitation in these two
groups.
Individuals with bilateral below-knee
am putation and those with mixed levels
of lower-extremity amputation have
been given a favourable prognosis for
successful rehabilitation using pros
theses.9'12 These views are supported by
our findings (Table II). We agree with
Van de V en19 that the terms “prosthetic
use” and “prosthetic wear” require
further definition. Evaluation scales for
the degree of prosthetic rehabilitation
have been outlined by several au
thors,20-23 and we used the 1972 classi
fication of Hamilton and Nichols.
Conclusion
The results of our study indicate that
about half of the amputees use a wheel
chair as the principal mobility aid. At
follow-up two thirds of those with bila
teral amputation who were fitted with
prostheses continued to use the pros
theses to some extent. The outcome of
bilateral amputation does not seem to
be influenced by the site of the initial
am putation and, from the subjective in
quiries, amputees prefer to retain their
knee joint even if they have already
had one above-knee amputation. Suit
able accommodation and social support
play an important part in the success
or failure of prosthetic rehabilitation
and the final degree of independence.19,24
178
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Aneurysmal Bone Cyst of the Vertebra
with Paraplegia*
M ichael A. R o sm a n , m d , fr c s [ c ]

Aneurysmal bone cyst, a benign lesion,
is difficult to diagnose radiologicaily,
particularly in the spine, but has a
characteristic microscopic appearance.
Treatment of spinal lesions consists of
curettage, with or without bone grafting,
together with irradiation at low doses
(1000 to 2000 rads). The author reports
a case of aneurysmal bone cyst of the
neural arch associated with neurologic
complication, which illustrates some
typical features of such cysts of the
spine. The condition should always
be considered in patients with lytic
lesions of the spine, and prompt
surgical intervention is recommended.
La dysplasie fibreuse des os de la
colonne vertebrale, une lesion benigne
chez I’enfant, est difficile a diagnostiquer
a la radiologie, mais elle presente un
aspect microscopique caracteristique.
Le traitement tient dans le curettage,
avec ou sans greffe osseuse, associe
a une irradiation a faible dose (1000 a
2000 rads). L'auteur decrit un cas de
dysplasie fibreuse de I'os de I'arc neural,
associee a des complications neurologiques, qui illustre les caracteristiques
typiques de ces kystes de la colonne
vertebrale. On devrait toujours
considerer cette affection chez les
patients souffrant de lesions lytiques
de la colonne vertebrale, et une
intervention chirurgicale rapide est
recommandee.

Aneurysmal bone cyst, a benign lesion
of young patients, was first described
by Jaffe and Lichtenstein.1 It may occur
in almost any part of the skeleton but
is most frequently seen in long tubular
bones. The second most common site
is the vertebrae, where the lesion has a
particular predilection for the neural
arch,2-6 but it may occur in the vertebral
body4,6,7 and involvement of an adjacent
vertebra is not uncommon.5,8 The

*From the department of orthopedic
surgery, Montreal Children’s Hospital,
Montreal, PQ
Reprint requests to: Dr. Michael A.
Rosman, department of orthopedic
surgery, Montreal Children’s Hospital,
2300 Tupper St., Montreal, PQ H3H 1P3
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destructive lytic process destroys a ver
tebral segment and there may be even
tual intraspinal extension with extra
dural compression of the cord. The pa
tient may suffer from pain, muscle
spasm, limitation of motion, radiculitis,
paraparesis and paraplegia.4
The radiologic appearance of aneu
rysmal bone cyst of the spine is fre
quently not diagnostic5,7 and it may be
difficult to demonstrate the bony shell
that is so characteristic of eccentric cysts
in long bones. The osteolytic process
may be attributed initially to primary
or metastatic tumour when a vertebral
body is involved, since an aneurysmal
cyst is expected to be found more fre
quently in the neural arch or the trans
verse process. When a spinous process
is the site, it is often greatly expanded
and ballooned; this finding is more
typical of the lesion in the long bones.
The diagnosis of aneurysmal bone cyst
therefore must be considered in all pa
tients with lytic lesions of the vertebral
column.
The pathologic findings9 associated
with aneurysmal cyst are characteristic.
The bony expansion is surrounded by a
thin shell of subperiosteal new bone and
consists of a honeycombed mass whose
spaces are filled with blood. Micro
scopically there are blood-filled cavern
ous spaces without an endothelial lin
ing, elastic lamina or muscle layer. The
walls consist of fibrous tissue and con
tain osteoid and multinucleated giant
cells. The latter have been responsible
on occasion for the diagnosis of giant
cell tumour. Giant cell tumours are rare
in the vertebral column and are most
frequently found in persons over 20
years of age.
The case described below illustrates
some of the typical clinical features of
aneurysmal cyst of the spine. The neu
rologic findings are of special interest.

diagnosis of aneurysmal bone cyst was
established.
The patient was transferred to the
Montreal Children’s Hospital on the third
postoperative day for further management.
The physical findings on examination on
her arrival were normal. Roentgenograms
of the dorsal spine (Fig. 1) showed the
presence of a lytic erosion of the lamina
of T-6, some collapse of the vertebral
body laterally and absence of the trans
verse process and pedicle on the right
side. Tomograms (Fig. 2) revealed similar
findings as well as a soft-tissue swelling
on the left. The patient’s condition was
stable on bed rest and the attending sur
geon decided to provide her with additional
support by means of a Milwaukee brace
and to delay further specific investigations
and treatment.
On the 19th postoperative day, the pa
tient became incontinent, progressive para
paresis developed and she rapidly became
completely paraplegic. Myelography (Fig.
3) carried out as an emergency procedure
disclosed a complete block at the T6-7
interspace. Laminectomy was performed
without delay. At operation destruction of

Case Report

A 7-year-old girl complained of mid
dorsal back pain of 2 months’ duration.
Physical examination revealed no abnor
mality. Roentgenograms of the spine
showed a lytic defect in the T-6 vertebral
arch. During biopsy of the lesion bleeding
was so profuse that the orthopedic surgeon
was obliged to close the wound without
definitive treatment. However, a histologic

FIG. 1— Initial dorsal spine roentgeno
gram showing lytic destruction of T-6
lamina, collapse laterally and destruction
of transverse processes and pedicles (ar
rows).
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the posterior arch of T-6 and half that of
T-5, as well as of the transverse pro
cesses, was discovered. Tumour and granu
lation tissue, reddish-purple in colour, was
compressing the cord forward extradurally; this was removed. Lateral fusion was

performed with addition of a Harrington
rod. The patient gradually recovered mus
cular strength over the following 3 weeks.
Only ankle dorsiflexion was not restored
and this was treated with braces.
Two weeks postoperatively radiation
therapy was commenced to a dose of up
to 2000 rads. One month after opera
tion she was placed in a body cast and
kept flat in bed for an additional 2
months. The cast was then changed and
weight bearing begun. The patient was
still unable to dorsiflex the ankles. A
Milwaukee brace was applied 6 months
after operation. The patient was examined

1 year after operation and roentgenograms
were obtained (Fig. 4). Clinical assessment
of the fusion was difficult and therefore
16 months after the original surgery the
operative site was re-explored. The fusion
was found to be solid, so the Harrington
rod was removed.
More than 2 years after the first ex
amination the patient was found to be
neurologically fully recovered. The most
recent roentgenogram (Fig. 5) showed
regeneration of the pedicle and transverse
process. There was no evidence of recur
rence of the tumour.
Discussion

The etiology of aneurysmal cyst is
unknown but many explanations have
been put forward. Jaffe and Lichten
stein1 suggested that hemorrhage into a
pre-existing lesion was the initiating
factor. Lichtenstein9 believed that the
cyst was the result of an abnormal vas
cular disturbance associated with in
creased venous pressure. Others have
suggested that the condition results from
organization within a subperiosteal
hematoma,10 that it is a variant of a
giant cell tumour,1' or an angiomatous
malformation.9 Preoperatively and his
FIG. 2— Anteroposterior projection to
tologically this tumour is most likely to
mogram showing pedicle destruction (large
arrow) with soft-tissue swelling (small ar
be confused with eosinophilic granuloma
row).
or giant cell tumour.
The management of the aneurysmal
bone cyst is simple curettage,2’4'5'12 with
or without bone grafting. Recovery may
occur spontaneously or after only par
tial removal.2-3-12 Surgical treatment of
cysts of the vertebral column can be
more difficult particularly if the lesion
FIG. 4— One year after operation show
is located in the body or transverse pro
ing rod in place. Assessment of fusion is
cess of a vertebra.4-5-7 In the case de
not possible. D ye in canal passes freely
by site of previous block.
scribed, the cyst was located in the
lamina and pedicle of the vertebra so
that it was accessible surgically; the
presence of hemorrhage and proximity
of neural tissue, however, limited the
extent of the curettage. It was not pos
sible to fill the cyst cavity with graft
material and, after the laminectomy
and excision of the visible cyst, only a
lateral fusion was possible to achieve
stability. The Harrington distraction
rod was used to stabilize the spine
further. It was not possible to use a
compression system because the trans
verse processes were involved by tu
mour.
Radiation therapy as a modality of
treatment was used long before the
natural history of aneurysmal cysts had
been clarified. Recurrence rates follow
ing irradiation are low. When used in
conjunction with partial surgical re
moval, relatively low doses in the order
of 1000 to 2000 rads are recom
mended.5 These low doses appear to
have a beneficial effect.
When an aneurysmal cyst involves
FIG. 3— Myelogram shows complete
the spine, prompt surgical intervention
FIG. 5— Two years after operation
block at T6-7 interspace. Needle is ex pedicles (arrows) have regenerated. There
is advisable. As in this patient, com
ternal marker over T-6.
is no evidence of recurrence of tumour.
plete blockage of the spinal canal may
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bone cysts. Review o f twelve cases. J
Bone Joint Surg [Br] 50: 116, 1968
4. M acC arty CS, D ahlin DC, D oyle
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agement of aneurysmal bone cyst of
the vertebral column. J Bone Joint
Surg [Am] 49: 1597, 1967
6. Slowick FA j r , C ampbell CJ, K et telkamp DB: Aneurysmal bone cyst.
A n analysis o f thirteen cases. J Bone
Joint Surg [Am] 50: 1142, 1968
7. V erbiest H : Giant-cell tumours and
aneurysmal bone cysts of the spine.

occur suddenly and therefore when
the cyst is first diagnosed urgent myelography and prompt decompression are
indicated. In retrospect, this patient
should have had an elective myelogram
despite her normal neurologic status
as soon as her physicians made the
diagnosis and saw the extensive involve
ment o f the pedicle and lamina on the
roentgenograms. The development of
paraplegia, whether due to postbiopsy
hemorrhage, spontaneous hemorrhage
or further tumour growth, was pre
dictable.
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Critique of Item 600 (SESAP II)
The cause o f Raynaud’s phenomenon is not clear. The entity is characterized by
recurrent episodes o f vasospasm in the upper extremities precipitated by em o «™
stress or exposure to cold. It is often a secondary manifestation o f a m °re serious
systemic or vascular disease, or o f both, which may not becom e apparent f " “
years. The phenomenon is usually secondary to one o f the follow ing. 1) Buerge
disease- 2) collagen diseases, especially scleroderma; 3) cervical rib associated with
thoracic outlet obstruction, or 4) atherosclerosis. Therefore, all answers are correct.
Major attention should be given to the underlying disease. Since the
tions o f Raynaud’s phenom enon are thought to be secondary to sympathetic
hyperactivity, sympathectomy may be useful.

Reference

4 1 8 /1 . Spencer FC, Imparato A M : Peripheral arterial disease, in Schwartz SI (ed):
Principles^ o f Surgery, ed 2, New York, McGraw-Hill B ook C o. 1974, pp 901-903

DAVIS & GECK SURGICAL ESSAY AWARD FOR RESIDENTS
Davis & Geek annually awards $1000.00 to the surgical
resident submitting the best paper on a surgical topic to the
Canadian Journal of Surgery. This award is intended to pro
mote scientific and literary excellence among Canadian sur
geons in training.
The conditions o f entry for the 1978 award are the fo l
low ing:—
1. Candidates shall be currently engaged in a recognized
surgical residency program leading to eligibility tor the
Fellowship of the Royal College o f Physicians and Sur
geons o f Canada in one o f the surgical specialties (cardio
vascular and thoracic surgery, general surgery, neuro
surgery, obstetrics and gynecology, ophthalmology, oto
laryngology, orthopedic surgery, plastic surgery and
urology).
2. The material to be submitted shall be in the form o f a
manuscript relating to work in which a surgical resident
is or has been the prime or major investigator. Prior
oral presentation at a Royal College meeting or a surgical
forum meeting will not be a disqualification, but prior
publication as a formal paper in a journal will, lh e
paper should relate to any field o f surgical interest. The
manuscript must conform to the style requirements of
the Journal and must not exceed 3000 words o f text
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and six tables a n d /o r six figures. Coauthors are permitted
on the understanding that the candidate shall be the
first author and that only the first author shall be eligible
3 Entries must be received in the office o f the Journal no
' later than June 30, 1978. Each entry must be submitted
to the editorial office o f the Canadian Journal o f Sur
gery, PO Box 8650, Ottawa, Ont. K 1G 0G8, with a letter
stating that the paper is being submitted as an entry tor
the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property o f the Cana
dian Journal o f Surgery unless returned to the author
without publication.
.
.
All papers submitted will be judged by an independent
committee comprising at least one member o f foe editoria
board of the Journal, one fellow o f the Royal College o f
Physicians and Surgeons o f Canada, and one representati
o f The Canadian M edical Association, together with other
fellows invited to serve at the discretion o f the three perma
nent members o f the committee. For the purpose o f judging,
the candidates will be anonymous. The judges decision shall
The name o f the successful candidate and the title o f the
paper will be announced in the November 1978 issue o f the
Journal.
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Orthopedic Days 1978

intensive care unit; (d) total parenteral
nutrition—practical aspects; (e) arterial
blood-gas analysis and acid-base prob
lems in the critically ill; and (f) blood
component therapy in the critically ill.
Time will allow attendance at two of
these workshops.
The guest faculty will be: K. Chatterjee, professor of medicine, associate
chief, cardiovascular division and di
rector, CCU, University of California
at San Francisco; M.B. Goldstein, as
sociate professor, University of Toron
to; A. Grenvik, professor of anesthe
siology, director, critical care medicine,
University of Pittsburgh; K.N. Jeejeebhoy, professor, department of medi
cine, University of Toronto and head,
gastroenterology, Toronto
General
Hospital; Bryan W. Kirk, director, in
tensive care unit, health sciences cen
tre, and associate, professor of medi
cine, University of Manitoba, Winnipeg;
and Arthur Scott, professor and chair
man, department of anesthesia, Uni
versity of Toronto and director, in
tensive care unit, Toronto General
Gallstones
Hospital.
“Gallstones” is the title of the Fourth
Codirectors of the symposium are
International Symposium of the Cana E. Garner King, associate professor,
dian Foundation for Diseases of the University of Alberta and A. Aberman,
Liver (formerly the Canadian Hepatic associate professor of medicine, Uni
Foundation), to be held at the Ritz versity of Toronto.
Carlton Hotel, Montreal, May 12 and
Registration for the symposium is
13, 1978. Pre-registration is requested. limited; early application is advised.
Contact the Canadian Foundation for Fees are as follows: members and fel
Diseases of the Liver, Ste. 510, 42 lows, American College of Physicians
Charles St. E, Toronto, Ont. M4Y 1T4. or Royal College of Physicians and Sur
geons of Canada, $130; nonmembers,
$195; residents and associates, $65.
Critical Care
Further information may be ob
The first biennial critical care tained from the division of continuing
symposium, entitled “Critical Care medical education, 12-103 Clinical
Medicine, 1978—A Pot Pourri”, will Sciences Building, University of Al
take place June 15 to 17, 1978 at the berta, Edmonton, Alta. T6G 2G3.
Banff Springs Hotel, Banff, Alberta.
It is sponsored by the American Col BOOKS RECEIVED
lege of Physicians, the Royal College
continued from page 174
of Physicians and Surgeons of Canada,
Das
Typische Rontgenbild des Skeletts.
the department, of medicine, division
Standardbefunde und Varietaten vom
of continuing medical education, fa
Erwachsenen und Kind fur Arzte, Stuculty of medicine, University of Al
denten und Radiologie-Assistenten. Ru
berta, Council of the College of Physi
dolf Birkner. 566 pp. Illust. Urban &
cians & Surgeons of Alberta, Eli Lilly
Schwarzenberg, Munich, 1977. Price not
stated. ISBN 3-541-07811-1.
& Company (Canada) Limited and the
Upjohn Company of Canada.
Urinary System Malformations in ChilThe symposium is intended to pro
dren. Proceedings of the International
Pediatric Urological Seminar, Philadel
vide the physician, surgeon, anesthetist,
phia, 1976. The National Foundation pediatrician, or general practitioner
March of Dimes. Birth Defects: Original
actively involved in care of critically
Articles Series, Volume XIII, Number
ill patients, with an up-to-date survey
5, 1977. Edited by Daniel Bergsma and
John W. Duckett. 481 pp. Illust. Alan
of acute care medicine.
R. Liss, Inc., New York, 1977. $50.
The following limited attendance
ISBN 0-8451-1014-4.
workshops will be held: (a) ventilators
— basic mechanisms, utilization, wean La Vagotoinie Supra-Selective. L.F. Hollender et A. Marrie. 144 pp. Illust. Mas
ing; (b) hemodynamic monitoring; (c)
son S.A., Paris, 1977. Price not stated,
newer antibiotics and their use in the
paperbound. ISBN 2-225-46805-2.
A course entitled “Neck and Shoulder
Pain” sponsored by the University of
British Columbia’s division of continu
ing education will be offered Apr. 27
and 28, 1978 at the G.F. Strong Re
habilitation Centre, 4255 Laurel St.,
Vancouver.
Guest faculty will be: R.L. Cruess,
chairman, division of orthopedic sur
gery, McGill University and orthopedic
surgeon-in-charge, Royal Victoria Hos
pital, Montreal; J.W. Fielding, clinical
professor of orthopedic surgery, Colum
bia University College of Physicians
and Surgeons and director o>f ortho
pedic surgery, St. Luke’s Hospital, New
York; and R. Romano, clinical pro
fessor of orthopedics, University of
Washington, Seattle.
For further information contact the
division of continuing education, In
structional Resources Centre, The Uni
versity of British Columbia, Vancou
ver, BC V6T 1W5.
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